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Abstract
This thesis describes the development, characterisation and application of a portable spec-
troscopy system for ultra-sensitive, real-time detection of breath ethane. In healthcare,
breath ethane is a widely accepted marker of free radical-induced cell damage and may be
used to indicate changes in oxidative stress.
The aim was to deliver a compact instrument capable of long-term, on-site use in a clinical
environment, while also retaining the high performance previously achieved by lab-based
systems at the University of Glasgow. The newly developed instrument has a sensitivity of
70 parts per trillion with a 1Hz sampling rate. The system incorporates a cryogenically-
cooled lead-salt laser and uses a second derivative wavelength modulation detection scheme.
A thermally-managed closed-loop refrigeration system has eliminated the need for liquid
coolants.
The instrument has been ﬁeld-tested to ensure target performance is sustained in a range of
environments, both indoor and outdoor. It has since been used in a number of pilot clinical
studies, both oﬀ-site and on-site, in which breath ethane was monitored as a marker of
oxidative stress. The three main clinical areas investigated were dialysis, radiotherapy and
intensive care. In the intensive care study, the instrument was modiﬁed to enable automatic
breath sampling of inspired and expired gases of ventilated patients. This technique proved
highly successful and the instrument then remained at the Southern General hospital, where
it continued to be used as part of a wider study into breath ethane in intensive care patients.
The use of the new spectroscopy system has enabled ultra-sensitive, rapid analysis of a
ii
large number of breath samples. The use of the new instrument, in particular for continual
breath monitoring, has enabled the detection of short-lived ﬂuctuations in breath ethane,
yielding some interesting ﬁndings in a number of pilot clinical studies. Our results suggest
that breath ethane may be used as an indicator of dynamic changes in oxidative stress.
Further studies will be required to determine if such monitoring is of clinical beneﬁt.
Chapter 1 gives a general introduction to spectroscopy and some background to our project.
A number of spectroscopic techniques and laser sources are discussed, along with a review
of previous work in ethane detection. In chapter 2 some background theory of molecular
spectroscopy is given, with a more detailed discussion of the wavelength modulation tech-
nique. Chapter 3 describes in detail the development of the portable spectroscopy system.
The achieved performance and factors contributing to this performance are discussed in
chapter 4. The ﬁeld test of the instrument is reported on in chapter 5. In chapter 6 the
application of the technology to breath analysis and the current challenges in this ﬁeld are
discussed. Example breath ethane measurements for healthy controls are provided. The
clinical pilot studies conducted using the new system in areas of dialysis, intensive care
and radiotherapy are discussed in chapters 7, 8, and 9 respectively. Chapter 10 contains
the thesis summary and conclusions, with suggestions for future work.
iii
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Preface
During my PhD I was supervised by Dr Ken Skeldon and Prof Miles Padgett. I devel-
oped the portable instrument mainly under the supervision of Ken, who had previously
developed the lab-based system in the Glasgow Optics group. I designed and set-up the
more compact optical conﬁguration. I modiﬁed the software previously controlling the
lab-based instrument for use with the portable instrument and integrated all hardware
and software components. Later I further modiﬁed the software for use with the auto-
matic sampling system along with other instrument adjustments. Ken assisted me with
the development of the electronics, the incorporation of the instrument components into
the ﬂight-case housing and the resolution of thermal management issues. Upon instrument
completion I characterised the performance and determined the contributing noise factors.
The Appleton outdoor ﬁeld-trial was a team eﬀort overall with Ken, Graham Gibson and
I working on the instrument operation in the ﬁeld.
I played a key role in the three main clinical studies. In the dialysis study I developed
and subsequently modiﬁed the breath sampling protocol. I collected and measured a large
number of patient breath samples, analysed the data and liaised with the clinicians. I
worked closely with Lesley McMillan, who also collected and measured a large number of the
breath samples and performed the statistical analysis of the data. In the radiotherapy trial
I developed the electronic sampling rig. Lesley and I designed and constructed the other
sampling apparatus such as the mask assembly. Together we collected the breath samples
from radiotherapy patients at Ninewells hospital, Dundee and subsequently analysed them
in the lab.
xiii
During the intensive care study I spent a large proportion of my time working in the
Southern General hospital with the instrument based on-site. I manually collected and
measured the majority of the breath ethane samples obtained from a number of ventilated
patients. Recording of other clinical parameters was enabled by the clinical and medical
physicists at the Southern General hospital. I modiﬁed the instrument to enable automated
gas sampling from the ventilator. In addition to instrument use during the trial I also
worked to maintain instrument performance and resolve any problems that arose before
and during the trial. Ken assisted with problems encountered with laser cooling while the
instrument was based on-site. These were eventually resolved by the replacement of the
compressor used in the cooling system. During all periods of automated breath collection
at the patient bedside I remained in the hospital to monitor the instrument operation and
performance. Later, the intensity of breath sampling was increased and I worked closely
with Lesley to monitor breath ethane in patients regularly over periods of up to four
days. Ethical approval for all clinical studies was dealt with by Lesley or by our clinical
collaborators.
There were also a number of parallel strands to our project including investigations of
breath ethane analysis in areas such as exercise, zoology and other clinical conditions. I
was involved in collection and measurement of breath samples and maintenance of both
the previous lab-based instrument and the portable instrument throughout the course of
these studies.
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Chapter 1
Introduction to spectroscopy
This chapter gives a general introduction to laser spectroscopy. A number of laser sources
and spectroscopic techniques are described. An overview of previous work in ethane de-
tection is given along with some background to our project.
1.1 Spectroscopy
Spectroscopy is deﬁned as the measurement and interpretation of electromagnetic radi-
ation absorbed or emitted by molecules, atoms, or ions undergoing transitions between
allowed energy levels [1]. Spectroscopy has provided and continues to provide qualitative
and quantitative analysis of materials, ranging from the biochemical constituents of cells
[2] to the atmospheric composition of extra-solar planets [3]. The ﬁeld of spectroscopy
is rapidly expanding and many spectroscopic techniques are commonly applied across a
wide range of applications including medical imaging, environmental monitoring, security
and defence and energy research. Spectroscopy is both a subject of study, to further the
knowledge of fundamental science, and a practical tool throughout scientiﬁc, and in many
cases interdisciplinary, research [4].
1
CHAPTER 1. INTRODUCTION TO SPECTROSCOPY
Progress in the ﬁeld of spectroscopy rapidly gained momentum through the invention of the
laser. When Theodore Maiman built the ﬁrst laser in 1960 he described it as a ‘solution
seeking a problem’. Over the next few years, however, the potential use of lasers was
envisaged and a massive eﬀort was made to ﬁnd materials that showed lasing action [5].
Since then, the technology has undergone huge development and lasers have found their
place in the heart of applications such as sensing, communications, welding and medicine.
In addition to the numerous practical applications, lasers have also enabled the discoveries
of new phenomena and opened up new branches of physics.
In terms of spectroscopy, the application of lasers has been described as ‘an unprecedented
revolution’. Compared with other light sources, lasers oﬀer higher power, monochromatic-
ity and coherence. The unique properties of lasers have increased sensitivity and selectivity
of traditional spectroscopic techniques such as infrared (IR) absorption spectroscopy, over-
coming problems of lower source intensity and poor detector sensitivity. In addition to the
enhancement of previous spectroscopic techniques, lasers have enabled the development
and introduction of new spectroscopic methods, such as those based on the stimulated Ra-
man eﬀect [6], and techniques involving nonlinear processes such as multi-photon excitation
[7]. Spectroscopy has signiﬁcantly beneﬁted from the use of tunable diode lasers, ﬁrst de-
veloped in the mid-1960s. Tunable diode lasers, particularly the lead-salt diode, quickly
found broad use in high-resolution laser absorption spectroscopy [8]. Spectroscopy using
tunable laser diodes, often referred to as Tunable Diode Laser Absorption Spectroscopy
(TDLAS), is widely used as a technique for the detection of trace gases.
1.2 Gas detection
Gas detection is important in a wide variety of areas such as environmental and indus-
trial monitoring, agriculture, and medicine. In industry, monitoring of gas emissions is
important for safety and pollution control and, more recently, also as a control tool for
manufacturing processes [8]. Environmental applications include monitoring of greenhouse
gases or pollutants. Agricultural applications include the monitoring of food production
processes or storage conditions. For example, a number of volatile organic compounds are
emitted during fruit fermentation or meat degradation [9]. In medicine a growing area of
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research in gas detection is breath analysis, which is motivated by the prospect of non-
invasive clinical diagnosis, therapeutic management or monitoring of disease or conditions.
The ﬁeld of breath analysis has gained much momentum in recent years, due in part to the
relatively recent developments of real-time trace gas sensor technologies [10, 11, 12, 13].
There are a variety of gas sensing techniques including gas chromatography (GC), mass
spectrometry (MS) or combinations of the two (GC-MS), chemiluminescence, Fourier trans-
form infrared spectroscopy (FTIR) and electrochemical sensors [14]. Laser-based gas de-
tection systems can oﬀer analysis at high sensitivity and selectivity, and often in real-time.
Therefore they are commonly applied in applications where there is a need for rapid, speciﬁc
and precise measurements of trace gases. For example, fast, precise and highly sensitive
measurement of ammonia is required for process control both in the semiconductor industry
and air quality monitoring [15].
1.3 Spectroscopic trace gas detection
Absorption spectroscopy is a method of determining the concentration of a gas, or gases,
from the measured optical absorption spectrum (or fragment) of the gas mixture. Infrared
absorption spectra result from the absorption of electromagnetic radiation as molecules
undergo transitions between allowed electronic, vibrational and rotational states. Infrared
laser absorption spectroscopy is an extremely eﬀective tool for the detection and quantiﬁ-
cation of molecular trace gases, with a demonstrated sensitivity ranging from parts-per-
million (ppm 10−6) to parts-per-trillion (ppt 10−12) levels depending on the speciﬁc gas
species and the detection method employed [16].
1.3.1 Source requirements
For trace gas detection using infrared absorption spectroscopy it is vital that the infrared
source can be tuned to the precise wavelength corresponding to an absorption transition
of the target gas. The ideal source would oﬀer high power to achieve high signal-to-
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noise ratios, a narrow linewidth to enable selectivity and resolve absorption features and
single-mode operation to avoid contamination from other species. Other desirable features
are room temperature operation, high beam quality, ease of tunability to the required
wavelength, low but fast tuning rates, low amplitude modulation, compact package size,
and reliable long-term performance with minimal susceptibility to changing environmental
conditions [17].
The majority of gases have their fundamental absorption bands in the mid-IR spectral
region (∼ 2 − 25μm) [18]. However the usefulness of laser spectroscopy in this region
has been limited by the availability of convenient tunable laser sources [19]. The ﬁeld of
trace gas detection lacks the mid-IR equivalent of broadly tunable lasers such as dye lasers
for the visible region or Ti:Saph for the near-IR region [20]. Advances in technologies
include optical parametric oscillators, sources based on diﬀerence frequency generation,
tunable solid-state lasers and quantum cascade lasers [10]. Despite recent developments,
there still exists a distinct lack of choice with respect to commercially available, widely
and continuously tunable sources around 3.5μm. The use of a variety of mid-infrared laser
sources for sensitive, selective, and quantitative trace gas detection is discussed in a review
by Tittel et al [17].
Overtone molecular transitions generally correspond to frequencies in the near-IR region,
where widely tunable continuous-wave (cw) semiconductor lasers and detectors are more
readily available with room temperature operation. Common commercial diode lasers,
made from the III–V group of semiconductor materials, emit at red and near infrared
wavelengths from about 0.63μm − 1.55μm [8]. For example, near-infrared InP-based
lasers, which were primarily developed for optical telecommunication, are commonly used
in trace gas sensing. These technologically matured devices of high reliability emit in the
1.1 - 2.0μm range, where overtone absorption bands of many molecules are present [21].
However, overtone absorption coeﬃcients are typically a factor of ∼ 30 − 300 weaker than
those of the fundamental [19] so there is a balance to be struck when deciding on the laser
choice for a particular application.
Further development of gas sensors incorporating the new laser technologies combined with
a variety of spectroscopic techniques could enable remote sensing using portable, automated
devices without compromise to the high sensitivity, selectivity and speed already associated
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with many types of laser spectroscopy.
A brief description of several mid-IR sources follows:
1.3.2 Direct mid-IR laser sources
Lead-salt lasers
When lead-salt tunable diode lasers were ﬁrst developed at the MIT Lincoln Laboratory
in the mid-1960s they found immediate application as tunable sources for high resolution
laser absorption spectroscopy [8]. Available across the 3−30μm spectral range, these lasers
are based on IV-VI semiconductor materials, such as binary compounds like PbTe, PbSe,
and PbS or tertiary compounds like PbSnTe, PbSnSe and [22]. A simple lead-salt diode
laser consists of a single crystal of these semiconductor materials to form a p-n junction.
When a suﬃciently large forward bias current is applied, charge carriers (electrons or holes)
are injected across the p-n junction. Stimulated emission across the band gap between the
conduction and nearly full valence band provides the gain mechanism for lasing action. The
cleaved ends of the crystal act as mirrors to form the optical cavity [23]. A considerable
reduction in threshold current can be achieved through the use of a double heterostructure
(DH) laser, in which a thin layer of a semiconductor is sandwiched between layers of a
diﬀerent semiconductor [24]. A diagram of a DH laser is shown in ﬁgure 1.1.
The output lasing wavelength is determined by the energy band gap, which is dependent
upon semiconductor composition and crystal temperature. Any given device can be actively
tuned in wavelength over ∼ 100 cm−1 by changing the device temperature, or over tens
of cm−1 by changing the injection current [17]. As lead-salt lasers are generally compact,
oﬀer wide tuning and are commercially available in the mid-IR range, they are widely
used in spectroscopy. At present, lead-salt tunable diode lasers manufactured by Laser
Components (Olching, Germany) are suitable for cw operation around 3.5μm. However,
sensors based upon lead salt diode lasers are typically large in size as cryogenic cooling is
required [19]. The lasers are therefore thermally cycled many times over their lifetime. This
can result in permanent changes in lasing wavelength, tuning properties, modal structure
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Figure 1.1: Diagram of a double heterostructure lead-salt diode laser
and output power. Other disadvantages include low power output (typically < 1mW) and
poor beam quality [25].
Quantum cascade lasers
Recent advancements in quantum cascade (QC) lasers have led to an attractive mid-IR
source option for ultra-sensitive laser absorption spectroscopy [26].
QC lasers are semiconductor lasers based on intersubband transitions in a multiple-quantum-
well heterostructure, designed by means of band-structure engineering and grown by molec-
ular beam epitaxy [27]. The optical transitions in QC lasers occur between conduction band
sublevels (subbands), rather than between the conduction band and valence bands [28]. A
key advantage of this is that the wavelength of the emitted light is therefore dependent on
the properties of the quantum heterostructure, rather than the bandgap of the material
[25].
The design, fabrication and operation of the ﬁrst QC laser was described by Faist et al in
1994 [29]. QC lasers can now be fabricated to operate over a wide range of wavelengths
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from ∼ 3 − 24μm [30]. However, material systems that can provide reliable operation at
wavelengths shorter than 4μm are still under development. Recently, Revin et al reported
the realization of a InGaAs/AlAsSb/InP QC laser operating at wavelength range 3.05μm 
λ  3.6μm) [31]. Interband cascade (IC) lasers based on interband transitions have also
been reported in the 3− 5μm region [32].
QC and IC lasers could play an important role in future sensing applications as they of-
fer high power and narrow linewidths [30]. Most QC laser spectrometers currently use
distributed feedback (DFB) single-mode QC lasers, which can be operated at room tem-
perature in pulsed mode, but usually require operation at liquid nitrogen temperatures for
continuous output [25].
1.3.3 Mid-IR sources based on nonlinear frequency conversion
Diﬀerence frequency generation
Diﬀerence frequency generation provides a convenient means of generating mid-IR radi-
ation using available near-IR and visible robust laser sources [16]. A number of mid-IR
sources based on diﬀerence frequency generation (DFG) have been designed and used in
spectroscopy.
If two laser beams at frequencies ω2 and ω3 are incident on a second order nonlinear optical
crystal, a beam can be generated at the diﬀerence frequency ω1 = ω3−ω2. By convention,
the laser beam with the highest frequency ω3 is called the ‘pump’, the one with the lowest
frequency ω1 is the ‘idler’ and the remaining one is the ‘signal’ at a frequency ω2 [20]. The
idler wavelength can be tuned by tuning the pump laser, or signal laser or both.
In order for this process to take place, both energy and momentum need to be conserved.
‘Phase-matching’ requires that the wavevectors of the pump, signal and idler beam obey
k1 = k3 − k2. This ‘phase-matching’ condition can be fulﬁlled in birefringent crystals
by taking advantage of the fact that refractive index changes as a function of the incident
angle, temperature or wavelength. Alternatively, it can be fulﬁlled in ‘quasi-phasematched’
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crystals with a period modulation in the nonlinearity such as periodically poled lithium
niobate (PPLN) [33].
Radiation at around 3.4μm can be generated by diﬀerence frequency mixing of a diode
pumped Nd:YAG laser at 1064 nm and an external-cavity diode laser at 808 nm in PPLN
[34].
Optical parametric oscillators
Frequency conversion using optical parametric oscillators is an eﬀective way of generating
broadly tunable mid-infrared light [20]. Recent advances in robustness and compactness
make them an attractive source for a number of spectroscopic applications.
An optical parametric oscillator (OPO) consists of a nonlinear optical crystal placed inside
an optical cavity. An incident input ‘pump’ beam with frequency ω3 is converted to two
output waves at lower frequencies ω1 and ω2 (named ‘signal’ and ‘idler’) via a non-linear
interaction [7]. Energy conservation requires ω3 = ω1 + ω2. The optical cavity resonates
either the signal or idler wave (singly resonant) or both (doubly resonant). How the
frequency is divided between the new signal and idler waves is determined by the phase-
matching condition that the sum of the signal and idler wavevectors (k–vectors) must
equal that of the pump [16]. The parametric process can also be used in optical parametric
ampliﬁers (OPAs) to boost infrared output powers.
Radiation at around 3.4μm can be produced using a PPLN-based OPO pumped by a
Nd:YAG laser at 1064 nm [35].
1.4 Optical spectroscopic techniques
Laser sources such as those described above can be used in conjunction with number of
optical techniques to enable trace gas detection by enhancing the signal or reducing noise.
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Figure 1.2: Typical experimental set-up for wavelength modulation spectroscopy
A brief description of a selection of these techniques is described below.
1.4.1 Wavelength or frequency modulation spectroscopy
Wavelength modulation spectroscopy
Wavelength modulation spectroscopy (WMS), also known as harmonic detection or deriva-
tive spectroscopy, involves modulation of the laser light at a particular frequency (∼ kHz)
while tuning the wavelength through the absorption feature of an absorbing species. This
leads to the generation of signals at diﬀerent harmonics of the modulation frequency, the
strength of which are proportional to the absorption [36]. The required harmonic can
be detected using a lock-in ampliﬁer. A diagram of a typical WMS experimental set-up
is shown in ﬁgure 1.2. This is our adopted technique and is discussed in more detail in
section 2.3.
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Frequency modulation spectroscopy
Wavelength modulation (WM) and frequency modulation (FM) techniques are extremely
similar. Each method attempts to maximize sensitivity by shifting the detection band
to high frequencies to avoid excess (1/f ) laser noise [37]. However WM techniques are
characterised by a modulation frequency that is much smaller than the linewidth of the
absorption feature and a modulation amplitude that is of the order of this linewidth [8]. On
the other hand, FM spectroscopy is characterised by a modulation frequency that is larger
than the width of the absorption linewidth and a small modulation amplitude [36]. This
results in distinct frequency sidebands, spaced from the strong optical carrier frequency
by multiples of the modulation frequency. The spectral feature of interest can therefore
be probed by a single isolated sideband. Absorption can be measured by monitoring the
heterodyne beat signal that occurs when the FM spectrum is distorted by the eﬀects of
the spectral feature on the probing sideband [38].
One-tone FMS detects the signal at the modulation frequency while two-tone FMS uses
a pair of closely spaced frequencies to modulate the laser and quantiﬁes absorbance by
demodulating the detector output at the diﬀerence [37].
1.4.2 Cavity-enhanced spectroscopy
Cavity-enhanced spectroscopy takes advantage of long optical pathlength absorption in
high ﬁnesse optical cavities and there are a number of developed techniques.
Cavity ring-down spectroscopy
Cavity ring-down (CRD) spectroscopy is a sensitive absorption technique based upon the
measurement of the rate of absorption of a light pulse conﬁned in an optical cavity [39]. In a
simple CRD set-up a short laser pulse is coupled into the cavity and the subsequent decay,
due to transmission and absorption losses, is monitored by detection of the light pulses
exiting through an output mirror. The sample absorbance and therefore concentration
10
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Figure 1.3: Typical experimental set-up for CRD spectroscopy, with optional mode match-
ing optics [39].
can then be deduced by comparison of the decay time of the light due to absorption and
transmission losses in an empty cavity with the decay time for a cavity also containing the
absorbing gas sample. A schematic diagram of a typical experimental set-up is shown in
ﬁgure 1.3. The technique achieves extremely high sensitivities, ∼ 10−9 cm−1, by using high
ﬁnesse cavities and pathlengths of several km and it has the advantage that the decay rate
is independent of the laser amplitude. However the use of highly reﬂective mirrors with
reﬂectivities of > 99.995% is required making the technique extremely sensitive to mirror
degradation [40]. The continuous-wave version of the CRD technique is sometimes known
as cavity leak-out spectroscopy (CALOS).
Cavity-enhanced absorption spectroscopy
Another CRD variant is cavity-enhanced absorption spectroscopy (CEAS) also known as
integrated cavity output spectroscopy (ICOS). In this scheme the cavity length is dithered
and the laser light is coupled into the high ﬁnesse cavity via accidental coincidences of
the light with many cavity modes. The absorption of the gas sample within the cavity is
determined by the time-integrated decay of radiation, which is eﬀectively a time integration
of the ring-down curve [17].
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Figure 1.4: Typical experimental set-up for photoacoustic spectroscopy [41].
A review by Berden et al gives an overview of a number of CRD experimental schemes
[39].
1.4.3 Photoacoustic spectroscopy
Photoacoustic spectroscopy (PAS) is based on the photoacoustic eﬀect, in which acoustic
waves result from the absorption of radiation [16]. When radiation is directed into a pho-
toacoustic cell containing the target gas, molecular absorption of photons results in the
excitation of molecular energy levels. The excited states lose energy by radiative processes
(such as spontaneous or stimulated emission) or by collisional relaxation which results in
localized heat release in the sample gas [41]. Modulating the radiation at an acoustic fre-
quency periodically changes the temperature of the sample gas, giving rise to a pressure
change at that frequency. The resulting acoustic signal can be detected using a sensitive
microphone. A typical experimental set-up is shown in ﬁgure 1.4. As the generated signal
is very weak, a photo-acoustic cell is used as an acoustic resonator, with the laser modu-
lation frequency chosen to match a resonance frequency of the cavity. Further sensitivity
improvements are possible by using multipass or intracavity arrangements and using mi-
crophone arrays instead of single microphones [40]. PAS can achieve high sensitivities with
a large dynamic range and has the advantage that it can be easily used with a variety of
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laser sources. However integration times tend to be longer than 1 s and suﬃcient sampling
pressures (∼ 100 torr – 1 atm) are required [17].
1.5 Trace ethane detection
Ethane gas, C2H6, has sparked interest in applications as diverse as oil prospecting and
healthcare. Such applications often require rapid concentration measurements at the part
per billion (ppb) or even sub-ppb levels presenting a considerable technological challenge.
1.5.1 Background to our project
Researchers in the Optics group at the University of Glasgow working in collaboration with
Shell Global solutions developed a trace ethane gas sensor, motivated by the potential ap-
plication to oil prospecting [42]. Since oil and gas reservoirs are known to gradually leak
hydrocarbon gases to the surface their detection may assist in the identiﬁcation of new
locations of such reservoirs. Measurement of ethane concentration along with wind speed
and direction can be inverted to establish a source distribution, allowing rapid and remote
surveying of a large area. This concept was demonstrated following the development of the
real-time ethane gas sensor. The system was a modiﬁcation of a commercial instrument
from Aerodyne systems. A liquid N2 cooled lead-salt laser combined with a second deriva-
tive wavelength modulation scheme was used to achieve a sensitivity to ethane of 100 ppt
with a 1Hz sampling rate. A number of ﬁeld trials were conducted in the Middle East [43]
(See chapter 5).
Subsequently, the potential of ethane in healthcare was realised. Ethane gas is a widely
accepted marker of free-radical-induced cell damage. It is exhaled in the breath, typically
at a concentration of ∼ 2 ppb. As it can be measured non-invasively ethane is of interest as
a breath biomarker in a number of healthcare applications. However, as with many breath
gases, there are a number of challenges in both in the detection and the interpretation of
the results. Many previous studies in this ﬁeld have made use of oﬀ-line techniques such
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as GC-MS. Ultra-sensitive, rapid detection technology is required to further investigate
ethane’s clinical potential. The motivation behind breath ethane analysis is discussed in
detail in chapter 6.
Given the increasing interest in the ﬁeld of breath analysis and, in particular, the poten-
tial applications of breath ethane detection, a spectroscopy system was developed by the
Glasgow Optics group and dedicated to the breath ethane research [44]. The achieved
sensitivity corresponding to a 1Hz sampling rate was better than 100 ppt. The system
was used in a variety of applications in healthcare and life science [45, 46]. The short
analysis time allowed a large number of breath samples to be rapidly measured with high
sensitivity and selectivity. However, the system required discrete sampling methods for
the breath collection followed by lab-based analysis due to its size and bulk along with the
requirement for liquid nitrogen. Therefore it was not possible to fully exploit the real-time
nature of the technology.
The development of a portable system was therefore required to enable breath ethane
detection on-site in a clinical environment. It was uncertain if a system based on the
previous technology could be made more compact, without compromise to the previously
achieved performance. Therefore, a large proportion of the work undertaken was concerned
with the development and characterisation of this new portable ethane spectroscopy system.
Following the completion of the new system, a considerable amount of time and eﬀort was
spent applying the technology in a number of pilot clinical studies.
1.5.2 Related work in ethane detection
The traditional technique for analysis of the majority of breath gases, including ethane, is
GC combined with MS or other variants. These techniques have a number of limitations,
further described in section 6.2.2. Optical techniques are inherently better suited to breath
monitoring applications due to the combination of sensitivity, selectivity and speed.
A number of groups have used optical techniques for the measurement of breath ethane.
The ﬁrst work demonstrating ppb-level ethane measurements in human breath was reported
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in 2001 by Dahnke et al who used a liquid N2-cooled tunable CO-overtone sideband laser to
perform high cavity leak-out spectroscopy [47]. Under optimum conditions, an integration
time of 5 s corresponded to a minimum detection limit of the order of 100 ppt ethane.
Ethane was analysed in the breath of a smoker a few minutes after they had smoked a
cigarette. The technique was later used to measure online ethane traces across individual
exhaled human breaths, with a stated sensitivity of 500 ppt and a time resolution of 
800ms [48]. However breath ethane was only recorded after controlled inhalations following
exposure to a high concentration of 1 ppm ethane.
The same group also developed a portable spectrometer by replacing the CO laser with
a source based on both diﬀerence frequency generation (DFG) in a periodically poled
lithium niobate (PPLN) [34] and later with an optical parametric oscillator (OPO) [49].
By using an OPO combined with cavity leak-out spectroscopy and further improving the
technology, an extrapolated ethane detection limit of 6 pptHz−1/2 was reported in 2004
[50]. An example breath ethane measurement of 2.4± 0.5 ppb ethane was given. However
this was not signiﬁcantly diﬀerent from the concentration of the ambient air, measured to
be 2.7±0.5 ppb. There may have been issues with the use of the transition at 2966.9 cm−1,
which overlaps with a methane transition. In 2006 the group reported on a mid-IR laser
cavity leak-out spectrometer based on continuous-wave diﬀerence frequency generation with
an ethane precision of 270 ppt and a time resolution of 1 s [51]. Although the sensitivity
was lower than that previously reported, the room temperature operation enabled a size
reduction of the system, allowing transportation by car.
Mu¨ller et al have developed an OPO based on PPLN for photoacoustic trace gas detec-
tion between 3.1 and 3.9μm. Applying this OPO in an photoacoustic spectrometer, an
ethane detection limit of 110 ppt was achieved with an integration time of 10 s [35]. This
was further improved to a detection limit of 25 ppt for ethane with a 30 s time constant
[52]. However these detection limits were calculated from noise measurements. Since the
concentration measurements were taken at atmospheric pressure the ethane concentrations
couldn’t be accurately determined due to interference from neighbouring species such as
water. Therefore a liquid nitrogen cooling trap was required to freeze out disturbing gases.
A example measurement of ambient air yielded an ethane concentration of 4. ± 0.5 ppb.
Similarly, an OPO was used with photoacoustic spectroscopy by van Herpen et al to mea-
sure ethane [53]. The detection limit was determined to be 0.1 ppb, with a scan time 40 s.
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A higher power OPO was subsequently developed, which had the potential to improve the
ethane sensitivity [54].
Over the last few years there have been considerable developments in interband cascade
(IC) laser and quantum cascade (QC) laser technologies. For example, a continuous-wave
distributed feedback (DFB) ICL fabricated by the NASA–JPL was used in a trace ethane
gas sensor [55]. The laser was liquid nitrogen cooled to ∼ 80K and had a maximum power of
12mW. The instrument incorporated a 100m optical path Herriott multipass cell and used
wavelength modulation spectroscopy (WMS) to achieve an ethane sensitivity of 0.15 ppb
with a 1 s acquisition time. Wysocki et al recently reported on a dual trace-gas sensor which
incorporates two liquid nitrogen cooled IC lasers operating at 3.33μm and 3.56μm [56].
Second derivative wavelength modulation at two diﬀerent frequencies was used to enable
simultaneous detection of both ethane and formaldehyde. Minimum detection limits of
3.5 ppb for formaldehyde and 150 ppt for ethane were demonstrated with a 1 s integration
time. Breath ethane results have not yet been reported using these systems.
Parameswaran et al used an IC laser together with oﬀ-axis integrated cavity output spec-
troscopy (OA–ICOS) to develop a portable system with a calculated minimum detectable
ethane concentration of 0.12 ppbHz−1/2. The system was used for measurement of breath
ethane in smokers, at 30min intervals after they had smoked a cigarette [57].
1.6 Discussion
An introduction to the ﬁeld of spectroscopy and to our work has been given along with a
brief description of a number of mid-infrared sources and optical techniques. An overview of
current and previous breath ethane detection using optical techniques has been presented.
While the technology is greatly advancing, due to developments in both laser sources and
detection systems, the majority of the breath ethane clinical studies are carried out using
the traditional non-optical techniques. Therefore a principal aim of the work reported here
was not only to develop an ethane spectroscopy system that could be used in a clinical
setting but also to use it to record novel clinical data in the hope of furthering pilot studies
and knowhow in the ﬁeld of breath ethane analysis.
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Molecular absorption spectroscopy
This chapter gives background and theory behind molecular absorption spectroscopy. The
chosen technique of wavelength modulation is examined in more detail.
2.1 Molecular transitions
The energy E1 of a molecule can be changed to another allowed energy level E2 by the
exchange of energy. This energy change can result from the absorption or emission of a
photon and must obey
ΔE = hν (2.1)
where ΔE = E2 − E1, ν is the frequency and h is Planck’s constant. If radiation of a
particular frequency is incident on a material and satisﬁes the condition that the photon
energy corresponds to that of an allowed energy transition, then some of the radiation will
be absorbed by the material. This principle is used in molecular absorption spectroscopy.
Most molecules have their fundamental vibrational transitions in the mid-infrared region
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Anti-symmetric stretchSymmetric stretching Bending
Figure 2.1: The independent vibrational modes of water, of which all three are infrared
active
(∼ 2 – 25μm) [18]. Transitions between vibrational energy levels are typically at a spacing
of 20 x 10−21 J [1]. A commonly used unit in molecular spectroscopy is the wavenumber,
λ¯, deﬁned by
λ¯ =
1
λ
(2.2)
Wavenumbers are traditionally expressed in cm−1 units and are a convenient way of ex-
pressing the frequencies corresponding to molecular transitions.
Molecular vibrations can be subdivided into two classes: stretching, where the distance
between the atoms in a molecule is changed, or bending, where the angle between the
atoms in a molecule is changed. For example, water undergoes three independent types
of vibration, shown in ﬁgure 2.1. All three types of vibrations are infrared active. For a
molecule to absorb infrared radiation it must undergo a net change in dipole moment as a
result of vibrational or rotational motion. Diatomic molecules such as N2 and H2 do not
absorb IR because stretching does not change the dipole moment.
The stretching vibration frequencies depend on the strength of the bond, which depends on
the particular atoms in the bond and the bond type (i.e. single, double or triple). Typical
fundamental frequencies for a number of diﬀerent types of bond are given in table 2.1.
2.1.1 Transition broadening
Molecular energy transitions are always broadened due to three main causes:
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Bond λ (cm−1)
O–H 3600–3700
N–H 3000–3400
C–H 2850–3000
C≡N 2200–2300
C≡C 2050–2300
C=C 1500–2000
Table 2.1: Fundamental stretching frequencies for a selection of bonds [58].
Natural broadening
As a result of the Heisenberg uncertainty principle the energy transitions in a molecule are
not truly discrete but have a ﬁnite width ΔE. This linewidth is determined by the mean
lifetime τ as
ΔE ∼ 
τ
(2.3)
This leads to a natural broadening of the lineshape which can be described by a Lorentzian
function. Natural linewidths in the infrared are relatively narrow, typically ∼ 10−4 cm−1.
Collisional (Pressure) broadening
Absorption and emission processes are disturbed by the collision of other molecules with
the absorbing molecule. Molecular collisions decrease the lifetime of the state, increasing
the uncertainty in photon energy, and therefore broadening the transition linewidth. Col-
lisional broadening depends on both the pressure and the temperature of the gas and the
broadening eﬀect is described by a Lorentzian proﬁle. The half linewidth is given by
γL = γ0
P
P0
√
T0
T
(2.4)
where T is the temperature, P is the pressure and γ0 is the half linewidth at temperature
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T0 and pressure P0.
Doppler broadening
Doppler broadening arises due to the thermal motion of the molecules in the gas. The
transition frequencies of each molecule will be red or blue shifted from the centre line
frequency by the Doppler eﬀect depending on the velocity of the molecule. The higher the
temperature of the gas, the greater the distribution of velocities in the gas and therefore the
broader the line. The lineshape is described by a Gaussian proﬁle and the half linewidth
is given by
γD =
ν0
c
√
8kT ln(2)
M
(2.5)
where ν0 is the centre frequency, k is the Boltzman constant, T is the temperature and M
is the molecular weight all in SI units.
In the regions where the Doppler and pressure broadened widths are comparable the total
eﬀective lineshape is given by the convolution of the Gaussian (Doppler) proﬁle with the
Lorentzian (pressure broadened) proﬁle. This is known as a Voigt lineshape.
In tunable diode laser absorption spectroscopy (TDLAS) the laser wavelength is usually
scanned over an absorption line of the target gas. High selectivity is achieved by reducing
the pressure of the gas so that a sharp absorption feature is seen, isolated from nearby
contaminants. Reducing the pressure does reduce the sensitivity but this is not signiﬁcant
until the linewidth starts to become Doppler limited. Typically, TDLAS systems are
operated between 10 and 50mbar [8]. This is further discussed in section 4.5.3, where
example theoretical ethane absorption lineshapes are provided for a range of pressures.
2.1.2 Ethane transitions
The HITRAN molecular spectroscopic database provides information about molecular
spectra in the 1 to 20500 cm−1 region [59]. MOLSPEC is a Microsoft Windows program
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Figure 2.2: Three of the strongest transitions for ethane are at frequencies of 2986.72 cm−1,
2990.09 cm−1 and 2993.47 cm−1. The absorption is shown for 1 ppb ethane over a 100m
pathlength at a pressure of 40mbar and temperature of 296K.
that uses the HITRAN 2000 database to calculate and display molecular spectra based
on parameters entered by the user. Data in the following section was obtained using the
MOLSPEC program.
Ethane, C2H6, has strong molecule transitions around 3.4μm. Three of these transitions
are at frequencies of 2986.72 cm−1, 2990.09 cm−1 and 2993.47 cm−1. These correspond to
C-H stretching vibrations. Figure 2.2 shows the absorption for 1 ppb ethane over 100m
pathlength, at a pressure of 40mbar and temperature of 296K, for each of the three
transitions.
2.2 Absorption spectroscopy
The Beer-Lambert law, or Beer’s law as it is commonly known, expresses the relationship
between the absorbance of light and the properties of the material through which the light
is travelling. It can be expressed as
21
CHAPTER 2. MOLECULAR ABSORPTION SPECTROSCOPY
IT = I0exp
−α(ν)bc (2.6)
where α(ν) is the absorption coeﬃcient of the material at frequency ν, b is the path length
through the material, c is the concentration of the absorbing species in the material, IT is
the transmitted intensity and I0 is the incident intensity. The quantity α(ν)bc is known as
the absorbance. In the case of small absorbance the Beer law can be approximated as
IT ≈ I0[1− α(ν)bc] (2.7)
Rearranging equation 2.7 gives the fractional absorption of light as
I0 − IT
IT
= α(ν)bc (2.8)
At 2990 cm−1, 1 ppb ethane at 296K, 40mbar over a 100m pathlength has a fractional
absorption of 1.1 × 10−4 (see ﬁgure 2.2). Hence the absorption coeﬃcient at line centre
α(ν0) ≈ 11 cm−1. Since ultra-low gas concentrations produce an extremely small change in
light intensity the optical pathlength of the laser light is often extended. This increases the
absorption in order to achieve the high sensitivity required for trace gas detection. This can
be done by using cavity–enhanced methods [39] or by the use of a multi-pass cell, such as a
Herriott cell [60]. However, even in conjunction with a long-path length, direct absorption
measurements alone often cannot oﬀer the required sensitivity, particularly when overtone
transitions with signiﬁcantly weaker absorption coeﬃcients are used. Therefore a detection
technique such as wavelength modulation spectroscopy is often used in conjunction with
an increased pathlength.
2.3 The wavelength modulation technique
As described in section 1.4.1, wavelength modulation spectroscopy (WMS) involves mod-
ulation of the laser light at a particular frequency (∼ kHz) while tuning the wavelength
through the absorption feature of an absorbing species. This leads to the generation of sig-
nals at diﬀerent harmonics of the modulation frequency. As the laser is scanned through
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the absorption line, the desired harmonic signal is acquired from a lock-in ampliﬁer, or
phase sensitive detector (PSD). A PSD takes an input signal, multiplies it by a reference
signal and passes the result through a low pass ﬁlter, giving a maximum output voltage if
the two input signals are coherent. In this case, the output voltage is proportional to the
amplitude of the input signal. PSDs usually enable phase adjustment over 360 degrees to
ensure that the signals are in phase and therefore maximise the signal. The modulation
signal, or a multiple of this frequency, is used as the PSD reference signal. Applied to laser
spectroscopy, wavelength modulation and subsequent phase sensitive detection allows the
detection frequency to be increased to a level where noise sources such as 1/f laser noise
are signiﬁcantly reduced.
The technique requires that the linewidth of the laser is less than the width of the absorp-
tion peak. With a semiconductor laser, the modulation can be easily achieved by direct
modulation of the laser current. Other techniques include mechanical dithering of the
mirror and using external phase modulators.
2.3.1 Mathematical description
If the laser frequency ν is sinusoidally modulated at the frequency Ω and we assume pure
frequency modulation (FM) then the resulting transmitted intensity IT can be expressed
as a function of ν and time t as follows
IT = f(ν + m sinΩt) (2.9)
where the function f will take into account absorption, and other transmission losses for
each frequency ν. Assuming that the modulation frequency Ω and amplitude m are much
smaller than the linewidth of the absorption peak we can expand equation 2.9 using a
Taylor expansion [61] to give
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f(ν + m sinΩt) = f(ν) + m sinΩt
df
dν
+
m2
2!
sin2 Ωt
d2f
dν2
+
m3
3!
sin3 Ωt
d3f
dν3
+ · · · (2.10)
Using the identities
cos 2Ωt = 1− 2 sin2 Ωt (2.11)
sin 3Ωt = 3 sinΩt− 4 sin3 Ωt (2.12)
and combining terms equation 2.10 becomes
IT = [f(ν)+
m2
4
d2f
dv2
+ ...]+sinΩt[m
df
dν
+
m3
8
d3f
dν3
+ ...]+cos 2Ωt[−m
2
4
d2f
dν2
+ ...]+ ... (2.13)
Several terms are obtained in the transmitted intensity: A DC term, a term oscillating at
1Ω, a term at 2Ω and so on. Phase sensitive detection at the nth multiple of the modulation
frequency yields the nth derivative of the transmission proﬁle.
However, the Taylor expansion can be used by assuming m is small. i.e the modulation
amplitude is much smaller than the width of the absorption peak. That is true for FM
spectroscopy but not necessarily for WM spectroscopy. In WM, the low modulation regime
results in low sensitivity. In practice, the modulation amplitude is chosen to be close to
the linewidth to maximise the signal amplitude. However, it transpires that even in this
case the resultant signal at the nth harmonic of the modulation frequency is still similar
to the nth derivative of the absorption lineshape and is approximately proportional to the
concentration of absorbing gas [8]. In our regime we use a large modulation amplitude,
which results in a signiﬁcant distortion of the absorption lineshape.
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Figure 2.3: Graphical illustration of the wavelength modulation technique. (a)-(c) As the
laser wavelength is scanned across the absorption transition the laser wavelength modu-
lation is converted to amplitude modulation at the same frequency. The extent of this
conversion varies across the absorption proﬁle. (d) The ﬁrst derivative of the absorption
proﬁle, obtained by phase sensitive detection at the modulation frequency. (e) The sec-
ond derivative of the absorption proﬁle, obtained by phase sensitive detection at twice the
modulation frequency.
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2.3.2 Graphical description
If the laser wavelength is in the vicinity of an absorption transition of the gas, the frequency
modulation (FM) is converted to amplitude modulation (AM) at the same frequency, as
shown in ﬁgure 2.3 a–c. The amplitude modulated signal is detected using a photodetector
and then de-modulated using a PSD. As the wavelength is scanned across the absorption
proﬁle the magnitude of the resultant amplitude modulation varies and is dependent on
the slope (or derivative) of the absorption proﬁle. Therefore, plotting the ratio of the FM
to AM conversion against frequency yields the ﬁrst derivative of the absorption proﬁle, as
shown in ﬁgure 2.3 d. Similarly, plotting the rate of change of the FM to AM conversion
yields the second derivative of the absorption proﬁle, shown in ﬁgure 2.3 e. The 2nd order
spectrum is useful as it has a peak at line centre, which is proportional to the absorption.
2.3.3 Residual amplitude modulation
According to equation 2.13, if the laser wavelength is scanned away from an absorption line
the 1st and 2nd derivative signals should be reduced to zero. However in a semiconductor
laser modulation of the injection current produces a combined wavelength modulation
(WM) and intensity modulation (IM), with a phase shift between the two modulations
[36]. In WM spectroscopy the IM is an unwanted eﬀect which distorts the detected signal
and is detected even in the absence of an absorbing gas. The IM, often referred to as
residual amplitude modulation (RAM), depends on the wavelength characteristics of the
laser diode.
A conventional way of obtaining quantitative information about the target absorbing gas
despite the presence of RAM is to compare the measured signal to that generated by a
calibration gas of known concentration. This is the method we adopt in our spectroscopy
system. An alternative, calibration-free approach is to make use of the phase lag between
the WM and the RAM, which depends on the laser structure and the modulation frequency.
Duﬃn et al maximised this phase lag by optimising the modulation frequency and then
nulled the WM derivative signal to isolate the RAM, yielding absolute gas-line transmission
functions and enabling accurate measurements of linewidth and therefore pressure [62].
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This chapter has provided some background theory in the area of molecular spectroscopy
and has examined wavelength modulation spectroscopy, our chosen detection technique.
The following two chapters describe the development and characterisation, respectively, of
the portable ethane spectroscopy system.
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Development of the portable
spectroscopy system
This chapter describes the development of the portable spectroscopy system for the ultra-
sensitive, real-time measurement of ethane. An overview of the technology is ﬁrst given
with the construction described in more detail in the following sections.
3.1 Instrument overview
The system is based on high resolution absorption spectroscopy across a transition for
ethane gas at 3.34μm using a cryogenically-cooled lead-salt laser diode. A second derivative
wavelength modulation detection scheme is used. All components are housed in a portable
unit, dimensions 1m x 0.5m x 1m (L x W x H), as shown in ﬁgure 3.1.
The portable unit consists of three sections: The base section houses a compressor used for
laser cooling and a vacuum pump used to draw the gas sample through the system. The
upper section, which can be completely separated from the base, supports the optical table
on which the laser and optics are mounted, and a platform on which the laser controller
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and the detection electronics are attached. These sections are shown in ﬁgure 3.2. Finally,
there is a lid (see ﬁgure 3.1), which can also be removed.
Figure 3.1: Photograph of the ultra-sensitive, real-time portable ethane spectroscopy sys-
tem. The self-contained instrument has dimensions 1m x 0.5m x 1m (L x W x H)
The system is therefore a self-contained instrument and the only additional requirement
is hydrocarbon-free nitrogen gas for zero referencing (see section 3.4). The instrument is
controlled from a laptop computer using software written in LabVIEW.
3.1.1 Laser and optical conﬁguration
A schematic of the optical conﬁguration is shown in ﬁgure 3.3. A lead-salt laser diode (IR-
2990-GMP-WM, Laser Components) emits ∼ 0.2mW of light which undergoes multiple
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Figure 3.2: Photographic view of the instrument sections. The base houses the compressor
and vacuum pump. In the upper section the laser and optics are mounted on an optical ta-
ble. Above this a platform is supported on which the laser controller, PSDs and electronics
are mounted.
passes in a Herriott sample cell 0.55m in length. Exiting light is detected using a low noise
thermo-electrically cooled HgZnCdTe photodetector, PD1 (PVI-2TE, Vigo). Sample gas is
drawn through a sample inlet pipe to the Herriott cell by a 240 lmin−1 pump (Varian Inc.).
An air ﬁlter and regulator valve on the inlet to the cell maintains a pressure of 40mbar,
corresponding to a sample inlet ﬂow rate of ∼ 3 lmin−1. Around 5% of the light is split oﬀ
before the Herriott cell and directed through a 10 cm long reference cell containing ethane
at a concentration of 500 ppm± 2% also at 40mbar and onto a second photodetector, PD2.
This reference cell allows for continual calibration and wavelength stability checks.
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Figure 3.3: Schematic of the optical conﬁguration. All optics are mounted on a 90 cm by
45 cm lightweight optical table.
3.1.2 Detection scheme
A second harmonic wavelength modulation scheme is used, where the laser light is sine-
wave modulated at 8 kHz and ramped through the ethane transition at 1Hz. Two phase
sensitive detectors (PSDs) (LIA-MV-200-H, Femto) provide demodulated signals at twice
the modulation frequency. The reported sample cell concentration is based on curve ﬁtting
between the demodulated signals from PD1 and PD2. See ﬁgure 3.4. This is achieved
using a least squares ﬁtting algorithm in the LabVIEW software, which compares the 2f
lineshape from the sample channel to that of the reference channel and reports coeﬃcients
for the scaling factor and oﬀset. The ﬁrst of these coeﬃcients is used to calculate the
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Figure 3.4: 2f sample lineshape and ﬁtted lineshape as the laser wavelength is scanned
over the ethane transition. A LabVIEW least squares ﬁtting algorithm is used to calculate
the ethane concentration.
ethane concentration. As the magnitude of the measured signal in the sample and reference
channels is linearly proportional to the DC light levels at PD1 and PD2 respectively, the
calculated concentration is also multiplied by the ratio of the light levels at PD1 and PD2.
This normalises for changes in the overall light level and also for relative changes in the
light levels between the photodetectors.
3.1.3 Electronics and interfacing
Modulation
The entire modulation scheme and data analysis process is controlled by the LabVIEW
software controlling a commercial laser controller (PRO8000, Proﬁle). All electronics for
modulation and signal processing are custom-designed with the exception of the two PSDs.
The laser temperature and current are set in the software and are regulated by the laser
controller. The modulation signal at 8 kHz is produced by a high-frequency waveform
generator (MAX038CPP, Maxim). The sinusoidal signal is then improved using a ﬁlter
(UAF42AP Burr-Brown series, Texas Instruments). A ramped signal at a frequency of 1Hz
is produced directly in the LabVIEW software and is output via an analogue channel of
the data acquisition (DAQ) card (6026E, National Instruments). An operational ampliﬁer
(OPA620 Burr-Brown series, Texas Instruments) is used to add the sinusoidal signal to
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the ramp signal, and the resulting signal is applied to the laser current via the modulation
input on the laser controller. The strength of the modulation signal is controlled using a
variable resistor.
Signal ampliﬁcation and ﬁltering
The detected AC signals from the photodetector modules for both the sample and calibra-
tion cells are ampliﬁed by a factor of 10 using two op-amps (LT1028, Linear Technology).
These are chosen due to their low noise voltage density (typically 1.0 nV Hz−1/2). The
ampliﬁed signals are then also ﬁltered (UAF42AP). For second harmonic detection the
ﬁlters were optimised at twice the modulation frequency. The centre frequency of each of
the bandpass ﬁlters is easily adjusted using a variable resistor via a calibration dial. The
necessary resistor values to achieve the desired bandpass ﬁlter parameters were calculated
using a simple program supplied with the ﬁlter speciﬁcations. The transfer functions of the
various stages of the detection electronics were measured with a spectrum analyser (SR780,
Stanford Research Systems). A white noise source was used to measure the transfer func-
tion of the ﬁlter. The quality (Q) factor of the sample ﬁlter was determined to be 7.5 with
a peak gain of 4.05. The overall transfer function for the sample channel electronics (AC
gain and ﬁlter) were measured, this time using a swept sine wave source, and was found to
have a Q factor of 7.8 and an overall peak gain of 44.3. Figure 3.5 shows both the measured
transfer function for the sample channel ﬁlter and the measured overall transfer function
for the sample channel electronics (AC ampliﬁcation and ﬁlter).
As described, the two PSDs provide demodulated signals at twice the modulation frequency
for both the sample and calibration channels. The ﬁltered sinusoidal waveform from the
MAX038 oscillator is used as the input reference signal for the PSDs, which are chosen to
function in the 2f mode. See appendix A for all circuit diagrams.
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Figure 3.5: The measured transfer function of both the sample channel ﬁlter and the overall
transfer function of the electronics, which includes the AC gain by a factor of ∼ 10 provided
by a low noise op-amp.
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Figure 3.6: An example of the results section on the front panel of the LabVIEW control
software.
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Interfacing
The instrument is controlled from a laptop computer by software written in LabVIEW and
is designed for simple operation. The ‘results’ section of the front panel of the LabVIEW
program displays the measured ethane concentration against time. A user can easily view
the measured concentration results, average the ethane concentration over time, save results
in Excel format, clear the ethane-time chart, switch input lines to measure nitrogen gas,
and modify time intervals between zero-referencing (see section 3.4). Figure 3.6 shows an
example of the front panel results section. The control section of the front panel is used
to set the laser temperature and current, frequency of sampling, and monitor light levels,
calibration and sample 2f lineshapes and pressure.
The software previously developed to control the lab-based spectroscopy system was mod-
iﬁed for use with the new portable system. The laser and temperature controllers are
connected via a GPIB connection and PCMCIA card and are fully controlled by the soft-
ware. All detected analogue and digital signals are input to the software via the DAQ
card and corresponding connector block (6026E, National Instruments). These input sig-
nals include the following: Sample and reference photodetector DC light levels; sample
and reference demodulated signals output from the PSDs and the Herriott cell pressure.
The cell pressure is maintained at 40 mbar and is monitored using a pressure gauge (BOC
Edwards, APG100) ﬁtted between the cell and the scroll pump. Signals output via the
DAQ card comprise the current ramp (analogue) and the digital signals used to switch a
solid state relay, which opens/closes the valves used for zero-referencing (See section 3.4).
Two computer power supplies are used to power all components including the electronics,
photodetector modules, valves and pressure gauge.
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3.2 Laser cooling
3.2.1 Closed-loop cooling system
To achieve the desired output wavelength of ∼ 3.34μm the lead-salt laser requires operation
at cryogenic temperatures. Lab-based ethane spectroscopy systems previously developed
by the Glasgow Optics group used liquid nitrogen (N2) for the laser cooling. However, there
would be clear disadvantages of its use for portable technology: Firstly, the dewar required
to contain the laser is large. Secondly, the liquid N2 must be added before instrument use
and the temperature can take up to one hour to stabilise. Further, it must be topped up
when necessary, preventing long term uninterrupted use. Another factor to consider for
on-site use in a hospital is the potential lack of readily available liquid N2.
The portable instrument uses a closed loop cooling system (Cryotiger, Megatech Ltd) to
cool the laser to a temperature of around 88K. The entire cooling system consists of a cold
end, compressor and two gas transfer lines. This system has enabled a more compact laser
cold ﬁnger to be incorporated and therefore the entire laser dewar has been downsized by
around a factor of two in volume from the previous lab-based systems. Dispensing with the
need for liquid N2 has enabled use in a clinical environment. Issues such as intermittent
ﬁlling with liquid nitrogen causing unpredictable laser behaviour have been eliminated.
Initial cooling from room temperature to ∼80K takes several hours (see ﬁgure 3.7) but
once cooled, this temperature can be maintained over a over a period of weeks or even
months. Before cooling, the dewar is evacuated to a pressure of < 10−4 mbar using a turbo
pump. Occasionally the laser was ‘thermally-cycled’ by allowing the system to reach room
temperature, then re-evacuating the dewar, before re-cooling.
The two photodetector modules are thermo-electrically cooled to a temperature of ∼230K.
This is assisted by the addition of a computer fan with a heat sink to each module. It is
necessary to cool mid-IR detectors as the bandgap is smaller than it is for near-IR detectors
(approximately half since the wavelength is doubled). Thermal excitation of carriers would
lead to higher dark current noise unless the detector is cooled. Since the important factor
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Figure 3.7: Comparison of cooling times between closed-loop and liquid nitrogen systems.
Although laser cooling using the closed-loop system initially takes several hours, a key
advantage is the low temperature can be maintained for periods of months.
is exp−E/kT , the smaller bandgap energy E at mid-IR wavelengths requires a reduction in
temperature T to match performance at near-IR wavelengths.
3.2.2 Temperature control
The laser temperature is set and monitored via a temperature controller (Pro8000, Proﬁle)
using a silicon diode sensor (PT-1000) in the laser dewar. The sensor reports a resistance,
RA, which is converted to a temperature T in the software using the following formula:
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T =
233841−RA
525.9
(3.1)
The laser could be cooled to a minimum temperature of 77K but it was typically operated at
a temperature of 88K. This is further discussed in section 4.4.1. The required temperature
is achieved by setting the target resistance, RS , on the temperature controller. When
the temperature has stabilised, the actual resistance, RA, is reported as lower than the
target resistance, RS , by 2.32 kΩ, corresponding to a temperature diﬀerence of +4.4K. The
resistance oﬀset was easily compensated for in the software by automatic adjustment of the
target resistance. During instrument operation the temperature controller is operated using
the LabVIEW software via a GPIB connection and PCMCIA card (National Instruments).
A constant laser temperature was required during instrument operation for wavelength
stability. The laser controller holds the temperature constant to within a few mK. After
optimising the PID settings of the temperature controller, the temperature stability was
found to be better than that of the previous lab-based systems which use liquid nitrogen
for cooling.
3.2.3 Thermal management
The compressor is housed in the base section of the instrument along with the scroll pump.
Thermal management for this section is achieved via four AC fans mounted on the case
sides and with the use foam partitioning to direct the airﬂow. (See ﬁgure 3.8). The
compressor and pump are tightly secured using straps and vibrations are reduced using
rubber mounts. Two fans are also mounted on the case sides of the upper section. In
addition, a computer fan with a heat sink is attached to each of the two thermo-electrically
cooled photodetectors.
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Figure 3.8: Photograph of instrument where the optical table section has been rotated to
show the compressor and vacuum pump positions in the base. Thermal management is
achieved via cooling fans with air ﬂow controlled by foam partitioning.
3.3 Power requirement
The power requirement of the complete spectroscopy system, measured using an energy
meter, is shown in ﬁgure 3.9. The power requirement of the instrument is dominated by
the compressor of the laser cooling system and scroll pump used to draw gas through the
sample cell. The total power requirement is ∼1.8 kW (8A at 230V). On start-up, the
power requirement is momentarily higher.
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Figure 3.9: The total power requirement of the instrument is ∼1.8 kW. This is dominated
by the compressor and scroll pump.
3.4 Zero referencing and calibration
To provide a zero reference for the calculation of the ethane concentration, hydrocarbon-free
nitrogen gas is measured at regular intervals, determined by the settings in the software.
Typically zero-referencing occurs for 12 s after each 60 s measurement period. This is
achieved by switching between the sample inlet and a second inlet from which there is a
supply of nitrogen gas. In situations where the diﬀerence in ethane between two sources
is to be examined the zero reference can be taken as one of these sources, eliminating the
need for an external reference such as nitrogen. The zero referencing technique primarily
eliminates the eﬀects of slowly shifting optical fringing patterns in the Herriott cell, which
can aﬀect the sample 2f lineshape.
In addition, calibration is independently conﬁrmed using a hydrocarbon reference standard
certiﬁed in accordance with a ISO9001 (National Physical Laboratory). This contains
ethane at 4.01 ppb with a certiﬁcation accuracy of 2%. Upon measurement of the reference
standard, a calibration factor in the software can be adjusted until the reported and known
ethane concentrations are in complete agreement.
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3.5 Herriott cell
The necessary optical pathlength to enable sub-ppb sensitivity to ethane is achieved using
a Herriott cell. The Herriott cell is a multi-pass cell with astigmatic mirrors at each end.
The laser light enters and exits the cell through a small aperture in the input mirror
and during successive round trips the laser spot pattern undergoes a precessing ellipse,
where the number of passes is dictated by the cell geometry [60]. Aerodyne Research
produce multipass cells based on the Herriott conﬁguration. A variety of pathlengths can
be achieved using a ﬁxed set of astigmatic mirrors through a combination of mirror rotation
and separation changes. These cell conﬁgurations are nearly confocal [63]. The previous
lab-based ethane spectroscopy systems at the University of Glasgow incorporated a Herriott
cell 1m in length (AMAC-200, Aerodyne). The beam was arranged to exit the cell after
174 passes and, with the mirror separation of 0.88m, resulted in a total optical path length
of 153.5m. For compactness, the portable instrument incorporates a shorter Herriott
cell (AMAC-100, Aerodyne), with a mirror separation of 0.54m. Therefore to achieve
approximately the same pathlength as previous systems 284 passes would be required. A
Herriott cell with cell geometry conﬁgured for 366 passes was purchased. However, the
gain in sensitivity due to increased pathlength must be oﬀset against transmission losses
(discussed in section 4.5.2). Therefore the cell was aligned for a lower number of passes
than the maximum.
3.5.1 Alignment
A Helium Neon tracer beam, combined with the infrared beam using a calcium ﬂuoride
beam splitter, was used to align the Herriott cell. See ﬁgure 3.3. The collimated infrared
and tracer beams were directed into the cell using two steering mirrors. These mirrors
were adjusted until an exiting tracer beam was detected. However, signiﬁcant diﬃculties
in detecting the infrared beam were encountered when attempting to align the shorter
0.5m Herriott cell in this way, in contrast to the alignment of the 1m cells used in the
previous lab-based systems.
When aligning the 1m cells in the lab-based systems the input beams had been collimated
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and directed into the cell without the need to focus the beam. The required exiting tracer
beam and infrared beam had been detected by careful adjustment of the steering mirrors.
However, to align the shorter cell, for which the mirrors have a smaller radii of curvature,
it was necessary to calculate the beam size and focusing required at the entrance to the
cell.
Input beam parameter calculations
For a stable cavity, the radius of curvature of the beam wavefront must match that of the
mirrors. Each mirror in the Herriott cell is astigmatic, with radii of curvature Rx = 67.6 cm,
Ry = 74.0 cm. Using R = 70.8 cm as the average of the two radii and the mirror separation
d = 54.5 cm, the Rayleigh range, zr, can be calculated (see appendix B) using
zr 
√
d(2R− d)
4
=
√
54.4(2 · 70.8− 54.4)
4
= 34.4 cm (3.2)
The beam waist, ω0, of the infrared beam is then
ω0 =
√
zrλ
nπ
=
√
0.34 · 3.4 · 10−6
1.π
= 6 · 10−4 m = 0.6mm (3.3)
Therefore the input beam should be gently focused to achieve a beam radius at the centre
of the Herriott cell of ∼ 0.6mm.
For a beam waist of 0.6mm in the centre of the cell, the spot size on the mirrors (at
z = d/2 = 0.273m) is calculated using
ω(z) = ω0
√
1 + (
z
zr
)2 = 0.06
√
1 + (
0.27
0.34
)2 = 0.77mm (3.4)
Similar calculations show that the He-Ne tracer beam will have a beam waist of ω0 =
0.26mm and a spot size on the mirrors of 0.34mm. However, the reﬂectivities of the
mirror coatings are not optimised for this wavelength. In practice, larger spot sizes are
observed for the tracer beam.
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Calculation of the optimum position for the focusing mirror
A mirror with radius of curvature R = 1.5m was then used to focus the collimated beams
into the cell. To determine the optimum position for the curved mirror, ray transfer matrix
(RTM) analysis was used:
RTM analysis uses the paraxial approximation of ray optics, where all rays have some small
transverse distance (x) and angle (θ) relative to the optical axis of the system. The input
and output beams are described by vectors
(
x1
θ1
)
and
(
x2
θ2
)
respectively. The transfer
matrix M describes the eﬀect of an optical element on the input beam.
(
x2
θ2
)
=M
(
x1
θ1
)
(3.5)
and
M =
(
A B
C D
)
(3.6)
For a ray reﬂection oﬀ a mirror of radius of curvature R followed by free space propagation
for a distance d the transfer matrix becomes
M =
(
1 d
0 1
)(
1 0
− 2R 1
)
=
(
1− 2dR d
− 2R 1
)
(3.7)
Before being focused into the Herriott cell the infrared and tracer beams were approxi-
mately collimated. The radius of the infrared beam was measured using a photodiode to
be ∼ 1mm. This was done by placing the photodiode on an X-Y-Z translation stage and
determining the distance over which the beam intensity fell from the maximum to ∼ 1/e2
of the maximum.
For x1 = 1mm, θ1 = 0 and R = 1.5m(
x2
θ2
)
=
(
1− 2dR d
− 2R 1
)(
x1
θ1
)
=
(
1− 4d3 d
−43 1
)(
1
1000
0
)
(3.8)
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Figure 3.10: The Herriott multipass cell is aligned using a Helium Neon tracer beam. A
spot pattern is visible on each of the cell mirrors.
yielding
x2 = (1− 43d)/1000 (3.9)
θ2 = −4/3000 (3.10)
The required mirror distance d from the centre of the Herriott cell was calculated by setting
x2 = 0mm in equation (3.9) to yield d = 0.75m.
Therefore, to achieve the beam focus in the centre of the Herriott cell, a curved mirror,
R = 1.5m, should have been placed at a distance of 75 cm before the centre of the cell,
i.e. 47.5 cm before the aperture on the input mirror of the cell. The curved mirror was
ﬁxed at a distance of ∼ 48 cm before the input aperture mirror. A ﬂat mirror was used
immediately before the cell input aperture to direct the beam into the cell. With this
arrangement cell alignment was more easily achieved than with a collimated beam and
both an exiting tracer and infrared beam could be detected after multiple passes.
The detected tracer beam was then optimised for the infrared beam by adjustment of
the steering mirrors. Although the number of passes at this point was unknown, a rough
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estimate was made by immediately assessing the sensitivity to ethane using samples of
known concentration. The alignment was adjusted until the exiting beam could be used
to achieve a similar sensitivity to ethane as the lab-based system. To reach the higher
passes the trace beam spot patterns on the cell mirrors were observed (see ﬁgure 3.10).
The mirrors were then adjusted until the spot pattern appeared to resemble the required
pattern, as depicted in diagrams provided by Aerodyne.
3.5.2 Estimate of number of passes
The Herriott cell mirrors are nickel-plated aluminum with broad-band dielectric coating
mirrors, speciﬁed with a reﬂectivity, R, of 99.2%. Therefore, the theoretical power loss
can be calculated using T = Rn, where T is the fraction of light exiting the cell after a
certain number of passes n. Using the speciﬁed responsivity of the sample photodetector
(> 366600VW−1) and the measured voltage to estimate the power in the beam entering
the Herriott cell gave a power of ∼ 38μW. The power at the sample photodetector after
multiple passes in the Herriott cell was estimated to be ∼ 5μW. This measured transmission
of 13%, equates to a maximum of 255 passes, assuming the speciﬁed mirror reﬂectivities
of 99.2% were sustained. In practice, despite the use of air ﬁlters, the reﬂectivities will
be lower and it is likely that the actual number of passes is also lower. It is important to
note that, while the number of passes will aﬀect performance, it is not necessary to know
the precise number of passes in order to calibrate the instrument. Absolute calibration is
achieved using a known reference standard as described in section 3.4.
3.6 Discussion
In this chapter the development of the portable instrument has been described in detail.
The instrument design is based on that of the previously developed lab-based systems.
However, the requirement for a on-site use in a clinical setting has required a size reduction
and a key change to the laser cooling.
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The closed-loop cooling system, which has dispensed with the need for liquid nitrogen,
was purchased as a commercial piece of equipment (Cryotiger, Megatech Ltd) and over-
all has been extremely successful in the instrument. However, initially this aspect of the
instrument development presented the greatest challenge. The need for careful thermal
management and adequate ventilation for the compressor was diﬃcult to achieve in accor-
dance with the speciﬁcation that the instrument be compact. However, successful thermal
management was eventually achieved via the addition of more fans to the instrument case
and careful foam partitioning, enabling long-term uninterrupted use. Given that the base
section of the instrument, containing the compressor, accounts for almost one half of the
instrument bulk, future generations of the technology could be made signiﬁcantly more
compact by incorporating a laser that is operational at room temperature.
The length reduction of the Herriott cell also presented new challenges not experienced
in the development of the lab-based systems. Diﬃculties were encountered when aligning
the cell for the higher number of passes due to the shorter cell being signiﬁcantly more
sensitive to input beam size and focusing. These diﬃculties were overcome by calculating
the theoretically required beam parameters. Applying this in practice made the alignment
process easier and a suﬃciently long pathlength was obtained to enable sub-ppb ethane
detection.
A number of additional factors contributed to the overall size reduction of the instru-
ment: the optical breadboard supporting the injection optics has been made more compact
through careful planning and design; smaller PSDs have been incorporated, all electronics
has been custom-designed and are housed in a compact metal box. Despite the changes
described above, the performance of portable system has not been compromised when com-
pared to the lab-based system and higher performance has been observed with the portable
system. The following chapter presents results and discussion of the characterisation of the
portable instrument.
A paper reporting on the development and performance of the new instrument has been
published in Measurement Science and Technology [64].
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Chapter 4
Characterisation of the
spectroscopy system
This chapter reports on the instrument performance in terms of sensitivity, accuracy and
selectivity. Noise sources and other factors contributing to the performance are analysed
and discussed.
4.1 Performance
4.1.1 Sensitivity
The instrument has a sensitivity to ethane of 70 ppt with a 1Hz sample rate. Using the
absorption coeﬃcient α(ν0) ≈ 11 cm−1 (from section 2.2) this means that the instrument
can detect a minimum absorbance of
α(ν)bc = 1.1 · 10−3 · 100 · 70 · 10−12 = 7.7 · 10−6 (4.1)
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Figure 4.1: The performance of the ethane spectroscopy system. (a) Nitrogen gas measured
over 60 s. (b) Room air measured over 10min, with regular nitrogen zero-referencing.
The sensitivity is deﬁned as the standard deviation in the reported ethane concentration
when measuring hydrocarbon-free nitrogen gas. Figure 4.1 a shows a measurement of nitro-
gen gas (BOC Gases) over one minute. The mean concentration was found to be 0.01 ppb
with a standard deviation of 0.07 ppb. This typical measurement standard deviation is
also seen over a time interval of a few seconds and is not signiﬁcantly improved by further
increasing the measurement (averaging) time interval. An example of ambient ethane mea-
surement with regular nitrogen zero-referencing is shown in ﬁgure 4.1 b. For the reported
ethane concentration of 1.83 ppb (a typical ambient ethane level) the standard deviation
was again 0.07 ppb. Exhaled human breath also contains low concentrations (ppb) of
ethane. Figure 4.2 shows example measurements of exhaled breath ethane for both online
and oﬀ-line samples. In particular, online sampling with the achieved sensitivity allows the
increase in ethane associated with the gas exchange regions within the lung to be observed
over the course of a single exhalation (the so-called alveolar gradient). Analysis of breath
ethane is discussed in detail in chapter 6.
The sensitivity of the instrument is limited by a combination of intensity noise, detector
noise, electronic noise and optical fringing, further discussed in section 4.3. Although
concentration measurements are taken in a 1Hz bandwidth the instrument response time
is 2.5 s, limited by the ﬂow rate of gas into the sample cell.
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Figure 4.2: Example breath ethane measurements. (a) Room air followed by a breath
sample contained in a Tedlar sample bag. (b) Room air followed by a breath sample
exhaled directly into the instrument. In the latter case the rise in ethane can be detected
over a single breath
4.1.2 Accuracy
The accuracy of the instrument is considered in terms of its absolute calibration and
reproducibility as determined in the following experiments.
Calibration test 1
A test was performed to determine the agreement between the measured ethane concen-
trations and empirically calculated ethane concentrations of a series of gas samples. The
instrument was initially calibrated by measuring an ethane sample certiﬁed at 4.01 ppb
± 2% (National Physical Laboratory). The instrument calibration factor was adjusted
accordingly via the control on the front panel in the LabVIEW software. The ethane con-
centration was then recorded to be 3.9 ppb with a standard deviation of 0.07 ppb over a
30 s period.
The empirical gas mixes were obtained by ﬁrst ﬁlling a 100 l Tedlar gas sample bag (SKC
Ltd) to its full capacity of 110 l with hydrocarbon-free nitrogen gas. Then 10ml of ethane
at a concentration of 50 ppm±2% (BOC gases) was added to the sample bag through the
septum at the inlet tap using a syringe with a ﬁne needle. The septums reseal automatically
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Figure 4.3: Instrument calibration. (a) A sequence of measured ethane concentrations
showing agreement of 87 % with empirically calculated ethane concentrations. (b) A sec-
ond sequence of measured ethane concentrations also showing agreement of 93 % with
empirically calculated ethane concentrations. The agreement is seen to be highly linear for
both sequences.
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after being pierced. The gas mixture in the bag was allowed to mix for several minutes
before measurement. Gas was drawn from the 100 l bag into the instrument for 20 s,
corresponding to a removed volume of 1 l. The ethane concentration and standard deviation
was recorded. 10ml of 50 ppm ethane was then added to the remaining gas volume and
the process was repeated ﬁve times. In addition a small bag was ﬁlled with nitrogen
gas and measured as a zero reference. Errors on the empirically calculated mixes were
approximately 10% of the concentration while the measured errors (standard deviation
during measurement) were less than 0.1 ppb. Figure 4.3 a shows a plot of the experimentally
determined ethane concentrations against the calculated empirical concentrations with an
added trendline. The R2 value of 1.00 shows the relationship is linear and the gradient of
the of 0.87 shows that the measured and empirical readings agree to an overall accuracy
of 87%.
Calibration test 2
A second calibration test was performed using a modiﬁed technique to produce a series of
gas samples at empirically calculated ethane concentrations. Six Tedlar bags were ﬁlled
with nitrogen until they were at full capacity (5.5 l). Diﬀering volumes of 50 ppm± 2%
ethane was then added to ﬁve of the bags using a syringe as described above. The added
volumes were 2, 4, 6, 8 and 10ml while the remaining bag contained only nitrogen. The
empirical ethane concentration of each bag was calculated and the ethane concentration
and standard deviation was then measured for each. The results were plotted and are
shown in ﬁgure 4.3 b. Again the relationship is highly linear (R2 = 1) with an agreement
of 93% between the empirically calculated and measured ethane concentrations.
These calibration techniques were repeated and it was found that the agreement between
the empirical and measured ethane concentrations was generally better than 80%. Since
the agreement is always seen to be highly linear, the important factor appears to be the
initial calibration of the instrument with a known concentration. Therefore, for breath
ethane measurements obtained during our clinical trials, the instrument was regularly
calibrated using a certiﬁed ethane sample 4.01 ppb± 2%. For other applications where
higher ethane levels were recorded, the calibration was checked using a source at ∼ 90 ppb,
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obtained from careful dilution of our 50 ppm ethane gas cylinder.
Repeatability test
Figure 4.4 a shows the concentration reproducibility when measuring a constant ethane
sample every 2 min over a period of 12min. The mean ethane concentration was 4.58 ppb
with a standard deviation of 0.04 ppb. The range in the measurements was 0.13 ppb. The
ethane concentration was then measured approximately every 30min for 4 hrs as shown
in ﬁgure 4.4 b. The mean ethane concentration over the 4 hr period was 4.53 ppb with a
standard deviation of 0.05 ppb. The range in the measurements was 0.13 ppb. Therefore
the error in repeatability for an ethane concentration of 4.5 ppb is found to be within the
value of 0.07 ppb for the sensitivity. When measuring higher concentrations the range
in the measurements is higher. For example a gas sample measured twenty times over a
period of 4 hours and 30min was found to have a mean ethane concentration of 20.67 ppb, a
standard deviation of 0.02 ppb and a range of 0.76 ppb. In general, repeated concentration
measurements over a period of several hours were found to agree to within 3%.
The repeatability is limited by the eﬀects of thermally induced changes in alignment,
drift of electronic oﬀsets and shifting optical fringing patterns. As described in section
3.4, zero-referencing with nitrogen gas is used to reduce the eﬀects of optical fringing.
Repeatability within each zero-referencing interval is maintained at ∼ 0.07 ppb provided
that the referencing intervals occur with suﬃcient regularly (∼every 60 s). Longer term
repeatability (within ∼ 3%) is aﬀected by changes in light levels at the photodetectors
(see section 4.6.2) and drifting electronic oﬀsets. The instrument was always calibrated on
start-up to take account of day to day variations in these parameters.
4.1.3 Selectivity
Operation at low pressure is vital for selectivity as it reduces the overlap between neigh-
bouring transitions. Figure 4.5 shows the transmission of water, methane and ethane at
a pressure of 40mbar, temperature of 296K over a 100m pathlength from the HITRAN
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Figure 4.4: Reproducibility of measurements of a constant ethane sample over a period of
(a) 12min (b) 4 hrs. The readings agree to within 0.07 ppb. In general, the concentration
reproducibility is better than 3%.
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Figure 4.5: Water, methane and ethane transitions given by the HITRAN database for a
pressure of 40mbar, temperature of 296K over a 100m pathlength.
database. The ethane absorption lines of 2990.09 cm−1 and 2986.72 cm−1 are chosen due
to their isolation from large absorption features of atmospheric species such as water and
methane.
Ideally, rather than zero-referencing using nitrogen, a gas would be used containing all
species in the sample to be measured in the same concentration with only ethane absent.
This of course is impossible to achieve in practice and therefore low concentrations of
background species remain a small source of error.
The cross sensitivity to other species depends on absorbance due to slight overlap with
neighbouring transitions and also due to the fact that the laser emission may not be
completely single-mode. Absorption of light from other laser modes can overlap with an
absorption line of a contaminating species. The cross–sensitivity to methane, for example,
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was found to vary between 10000:1 and 1000:1 as the modal properties of the laser were
observed to decline over time.
The presence of signiﬁcant interference from contaminants was easily established using
our detection technique: Via the LabVIEW software, the proﬁle of the ethane absorption
transition could be continually monitored. In the rare case of contamination, the shape
of the ethane transition was visibly distorted on the laptop screen. In such cases, the gas
samples could be discarded. Generally, problems with contamination were not encountered
but care was needed during our clinical trials, for which a range of cleaning ﬂuids were
used. This is further discussed in section 7.2.3.
4.2 Theoretical contribution of noise sources
Theoretical noise contributions were calculated using the datasheet speciﬁcations for pho-
todetectors and electronic equipment and estimating the power at the sample photode-
tector. Experimental noise contributions from the detectors and electronics were then
measured using a Stanford Research Systems SR780 analyser and the results compared.
4.2.1 Detector noise
The sample and reference detector modules (VIGO PVI-2TE) each consist of an infrared
detector optimised for 3.4μm operated in photovoltaic mode, combined with a DC coupled
voltage preampliﬁer (VIGO MVPDC). These modules were chosen as they are extremely
compact (dimensions 70 x 45 x 19mm) and oﬀer a high detectivity (D∗), speciﬁed to be
∼ 2 · 1011 cmHz1/2 W−1.
The noise equivalent power (NEP) gives an indication of the size of the minimum signal
that can be detected with the photodetector modules. Using the stated detectivity of D∗ =
2 · 1011 cmHz1/2 W−1, the photodetector active area of A=1mm2 and the measurement
bandwidth of Δf = 33.3Hz (corresponding the PSD time constant setting of 30ms), the
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NEP was calculated as
NEP =
√
AΔf
D∗
=
√
0.01 · 33.3
2 · 1011 = 2.89 · 10
−12 W = 2.89 pW (4.2)
For a laser temperature T =89.7K and laser current I =0.565A, the measured voltage at
the sample photodetector is ∼ 1.8V. From the speciﬁed responsivity of the photodetector
module (3.67 · 105 VW−1) this equates to an approximate power at the sample detector of
5μW.
Therefore
Detector noise – to – signal =
NEP
P
=
2.89 · 10−12
5 · 10−6 = 5.77 · 10
−7 (4.3)
4.2.2 Shot noise
The ethane transition at 2990.01 cm−1 corresponds to a frequency of ν =89.7THz
Therefore the energy E of each photon
E = hν = 5.95 · 10−20 J (4.4)
No of photons at a given power P
Photon No. (P ) =
P
E
(4.5)
For a power of 5 μW at the sample photodetector,
Photon No. (5μW) =
5 · 10−6
5.95 · 10−20 = 8.4 · 10
13 s−1 (4.6)
Shot noise – to – signal =
√
Photon No. (P )Δf
Photon No. (P )
=
√
8.4 · 1013 · 33.3
8.4 · 1013 = 6.30 · 10
−7 (4.7)
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Figure 4.6: Calculated noise to signal ratios for shot, detector and electronic noise. At a
power of 5μW at the sample photodetector the shot noise is marginally dominant.
Therefore it appears that for a power at the sample photodetector of 5μW the shot noise
and detector noise are approximately equal, with the shot noise being marginally dominant.
Electronic noise was minimised by using low noise op-amps to amplify the detected AC
signals pre-PSDs as described in section 3.1.3. In theory, the speciﬁed voltage noise of
1 nVHz−1/2 for the op-amps would dominate the electronic noise contributions.
Figure 4.6 shows how the theoretical contribution from the detector noise, shot noise and
electronic noise vary with power at the sample photodetector. At a power of 5μW at
the sample photodetector the shot noise dominates. For power 4μW the detector noise
dominates the shot noise.
From the HITRAN database, the fractional absorption coeﬃcient for 1 ppb ethane is
1.1·10−6 m−1 at λ=2990.01 cm−1, P= 40mbar, T=296K. The theoretical contribution
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Noise source Theoretical Ethane detection
signal to noise ratio limit (ppt)
Electronic 1.56·108 0.06
Detector 1.70·106 5.34
Shot 1.57·106 5.78
Combined 1.15·106 7.87
Table 4.1: Theoretical noise contributions. The resulting ethane detection limit was cal-
culated using the fractional absorption coeﬃcient for 1ppb ethane at λ=2990.01 cm−1,
P=40mbar, T=296K and over a 100m pathlength.
of each noise source to the ethane sensitivity was calculated using the signal to noise ratio
and this fractional absorption coeﬃcient over a 100m pathlength. The results are shown
in table 4.1.
4.3 Experimentally determined contribution of noise sources
4.3.1 Measured noise spectra
Figure 4.7 shows noise spectra measured at the detection frequency of 16 kHz at the output
of the detection electronics but before the PSDs. The basic electronic noise was measured
by grounding the circuit at the photodetector input with a 50Ω terminator. The combined
contributions due to detector noise, electronic noise and intensity noise are also shown.
The intensity noise includes shot noise, laser amplitude noise and vibration-induced noise.
Since each noise measurement included the previous noise source the eﬀective individual
contributions due to detector noise and shot noise were calculated by quadrature subtrac-
tion. The corresponding signal to noise ratios and contributions to the ethane sensitivity
were calculated and the results are shown in table 4.2.
The achieved working sensitivity of 70 ppt agrees extremely well with the sensitivity cal-
culated from noise measurements. However, this value is a factor of 10 higher than that
calculated directly from the theory using photodetector datasheet speciﬁcations.
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Figure 4.7: Noise spectra measured post-photodetector electronics but pre-PSDs. The
contributions due to shot and laser amplitude noise, photodetector noise and electronic
circuit noise (circuit grounded at photodetector input with a 50Ω terminator) are shown.
Noise source Measured noise Signal to noise Ethane detection
(nVHz−1/2) ratio limit (ppt)
Electronic 1089 2.86·105 32
Detector 1499 2.08·105 44
Intensity 1416 2.20·105 41
Combined 2332 1.34·105 68
Table 4.2: Measured noise contributions. The resulting ethane detection limit was cal-
culated using the fractional absorption coeﬃcient for 1 ppb ethane at λ=2990.01 cm−1,
P=40mbar, T=296K and over a 100m pathlength.
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There are a number of possible reasons that the experimentally determined signal to noise
ratio is lower than that calculated theoretically.
Thermal noise
An additional source of noise will be thermal (Johnson) noise due to the resistance, R, of
the photodetector module. This resistance is the total equivalent resistance, including the
internal resistance of the detector and the load resistance from the circuit, at the output
of the detector [65]. The thermal noise current, ith, (per root Hz) is given by
ith =
√
4kT
R
(4.8)
Current noise
The optical signal to noise ratio has been computed for shot noise. This translates to
photodiode current through
signal – to – noise =
Poptical√
2ePoptical
=
√

2e
·√Poptical =
√
ηPoptical
2hν
(4.9)
where  is the responsivity and η is the quantum eﬃciency of the detector. Therefore the
signal to noise ratio for shot noise is reduced through the quantum eﬃciency.
Second harmonic component
The signal to noise calculations have been made on the basis of the peak height of the direct
absorption line. However it is the second harmonic component that is actually measured.
At the optimum modulation index of 2.2 the central peak height the is ∼ 0.33 times that
of the absorption line peak. Therefore the signal to noise ratios will be lower than those
previously calculated.
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Finally, it is worth noting that the calculated ethane sensitivity values in tables 4.1 and 4.2
are based on a signal to noise ratio of unity. In practice a higher ratio (≥ 2) is required.
4.3.2 Eﬀect of reducing power
Since detector noise–to–signal is inversely proportional to the power and shot noise–to–
signal is inversely proportional to the square root of the power the dominant noise source
was determined experimentally by reducing the laser power at the sample detector by
adjusting the beam alignment and measuring the resulting decrease in sensitivity. Figure
4.8 a shows the dependence of the standard deviation in measured ethane concentration
(over 30 s) on the power at the sample photodetector module. The measured sample was at
a constant concentration of 1.53 ppb. Changes in reported concentration due to the changes
in light levels were compensated for. As shown in ﬁgure 4.8 b, the sensitivity appears
to be proportional to the square root of the light level, suggesting that the shot noise
does dominate the detector noise. These experimental results agree with the theoretical
calculations that the shot noise dominates slightly over detector noise.
4.3.3 Comparison of vibrational noise
Vibrational noise is introduced from the compressor and vacuum pump within the base
compartment of the instrument. However, the overall sensitivity is not compromised as
compared to the previous lab-based system in which the pump is isolated and liquid ni-
trogen is used. A comparison of the DC light levels from the sample cell photodetector
in the lab-based system and the portable system is shown in ﬁgure 4.9. Despite the con-
siderable increase in vibration-induced intensity noise at the photodetectors there is no
up-conversion of this noise compromising the signal at the detected frequency of 16 kHz.
This is reassuring since it would otherwise be diﬃcult to suppress such noise, given the
need for a compact design.
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Figure 4.8: a) The eﬀect of reducing the power at the sample photodetector on the standard
deviation in reported ethane, for a constant concentration of ethane measured over a 30 s
time period. b) It can be seen that the standard deviation is approximately inversely
proportional to the square root of the sample light level, suggesting that the shot noise
dominates the detector noise.
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Figure 4.9: Comparison of DC-coupled intensity noise measured at the sample cell pho-
todetectors in the new portable instrument and existing lab-based system. Despite clear
coupling of vibration from the compressor and pump housed within the new unit, potential
up-conversion of this noise has no noticeable eﬀect on measured sensitivity.
4.4 Laser parameters
4.4.1 Temperature and current
The laser output wavelength is tuned to an ethane transition by adjusting the laser tem-
perature and current. Increasing the laser temperature decreases the wavelength and vice
versa. Increasing the current also has the eﬀect of decreasing the wavelength. A change
in wavelength of 1 cm−1 could be achieved by a temperature change of ∼ 2K or a current
change of ∼ 20mA. Datasheets are supplied for each laser (Laser Components) in which
output wavelength, power and mode purity are speciﬁed for a range of current values at
four diﬀerent temperatures. Figure 4.10 shows one page of the datasheet for the laser used
in the portable instrument.
The charts suggest that the optimum performance of the laser for our application would
be at a temperature of 88K and current of 630mA. This choice of parameters should give
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Figure 4.10: Datasheets are supplied for each laser (Laser Components). The charts pro-
vide a useful reference point for the initial selection of the laser and for use in locating
temperature and current values for single-mode, highest power operation at the required
wavelength.
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Figure 4.11: Laser current and temperature values which resulted in an output wavelength
that corresponded to an ethane absorption transition.
single mode output at 2990 cm−1, corresponding to one of our two target ethane transition
wavelengths. These charts are useful guidelines as a starting point to locate the wavelength
which corresponds to a particular gas transition. In practice, the precise temperature and
current values corresponding to the wavelength of an ethane transition wavelength were
obtained by systematic variation of these parameters while scanning the laser in the usual
second derivative detection set-up and manually ‘searching’ for the gas transition using
a high concentration of the gas in a reference cell. Once a transition was located in the
reference channel, it was easy to verify if it was actually an ethane transition by ﬁlling
the cell with a gas sample of high ethane concentration and observing the eﬀect on the
sample channel. Following the location and identiﬁcation of an ethane transition, the
corresponding temperature and current settings were saved in the LabVIEW software to
enable the transition to be easily re-located upon instrument start-up.
Figure 4.11 shows the laser temperature and current values which produced an output
wavelength that corresponded to an ethane transition. Using the supplied mode charts it
was possible to estimate the wavenumbers of these transitions. The presence of a triplet
of strong methane transitions centred around 2988.93 cm−1 made the identiﬁcation of the
2990.09 cm−1 ethane transition easier (see ﬁgure 4.5). The ethane transitions were tracked
by slowly adjusting the laser temperature and compensating for the induced wavelength
change by adjusting the laser current accordingly. In order to also optimise the temperature
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and current settings for modal quality the height of the reference second derivative signal
was normalised to the detected light level and was monitored.
The laser was generally operated a temperature of 87.6K with a current of 630mA, corre-
sponding to the ethane transition at 2990.1 cm−1. These parameter settings were found to
give the optimum performance, with a high detected power and best mode quality than at
other allowable current/temperature combinations.
4.4.2 Modal purity
According to the datasheets the above temperature and current settings should have yielded
single mode operation of the laser. The lack of interference from other species suggested
that either the output was single mode or that any small fraction of power in other modes
was not signiﬁcant enough to cause noticeable interference. However the temperature
and current parameters often required slight adjustment after thermal-cycling of the laser
system. After the laser had been in use for over approximately two years this required
adjustment became more signiﬁcant. Despite the possibility of multimode operation, opti-
mum instrument performance more recently was found to be at lower current and higher
temperature values, of around T=89.7K and I=565mA. It appeared that the modal
properties of the laser had changed, as has been observed in the previous systems. This is
further discussed in section 4.7.
4.5 Further system parameters
4.5.1 Modulation
The modulation parameters (frequency and depth) used were chosen in accordance with
those calculated and optimised for maximum sensitivity in the previous systems. For
the lab-based systems developed in the Glasgow Optics group, the modulation frequency
was made variable and an optimum modulation frequency of ∼ 8 kHz was determined.
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Current modulation (mA) Wavelength change (nm) Ethane sensitivity (ppb)
0.33 0.01 0.19
0.67 0.03 0.08
1 0.05 0.17
Table 4.3: Varying the modulation depth aﬀected the ethane sensitivity, with an optimum
performance when the peak wavelength change corresponded to the transition linewidth.
The major increase in noise introduced by the design of the portable instrument is due to
vibration noise, which has been shown to be insigniﬁcant at 8 kHz (section 4.3.3). Therefore
the modulation frequency of the oscillator chip was set at 8 kHz in keeping with previous
systems and a ﬁxed resistor was used to keep the control electronics compact.
The FWHM linewidth of the ethane transition at 2990 cm−1 at a pressure of 40mbar and
a temperature of 296K is found from HITRAN to be Γ=0.03 nm=780MHz. The laser
linewidth is ∼ 30MHz. The wavelength modulation depth for the portable instrument
was initially chosen to be approximately equal to the transition linewidth, as was used
for the previous lab-based systems. The wavelength change of 0.03 nm corresponded to
an adjustment of the laser current by 0.7mA, achieved via the modulation signal input
on the laser controller. By varying the strength of the modulation, it was found that this
initial choice of modulation depth was approximately the optimum (See table 4.3). Details
concerning the theoretical optimisation of both parameters for our detection scheme were
discussed in [66].
4.5.2 Optical pathlength
The instrument sensitivity to ethane is dependent on the optical pathlength in the Herriott
sample cell. Although increasing the pathlength increases the absorption, the exiting light
level is also reduced. Therefore there will be an optimum number of passes to give the high-
est signal to noise ratio. Figure 4.12 a shows the theoretical transmitted fraction of incident
power after light losses due to two window transmissions and n passes in the Herriott cell,
using the speciﬁed mirror reﬂectivity of 99.2%. The theoretical gain in sensitivity for n
passes as compared with 1 pass is shown in ﬁgure 4.12 b. However, the gain in sensitivity
will scale either linearly or by the square root of the power, depending on the dominating
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Figure 4.12: (a) The theoretical fraction of incident power exiting the Herriott cell after
two transmissions and n reﬂections. (b) The theoretical gain in sensitivity by increasing n
as compared with 1 pass. This is shown for both a linear and square root dependence on
power at the sample detector
noise source. This is itself dependent on power. As calculated in section 4.2, for a power at
the sample detector of 5μW, the shot noise and detector noise are approximately equal and
therefore it is extremely diﬃcult to theoretically determine the precise optimum number of
passes. It appears from 4.12 b that the optimum will be around 200 passes and estimates
of pass number based on relative detected light levels (as described in section 3.5) suggest
that this has been achieved.
These results can be made more general by using the sensitivity S as
S ∝ nRn (4.10)
or in the case of shot noise limited sensitivity
S ∝
√
nRn (4.11)
Diﬀerentiating with respect to n and setting
dn
dS
= 0 (4.12)
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gives the maximum S as
n = − 1
lnR
(4.13)
or in the case of shot noise limited sensivity
n = − 2
lnR
(4.14)
With the mirror reﬂectivity of R = 0.992, this gives n∼120 or, for shot noise limited
sensitivity, n∼250.
4.5.3 Pressure
Optimum pressure
The operating pressure of 40mbar was chosen as it was previously determined to be a
good compromise between sensitivity and selectivity [66]. As described in section 2.1.1,
the transition linewidths depend on pressure and temperature. At a constant temperature
the linewidth scales linearly with the pressure and the Lorentzian half linewidth is given
by γL = bP, where b is the pressure broadening coeﬃcient. For ethane the air broadening
coeﬃcient is b =0.67 cm−1MPa−1 [67]. Decreasing the pressure reduces the linewidth,
increasing selectivity, until Doppler broadening becomes signiﬁcant. Since the reference
cell in the instrument contains ethane in nitrogen gas while the sample cell contains ethane
in ambient air, diﬀerences in pressure broadening may be a source of error.
For λ0 =2990.09 cm−1, T =296K and M =30 amu, the Doppler half linewidth is calculated
to be γD =3.36·10−3 cm−1. At 40mbar the Lorentzian half linewidth γL = 3.95·10−3 cm−1,
which is comparable with the Doppler half linewidth. In this region where the Doppler
and pressure broadened widths are comparable the total eﬀective line proﬁle shape is
given by the Voigt line shape. This lineshape is a convolution of the Gaussian (Doppler)
lineshape with the Lorentzian (pressure broadened) proﬁles. Figure 4.13 shows the direct
absorption Voigt lineshapes at 7 diﬀerent pressures obtained from HITRAN corresponding
to an ethane concentration of 1 ppm, temperature 293K over a 100m pathlength. A high
ethane concentration was used to avoid a severely quantised output.
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Figure 4.13: Theoretical Voigt transition proﬁles found using HITRAN for direct absorp-
tion at 7 diﬀerent pressures. Ethane concentration 1ppm, temperature 293K and 100m
pathlength.
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Pressure monitoring
The Herriott (sample) cell is maintained at a pressure of 40mbar to within 2% using a
regulator valve on the inlet to the cell and monitored in the LabVIEW control software
using a pressure gauge (BOC Edwards, APG100).
The reference cell is ﬁlled with ethane at a concentration of 500 ppm± 2% at a pressure
of 40± 0.1mbar. For a ﬁxed amplitude of scan (i.e. amplitude of laser current ramp)
the observed width in the LabVIEW control software of the measured reference ethane
transition is dependent on the cell pressure. Therefore any signiﬁcant increase in pressure
(i.e. a leak) is easily identiﬁed by an increase in the observed width of the ethane transition.
Eﬀect of pressure variation
Changes in pressure aﬀect the reported ethane concentration and the accuracy is therefore
dependent on the average pressure being maintained at the constant value of 40mbar. Fluc-
tuations in pressure about the average value aﬀect the sensitivity rather than the accuracy.
As described in section 3.1 the reported sample cell concentration is based on curve ﬁtting
between the demodulated signals from the reference and sample photodetectors. The least
squares ﬁtting algorithm in the LabVIEW software compares the 2f lineshape from the
sample channel to that of the reference channel and reports coeﬃcients for the scaling
factor and oﬀset. It is the scaling factor that is used to calculate the ethane concentration.
A increase in sample cell pressure will increase the absorption as there is more gas in the
cell, as shown in ﬁgure 4.13. This will aﬀect the 2f lineshape and leading to a change in
reported ethane concentration. This was tested by adjusting the sample cell pressure via
the valve on the inlet to the cell and recording the height of the sample 2f lineshape.
The results, shown in ﬁgure 4.14, show that the height of the 2f lineshape is directly
proportional to the pressure. As expected, this has a direct eﬀect on the reported ethane
concentration, also shown in ﬁgure 4.14. The reported ethane concentration was found to
be linearly proportional to the pressure over the 10–60mbar range.
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Figure 4.14: Measured eﬀect of sample cell pressure on the magnitude of the 2f sam-
ple lineshape and on the reported ethane concentration. Both were found to be linearly
proportional to the sample pressure (reference cell pressure kept constant).
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The experimental results suggest that maintaining the Herriott cell pressure to within
± 2mbar would reduce changes in reported ethane concentration to <1.5%. The reference
cell pressure is manually checked every few months and reﬁlled if necessary.
4.6 Other factors aﬀecting performance
4.6.1 Ambient temperature
The instrument was generally operated with good performance across a range of tem-
peratures both indoor and outdoor and no problems were encountered with temperature
variations during an outdoor ﬁeld trial of the instrument (See chapter 5).
However, large increases in ambient temperature ( 22 oC) were sometimes found to af-
fect the overall instrument performance. Initially, overheating aﬀected operation of the
instrument only while the lid was on, decreasing the performance of the photodetectors
and resulting in signiﬁcant loss of sensitivity. This was solved by the addition of larger
heatsinks and two computer cooling fans mounted on the photodetector modules. A more
serious issue was that the compressor was occasionally unable to maintain the required
laser temperature of around 90K. This was usually solved with thermal-cycling. More
recently, diﬃculties were encountered in even achieving the required low temperature for
laser operation. The eﬀect of ambient temperature and other factors on this was investi-
gated. The problem was eventually solved by replacing the compressor, after it transpired
that it had unexpectedly reached the end of its lifetime earlier than predicted.
An experiment was attempted to assess the eﬀect of temperature on the instrument sen-
sitivity. The instrument was operated in the lab and was measuring room air with all
doors and windows closed while the ambient temperature was increased using the air con-
ditioning/heating system and a number of electrical heaters. However in practice it was
extremely diﬃcult to control and measure the temperature the instrument was exposed
to, as there were large spatial ﬂuctuations in temperature across the room. No signiﬁcant
results were deduced from this experiment.
74
CHAPTER 4. CHARACTERISATION OF THE SPECTROSCOPY SYSTEM
4.6.2 DC light levels
To centre the scan of the laser wavelength over the ethane transition the supplied laser
current can require ﬁne adjustment on instrument start-up and often requires greater ad-
justment after thermal-cycling. The DC light levels at the reference and sample photode-
tectors depend strongly on the laser current. In addition, these light levels can slowly vary
during instrument operation due to thermally-induced changes in alignment. Therefore,
the calculated ethane concentration was multiplied by the ratio of the light reference DC
light level to the sample DC light level. This technique was used to normalize for changes
in the overall light level and also for relative changes in the DC levels between the pho-
todetectors. However the technique relies on the linearity of the photodetectors for both
DC and AC signals.
The eﬀect of varying the detected light levels on the reported ethane concentration was
investigated by adjusting the beam alignment. The results are shown in ﬁgure 4.15. The
slightly non-linear response of the detectors is signiﬁcant when the light levels are aligned
to below 50% of the maximum. However, thermally-induced alignment changes are nor-
mally within 25% of the maximum light levels and the impact on the reported ethane
concentration is small.
In addition to genuine changes in light level at the photodetectors, the reported values
vary due to drifting oﬀsets of the various stages of detection electronics, particularly the
photodetector modules. Oﬀsets can be compensated for in the LabVIEW software by
blocking the laser beam for a few seconds and manually adjusting the compensation value
in the program. This technique was found to be preferable to switching oﬀ the laser: The
heating caused by switching the laser back on results in a temporary change in wavelength
of the laser light. This can require up to a few minutes to settle down, often requiring ﬁne
adjustment of the laser current to return to the necessary working wavelength.
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Figure 4.15: Changes in reported ethane concentration due to reduced light levels at sample
and reference photodetectors
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4.6.3 Optical fringes
Optical fringing aﬀects the instrument accuracy and sensitivity, setting a limit on the time
intervals between zero-referencing. The fringes arise from reﬂections between objects at a
distance L apart. Optical fringes are observed in the reference channel with approximate
spacing of 0.6 nm. The spacing between the two surfaces causing back reﬂections and
therefore optical fringing can be calculated as follows:
Constructive interference occurs when 2L = mλ, where m is an integer.
Constructive interference next occurs for the new wavelength 2L = (m + 1)λnew
mλ = (m + 1)λnew =⇒ m = λnew
λ− λnew =
λnew
Δλ
 λ
Δλ
(4.15)
∴ L = mλ
2
=
λ2
2Δλ
(4.16)
For λ=3.34μm and a fringe separation of Δλ=1nm
L =
(3.34 · 10−6)2
2 · 10−9 = 0.0056m = 5.6mm (4.17)
This separation corresponds to the distance between the reﬂecting surfaces in the calcium
ﬂuoride beam splitter (5mm). These fringes were minimised by placing the beam splitter
at an angle of 45 o to the incident beam. Additional fringes were also observed in the
reference channel of ∼ 0.05 nm spacing corresponding to a separation distance L=11.2 cm.
This distance corresponds to the length of the reference cell and the fringes were suppressed
by maximizing the angle that the beam entered the reference cell. Weak optical fringes
with spacing 0.3 nm were observed in both the sample and ref channel and may be due
to back reﬂections between the microscope objective and the laser dewar window. These
could have been reduced with the use of a parabolic mirror to collimate the light exiting
the dewar, rather than the microscope objective.
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Sampling time 1 s
Response time 2.5 s
Ethane sensitivity 0.07 ppb
Minimum detectable absorption coeﬃcient 1.05 · 10−9 cm−1 Hz−1/2
Repeatability 3%
Cross-sensitivity to methane 0.1 – 1 ppb ethane per 1 ppm methane
Operating laser temperature 87.6K
Operating laser current 630mA
Modulation frequency 8 kHz
Modulation depth 780MHz
Optical pathlength ∼ 108m
Sensitivity to pressure change 1.9% per mbar at 40mbar
Maximum ambient operating temperature ∼ 25 oC
Required alignment 50%
Physical dimensions 1m x 0.5m x 1m
Weight ∼ 200 kg
Power requirement 1.8 kW
Table 4.4: Instrument speciﬁcation
4.7 Discussion
In this chapter the instrument has been characterised in terms of its sensitivity, accuracy
and selectivity. An instrument speciﬁcation is given in table 4.4. The sensitivity to ethane
of 70 ppt over a 1Hz sampling rate corresponds to a minimum detectable absorption coef-
ﬁcient of 1.05 · 10−9 cm−1 Hz−1/2. The noise sources contributing to this sensitivity were
investigated. The measured intensity noise was found to be around a factor of 10 higher
than the calculated shot noise. However the actual intensity noise will include additional
factors such as such as laser amplitude noise and vibrational induced noise. Since the
detector noise was also found to be almost a factor of 10 higher than expected a possible
explanation is that the detector responsivity, speciﬁed to be > 36000VW−1, was actually
much higher than this and therefore the estimated power at the photodetectors was there-
fore too low. However, even taking this into account, the electronic noise was found to be
signiﬁcantly higher than expected. It is possible that electrical noise from the oscillator,
the ﬁlters and/or the power supplies aﬀected the detected signals. This would have been
investigated much further had there not been a the need for immediate use of the instru-
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ment in a number of clinical trials. On the whole, however, the achieved sensitivity of
70 ppt for the portable system is actually better than the previous lab-based system which
had a sensitivity of 100 ppt.
The modulation depth, optical pathlength and operating pressure were also considered.
These parameters are similar in the sense that the optimisation of each is a compromise.
A large modulation depth gives a strong second derivative signal, but it must not be so
large that the signal is averaged out. Increasing the optical pathlength will increase the
absorption, but the reduced detected power results in a lower signal to noise ratio. While
increasing the pressure also increases absorption, it must be kept low enough to achieve
the required selectivity.
Thermal management issues were solved to a certain extent to deal with the eﬀect of
variations in ambient temperature. However the instrument performance is still aﬀected
by variation in detected DC light levels and electronic drift. Together with optical fringing,
there is a limit to the length of time the instrument can be operated with good performance
before zero-referencing. The photodetectors were carefully chosen from a limited number
of suppliers and have a high speciﬁed detectivity. However it would perhaps have been
useful to have considered more carefully the thermal stability to reduce drifting oﬀsets.
Optical fringing was reduced as far as possible. The use of a parabolic mirror rather than
a microscope objective may have helped further reduced this.
Finally, single mode operation of the laser is required to prevent absorption signals from
other modes interfering with the signal from the ethane transition. It has been found by the
Glasgow Optics group that single mode operation at one of two transitions, 2986.7 cm−1
and 2990.09 cm−1, is essential for our current and previously reported ethane sensitivity.
While not an easily quantiﬁable source of noise in terms of sensitivity reporting, it does
signiﬁcantly contribute to practical sensitivity. The modal structure of the lasers tends to
decline after prolonged periods, and particularly after thermal-cycling. Thermal-cycling
for the portable instrument was required every few months as power levels and mode pu-
rity were found to decline. Over the three years of laser use, the time intervals required
between thermal cycling decreased from several months to approximately one month. In
our previous systems, after several years the decline of mode purity signiﬁcantly aﬀected
the performance. By replacing the laser diode in our lab-based system a dramatic im-
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provement was instantly seen in the overall performance. The replacement (or at least
detailed re-characterisation) of the laser diode used in the portable instrument could be
useful. However the next generation of the system will instead incorporate a quantum
cascade laser or optical parametric oscillator.
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Field-trial of the portable
spectroscopy system
This chapter describes an outdoor ﬁeld trial in which the performance of the new portable
spectroscopy system was evaluated and data was collected for the further development of
gas dispersion models.
5.1 Background
There are many applications for spectroscopic trace gas detectors in industry [8, 15, 68].
The original motivation behind the development of a ﬁeld-portable ethane sensor at the
University of Glasgow was the potential application to oil prospecting as described in
section 1.5.1. Measurement of ethane concentration along with wind speed and direction
can be inverted to establish a source distribution, allowing rapid and remote surveying of a
large area. Current research in this area also involves the optimisation of gas dispersion and
inverse models for future trials [69]. A ﬁeld trial of the portable instrument allowed us to
gather information which was then used for further development of gas plume dispersion
and inverse models by other members of the Glasgow Optics group. We were also able
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to evaluate the instrument performance during outdoor use for measurements both while
stationary and while in a moving vehicle.
5.2 Outdoor ﬁeld trial
5.2.1 Overview
The trial was conducted at a disused airﬁeld in northern England and comprised a con-
trolled release of natural gas (5% ethane 95% methane) at a rate of 10 lmin−1. The
resulting ethane concentration was measured using the portable instrument at over ﬁfty lo-
cations around a track occupying the perimeter of the airﬁeld. The instrument was housed
in a van and, for the main part of the trial, was driven from one measurement location to
another. At each location the ethane concentration was monitored on a second by second
basis for a six min period via a sample inlet tube mounted above the vehicle. See ﬁgure
5.1. GPS position was also recorded for each location and measurement distances from the
release ranged from ∼ 20m to ∼ 500m. The instrument was also used to perform a number
of real-time gas plume traverses. A map of the measurement locations and plume traverses
is shown in ﬁgure 5.2. The wind speed and direction was simultaneously recorded by an
anemometer permanently located at the base station of the site also shown in ﬁgure 5.2.
The total power requirement, of around 2 kW (see section 3.3) was met by a 4 kVA (2.7 kW
continuous) portable petrol generator, capable of up to 13 hrs of operation between refu-
eling. The generator was transported on a trolley behind the van to reduce the eﬀect of
the vibrational noise on the instrument performance (see ﬁgure 5.1). An additional air
ﬁlter was added to protect against mirror losses in the Herriott cell due to the presence of
airborne dust.
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Figure 5.1: The portable instrument was housed in a van and the generator was trans-
ported on a trolley. Ethane concentration measurements were made via a sample inlet
tube mounted at the top of the vehicle. Measurements of wind speed and direction were
made using an anemometer (shown in the distance).
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typical prevailing wind
during the field trial
500m
gas release
static measurements
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Figure 5.2: Overhead view of the test track showing the tarmac track sections in grey.
The locations of static measurements (red circles) and plume traverses (black squares) are
shown relative to the gas release point (cylinder) and anemometer (green square).
5.2.2 Gas release
A controlled gas release was set up on a road crossing the airﬁeld, as shown in ﬁgure
5.2. A natural gas cylinder (Intertek) with validated ethane concentration of 5.03% was
connected through a regulator to a four-arm tubing pattern, each arm of length 8m as
shown in ﬁgure 5.3. At typical measurement distances of >100m from the cylinder this
more closely resembled an extended area source. The gas release rate of 10 lmin−1 was
checked regularly by determining the time to ﬁll gas sample bags of a known volume and
by also measuring ongoing weight loss from the cylinder using a weigh scale platform.
5.3 Results
Throughout the four days of the ﬁeld trial, an instrument sensitivity to ethane of around
150 ppt was observed. Very little degradation was observed over the trial, during which
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Figure 5.3: The four-arm natural gas release (foreground) and the instrument vehicle in
the distance.
sampling was on an average ∼ 8 hrs per day. This was frequently in the presence of airborne
dust, for example due to crop harvesting in an adjoining ﬁeld.
5.3.1 Measurement while stationary
Figure 5.4 a shows background ethane recorded over one such 6 min period with zero-
referencing using nitrogen gas every ∼ 90 s. This location is outside the plume with an
average ambient ethane concentration of 0.94 ppb and a standard deviation of 0.13 ppb.
In ﬁgure 5.4 b the location is downwind of the release point and ethane concentrations
ﬂuctuate as the plume direction alters with wind. The wind data was also recorded at a
1Hz sampling rate as shown in 5.4 c–d and later synchronised with the ethane data. This
information is being used to optimise methods for gas dispersion and inverse modelling.
5.3.2 Measurements while in a moving vehicle
Sub-ppb sensitivity was achieved while moving at speeds of up to 5 kmh−1 over relatively
rough terrain, as the system is highly robust to vibration and is liquid nitrogen-free. A
sequence of gas plume traverses were measured, in which the instrument was driven at
∼ 1 − 2m s−1 in a straight line perpendicular to the average wind direction. Since the
ethane concentration is displayed in real-time, this allowed the driver to continue the
traverse until after the plume had been fully measured.
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Figure 5.4: (a) & (b) Measured ethane concentration over 6 minutes for two locations P
and Q. Zero-referencing with nitrogen occurs every ∼ 90 s In (a) the location is outside
the plume and the instrument measures a stable background of 0.94±0.13 ppb. In (b) the
ethane concentrations ﬂuctuate as the plume direction alters with the wind. Corresponding
wind velocity data is shown in (c)-(d).
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Figure 5.5: Traverses of the gas release plume obtained by driving through the plume at a
speed of ∼ 0.9ms−1. In (a) a far ﬁeld measurement resembles the plume shape associated
with an area source, while in (b) a closer traverse reveals the individual plumes from the
four points of the extended release.
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Figure 5.6: Comparison of the measured ethane plume with a simple Gaussian model, at
a distance of 170m from the gas source. The Gaussian model shows the statistical ethane
concentration over the plume based on 2 min averaging, while our measurements represent
the instantaneous plume shape over the much shorter traverse time.
A typical result for the plume traverse at 0.9m s−1 at two diﬀerent proximities to the
release is shown in ﬁgure 5.5. The second of these corresponds to being very close to the
centre of the release location (∼ 20m) where the individual gas plumes originating from
each arm of the release could be resolved. In ﬁgure 5.5 a at a measurement distance of
∼ 170m the source more closely resembled an area release. For this plume a peak value of
23 ppb with a plume width (FWHM) of 12m was measured.
5.4 Discussion
A number of models are available to predict gas concentration from a known source [70, 71].
Many of these models, such as Gaussian plume dispersion models, rely on the averaging of
wind and concentration data over measurement times comparable with the gas transit time.
However, these models say little about the plume structure over much shorter timescales
associated with a simple traverse of the plume. Employing a simple Gaussian model [69]
with 2min wind data averaging yielded a peak value of 5 ppb and width 75m of the plume
at our measurement distance of 170m (ﬁgure 5.6). At the low wind speed of ∼ 1ms−1
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convection may have inﬂuenced the plume, reducing the validity of the model.
As would be expected, since the Gaussian shape is a statistical model of the gas plume based
on time-averaging, signiﬁcant diﬀerences are seen compared to the measured instantaneous
plume shape over the course of the traverse. However, it is reassuring to note that the
integral of each curve in ﬁgure 5.6 is similar, conﬁrming that the measured gas ﬂux is in
agreement with the set release rate of 10 lmin−1.
It has been shown that the location of an ethane gas source can be determined inversely
using simultaneous measurements of gas concentration and wind data and a gas plume
dispersion model such as a simple Gaussian model [69]. However, the use of a more complex
plume dispersion model may enable a more accurate source reconstruction. For example,
a model may be able to make use of instantaneous changes in ethane concentration rather
than a time-averaged model. The ethane concentration data generated using the portable
instrument during this ﬁeld-trial is currently being used for the development of a new gas
dispersion model, which may make use of the second by second concentration ﬂuctuations.
In addition to the generation of new ethane data, the instrument performance was eval-
uated in a changing outdoor environment. A sensitivity to ethane of around 150 ppt was
observed, with little degradation in performance throughout the trial. This is only a factor
of two lower than the typical performance in a thermally controlled lab environment of
∼ 70 ppt. The reduction in sensitivity during the trial is likely to be due to a combination
of factors such as thermal ﬂuctuations during outdoor use and the increase in vibration
noise associated with the generator use. The instrument also enabled sub-ppb detection
even whilst in a moving vehicle. Although a previous ethane spectroscopy system had
been used in hostile environments such as the desert [42] it had, until now, been limited
to stationary measurements. The portable system would not be of practical for use in a
desert environment due to the high power requirement and thermal management issues
associated with the compressor used to cool the laser. However, the trial gave us great
conﬁdence in the sustainability of the instrument performance in a changing environment,
particularly since its main use would be in a far less hostile environment such as a hospital
ward.
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Chapter 6
Breath analysis
This chapter describes the motivation behind breath ethane analysis, along with the current
detection techniques and technical challenges. The potential clinical application of breath
ethane monitoring is discussed and examples of inter and intra-variability in breath ethane
of healthy controls are given.
6.1 Background
The idea that human breath might provide information on health conditions dates back
to the era of Hippocrates, who is said to have told his students to sniﬀ the breath of
their patients. Even today it is recognised that some breath odours are associated with
particular diseases: uncontrolled diabetes leads to a smell similar to rotting apples due to
acetone in the breath, chronic renal failure can cause a smell similar to stale urine and
advanced liver failure can result in a musty ﬁsh-like smell in the breath [72]. Scientiﬁc
analysis of the breath began as early as the 18th century, when Antoine Lavoisier detected
CO2 in exhaled air. In the 1970s Nobel prize winner Linus Pauling determined more than
200 volatile organic compounds (VOCs) in human breath using cold trapping and gas
chromatography [73]. Since then more than 3000 VOCs have been identiﬁed in the breath
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[74]. Breath mainly consists of a mixture of nitrogen, oxygen, carbon dioxide, water, and
inert gases. The remaining small fraction of human breath consists of trace components
including VOCs at concentrations in the ppb or ppt range [75]. Not only does the detection
of such low concentrations presents technical challenges but interpreting the meaning of
the results is also diﬃcult. Phillips et al conducted a number of studies to build up a
database of the composition of VOCs in the breath across the population [74, 76]. Phillips
suggested that breath analysis could open up a non-invasive window on normal metabolic
pathways, and possibly illustrate how these pathways are altered in disease.
Today, conventional tests for clinical diagnosis and monitoring focus on blood and urine
analysis. Common blood tests include a full blood count, to detect conditions like infec-
tions, anaemia, and leukaemia, and tests for urea and electrolytes, to detect disease or
kidney malfunction [77]. However, blood and urine tests are invasive, often causing dis-
comfort and/or embarrassment. Results can be also subject to a signiﬁcant delay. On the
other hand, breath analysis is a non-invasive technique that could oﬀer invaluable clinical
information in real-time.
The ﬁeld of breath analysis has gained much momentum in recent years, due in part to
the relatively recent advent of accurate real-time measurement technologies. For example,
nitric oxide (NO) and carbon monoxide (CO) are two breath gases that have attracted
considerable interest in recent years as potential respiratory markers [72]. NO and CO
have been studied for a over a decade in a variety of lung pathologies and conditions such
as asthma [78, 79], chronic obstructive pulmonary disease (COPD) [80, 81] and cystic
ﬁbrosis (CF) [82, 83]. The use of fractional exhaled nitric oxide (FeNO) as a respiratory
marker is close to being incorporated into clinical practice. In 2003 the US Food and Drug
Administration cleared an FeNO analyzer for use in asthma management to be used in
conjunction with standard asthma outcomes [84]. Progress in this ﬁeld, reviewed in [85], is
attributable to the large number of studies conducted in this area showing strong correlation
between NO and airway inﬂammation and to the fact that portable FeNO analysers have
recently become available [86, 87]. This has made routine testing a practical possibility,
enabling home-monitoring of asthma symptoms.
Another area in which real-time breath monitoring may oﬀer clinically useful information
is in the assessment of oxidative stress (section 6.3).
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6.2 Challenges
Despite promising research and progress in a small number of ﬁelds, such as those de-
scribed above, breath analysis is not yet widely used in clinical practice. Progress has been
restricted due to a number of complicating factors [88]: Firstly, breath gases reﬂect a huge
variety of biochemical processes and it is often diﬃcult to interpret the physiological mean-
ing of the presence of such markers. Secondly, there are an enormous number of parameters
that can inﬂuence results, including exhalation kinetics, ambient levels etc. Thirdly, sub-
stances are often present in the breath in extremely low concentration. Measurement
techniques must be ultra-sensitive and rapid in order to detect dynamic processes. Ideally
measurement would be in real-time with results immediately available to the clinicians.
Therefore the technology must be portable so that it can be brought to the bedside.
6.2.1 Ambient levels and compensation methods
At rest a healthy adult has a respiratory rate of 12-15 breaths per minute with an aver-
age expiration volume of 500ml per breath [89]. The ﬁrst 150ml of the breath is tidal,
essentially ambient, air and the following 350ml is alveolar air from the lungs [72]. It is
the alveolar air that is of interest since it is at the alveolar membranes that blood gases
diﬀuse into the lung. Tidal air tells us nothing of a patient’s condition but breath samples
contain a tidal component which dilutes the alveolar air and eﬀects the total breath gas
concentration. Therefore ambient levels must be taken into account.
Hydrocarbon-free air
One technique is to have the volunteer breathe only hydrocarbon-free (HCF) air [90].
Theoretically, this technique would give the most accurate results since the concentration
of ethane in the exhaled breath would then be solely attributable to the production within
the body. However, the breathing of HCF air has a number of practical constraints: Firstly
a ‘washout’ period of time is required to rid the lungs of any remaining ambient ethane.
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Secondly, for a volunteer to breathe only HCF air, a special mask is required. The delivery
of HCF air has been investigated previously within the group. However, experience when
recruiting patients for pilot clinical studies has shown that a signiﬁcant proportion of
recruited patients would not be comfortable wearing such a mask for prolonged periods
of time. In general its use is impractical due to the expense, discomfort and prolonged
time periods required [72]. Therefore, it must be accepted that patients will normally be
breathing ambient air and that this must be corrected for.
Background subtraction
Exhaled breath gas concentration measurements are generally, and more practically, cor-
rected by subtracting ambient levels. This standard technique [75, 72, 91] takes account
of modest variations in ambient ethane levels. While this technique is not strictly correct
in a mathematical sense, since the alveolar and tidal volumes are not equal, the technique
is successful in highlighting changes in breath gas concentration arising from changes in
the production within the body and distinguishing those changes from those resulting from
ﬂuctuations in ambient levels. This technique is widely used and was our chosen technique,
ideal for use with large numbers of breath samples.
6.2.2 Previous studies and techniques
The majority of breath gases are analysed using Gas Chromatography (GC) combined
with Mass Spectroscopy (MS) and other variants. GC-based techniques reach detection
limits down to 0.2 ppb for ethane [92], enabling breath ethane analysis. Such methods are
generally time-consuming for large numbers of samples, although improved techniques have
been developed for sequential breath sampling [93]. Still, most GC based techniques require
pre-concentration of the breath sample and the use of adsorbents and drying agents to deal
with the large amounts of water vapour present in human breath [75]. Many compounds
can be detected without signiﬁcant delay using selected ion ﬂow tube mass spectrometry
(SIFT) [12]. However, this technique uses precursor ions and ethane cannot be detected due
to the lack of a dipole moment. The standard technique of chemiluminescence for measuring
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exhaled Nitric Oxide (NO) usually requires bulky and expensive analysers, although hand-
held electrochemical sensors have also been developed [87]. In general, studies of exhaled
carbon monoxide (CO) have used electrochemistry [94] or GC for measurement. While
portable electrochemical units oﬀer the advantage of on-site measurement they are usually
less sensitive than GC analysis, which is generally lab-based [72]. Due to these requirements
a fast, single-breath resolved breath analysis is not possible with GC [92].
Optical techniques are inherently better suited to breath monitoring applications due to
the combination of sensitivity, selectivity and speed. Breath NO has been detected using
tunable diode laser absorption spectroscopy [95, 96] and laser magnetic resonance spec-
troscopy (LMRS) [13]. An exhaled NO sensor (Breathmeter) based on laser absorption
spectroscopy is commercially available from Ekips Technologies, Inc. Breath CO has been
detected using absorption spectroscopy using tunable diode and quantum cascade lasers
[97, 98] and cavity ring-down spectroscopy [99]. Narasimhan et al used photo-acoustic
spectroscopy to measure breath ammonia in patients undergoing haemodialysis treatment
[100]. Cavity-ring down spectroscopy has been used to enable rapid breath ammonia de-
tection [101]. Such techniques are of interest for possible monitoring of kidney function
and eﬃcacy of dialysis.
Similarly, real-time techniques for the measurement of ethane could open up a new window
on the monitoring of oxidative stress. Real-time ethane detection is currently only possible
using optical techniques, such as those described in chapter 1.
6.3 Oxidative stress
6.3.1 Deﬁnition
Molecular oxygen readily accepts unpaired electrons to form a number of reduced (or
‘reactive’) oxygen species (ROS), including superoxide (O·−2 ), hydrogen peroxide (H202),
hydroxyl radical (HO·) and peroxyl (ROO·) and alkoxyl (RO·) radicals [102]. In biological
materials the generation of ROS is widespread and can lead to initiation and propagation
93
CHAPTER 6. BREATH ANALYSIS
of free radical chain reactions, resulting in extensive damage to biomolecules [103]. In
healthy organisms, normal production of free radicals and other ROS (eg. by metabolic
processes) is oﬀset to a certain extent by the antioxidant defence systems. However, the
balance is not perfect, resulting in some continual cell damage [72]. The term ‘oxidative
stress’ (OS) is deﬁned as an imbalance between oxidants and antioxidants in favour of the
oxidants [104].
6.3.2 Associated conditions
Although OS is a normal feature of our oxygen-fueled metabolism, it has also been recog-
nised as playing a role in the development of a wide range of conditions and diseases such as
lung cancer [91, 105], cystic ﬁbrosis [106], chronic obstructive pulmonary disease (COPD)
[107], acute respiratory distress syndrome (ARDS) [108] and asthsma [109]. In addition, OS
may be elevated by external factors such as cigarette smoke [110], environmental pollutants
[111] and exposure to ionising radiation [102].
6.3.3 Biomarkers
A number of biomarkers can be used for the measurement of OS. Blood markers in-
clude malondialdehyde (MDA), thiobarbituric acid reactive substances (TBARS), F2-
isoprostanes, glutathione (GSH) and oxidised low density lipoproteins (LDL) [112, 113,
114, 115]. Breath markers such as exhaled hydrocarbons oﬀer the advantage of non-invasive
monitoring [75, 116, 90, 117].
6.3.4 Ethane as a biomarker
The free-radical-induced oxidative breakdown of cell membrane lipids, known as lipid per-
oxidation, is a main target of investigation into OS [118]. Ethane gas, (C2H6), is formed
during the lipid peroxidation of omega-3 fatty acids in the cell membrane [119] as shown in
ﬁgure 6.1. Ethane is a well established marker of OS [116, 90, 117] and is considered to be
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Figure 6.1: Free radical attack on a double bond of a polyunsaturated fatty acid (PUFA)
initiates a chain reaction. Several possible products are generated, some of which can be
measured as markers of lipid peroxidation [123]
a particularly good marker for several reasons: Its means of generation is well understood
[75] and other potential sources (for example from the metabolism of bacteria in the colon)
are not considered to contribute signiﬁcantly [120]. More importantly, ethane appears in
the breath within seconds of the release of free radicals in the tissue [72]. Being both
poorly metabolised and poorly soluble in the body, volatile ethane diﬀuses rapidly into the
bloodstream and is transported to the lungs where it is exhaled [120].
Breath ethane has been shown to quickly arise following reperfusion injury during organ
transplantation [90] or during cardio pulmonary bypass [121, 122]. The speed of the ethane
response could facilitate non-invasive patient monitoring applications provided an appro-
priately periodic and rigorous sampling regime is used. Such monitoring has been recog-
nised as important for gaining insight into oxidative damage in various clinical conditions
[75, 103].
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Figure 6.2: Intra-variability of breath ethane of a healthy volunteer over one day
6.4 Ethane levels
6.4.1 Ambient ethane
The average ambient concentration for ethane in the Northern hemisphere has been re-
ported to be ∼ 2 ppb [124]. Ambient levels observed by the Glasgow Optics group are
typically in agreement with this. Oil reserves are believed to be the main contributor to
ambient ethane levels (See chapter 5). Although ambient levels are low, exhaled breath
ethane concentrations are often only higher than these levels by up to a few ppb. A key ad-
vantage of our technology is that it enables the resolution of even relatively small changes
in breath ethane above higher ambient levels. It is even possible to resolve changes in
ethane concentration across the breath, due to the increased proportional of alveolar air,
as shown in ﬁgure 4.2. This level of resolution may provide additional clinical information
over and above time-averaged ethane elevations. However, ambient ethane levels must be
taken into account in order to resolve subtle changes in breath ethane production.
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6.4.2 Breath ethane intra-variability
Since ethane is a ubiquitous marker of OS, breath ethane levels are known to vary con-
siderably even between healthy controls [46] and can even vary signiﬁcantly in a healthy
individual from day to day. Figure 6.2 shows the variability in breath ethane of a healthy
volunteer over a 24 hr period (except when the volunteer was asleep). Each breath sample
was a single exhalation of vital capacity into a 5 l gas sample bag (Tedlar, SKC). For each
breath sample, a corresponding ambient air sample was collected into a sample bag using
an oil free pump. The gas samples were then measured using the newly developed spec-
troscopy system. The error bars represent the standard deviation over the measurement
averaging time of ∼30 s. Background subtraction was performed as described in section
6.2.1. The subtracted ethane levels are seen to vary between 0.21 ppb and 0.81 ppb.
The overall level in the absolute accuracy of the reported ethane concentration is higher
that of the standard deviation in the measurement of the single sample due to factors
such as electronic drift, pressure, temperature as described in chapter 4. Subtraction of
inspired ethane from the expired ethane concentration reduces some of the systematic errors
associated with the above factors. Additional errors are introduced by the expiration and
breath collection technique (e.g. dilution of alveolar air is dependant on expired volume).
For the majority of our clinical studies, further described in chapters 7–9, it is the relative
changes in a patient’s breath ethane from their own ‘baseline’ level that may be of interest.
Therefore, the breath ethane results reported for our clinical studies are presented with
error bars representing only the standard deviation over the measurement averaging time,
to demonstrate the performance of the instrument over a single measurement. If absolute
accuracy is required then other factors have to be carefully taken into account.
6.4.3 Breath ethane inter-variability
A previous study conducted by the Glasgow Optics group showed that background-corrected
breath ethane in a group of 58 healthy control volunteers (26% smokers) ranged from 0
to 10.54 ppb [46]. The observed median of 1.9 ppb is a typical breath ethane level, with
signiﬁcantly higher levels typically observed in the breath of smokers. Smoking increases
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breath ethane levels both directly, in the cigarette smoke, and also indirectly, due to the
induced oxidative damage [110, 125].
6.5 Discussion
As described, increased oxidative stress has been associated with a large number of diseases
and conditions. It has been proposed that breath ethane analysis could give insight into
the biochemical processes occurring in a healthy or diseased human body [75]. However,
although breath analysis is often motivated by the prospect of early diagnosis of disease
[91], it appears more likely that the potential for breath ethane analysis is in monitoring
applications. This is due to the large number of factors aﬀecting breath ethane levels
leading to signiﬁcant inter and intra-variability of breath ethane levels even in healthy
controls. Single breath measurements of ethane for a healthy individual have been observed
to ﬂuctuate by several ppb over a few days making it diﬃcult to extract useful clinical
information from one measurement alone. However, in monitoring applications, such as
the assessment of response to therapy or disease progression, or in ﬁelds such as critical care
and transplantation medicine, rapid analysis of ethane in the breath may provide valuable
on-going clinical information.
A number of collaborative studies have been conducted by the Glasgow Optics group over
the past few years in a variety of areas such as lung cancer, organ transplantation, exercise,
respiratory inﬂammation in horses, and diet [45]. These trials required discrete sampling
methods for breath collection, with later analysis using the lab-based spectroscopy system
that was speciﬁcally dedicated to ethane breath analysis studies.
Following the development of the portable spectroscopy system, both discrete sampling
and on-site breath ethane measurement was made possible. Due to practical reasons, such
as the spread of geographical locations at which the trials were conducted, discrete sam-
pling was often used with subsequent measurement performed centrally using the portable
instrument. The instrument was then located on-site in the Southern General hospital,
Glasgow where the real-time nature of the technique could be exploited.
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The following three chapters report on pilot studies in three areas of healthcare in which
it was proposed that real-time breath ethane monitoring may oﬀer clinical beneﬁt. These
areas are dialysis, radiotherapy and intensive care.
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Dialysis study
This chapter reports on a pilot clinical study in which breath ethane was monitored as a
dynamic indicator of oxidative stress in patients as they received dialysis treatment.
7.1 Background
Over the last two decades, evidence linking oxidative stress (OS) and dialysis has grown.
A number of groups have reported elevation in markers of OS in haemodialysis patients
compared with healthy control groups [126, 127, 128, 129]. While increased OS is considered
to be a major factor in morbidity and mortality in dialysis patients [112], the factors
contributing to this increase are not clear [130, 131]. Suggested causes include the uremic
state [130], vitamin C deﬁciency [132], inﬂammatory status and duration of treatment [126].
In particular, it has been reported that the dialysis treatment per se may cause oxidative
damage due to dialysate quality or dialysing membranes, possibly by the stimulation of
primed neutrophils [130, 133]. Techniques directed toward preventing the damage from OS
are under investigation, such as the eﬀect of antioxidants [134, 135] and bio-compatible or
vitamin E-coated membranes [136].
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Past studies of oxidative stress using breath ethane have often involved only a small number
of ‘one-oﬀ’ measurements, for example before and after a treatment session. However,
this approach lacks the resolution to track rapid or short-lived eﬀects and this may have
contributed to inconsistent results seen in the literature [129, 137, 138]. The aim of this
study was to monitor dialysis patients’ changing breath ethane levels at regular intervals
during single dialysis sessions.
7.2 Materials and Methods
7.2.1 Participants
Thirty subjects were recruited from patients presenting at the renal dialysis clinics at Glas-
gow Western Inﬁrmary and Glasgow Gartnavel General Hospital. Patients were recruited
subject to the requirement that they were non-smokers and had not consumed alcohol for
at least 12 hrs prior to their arrival at the clinic. This was to minimise the risk of known
contamination issues. Six patient samples sets were later excluded: four due to anaesthetic
contamination, one due to unexplained excessive background ﬂuctuation that swamped
the breath samples and the other due to an inconsistent patient breathing technique. The
remaining 24 patients (age 65 ±16 yrs, mean ± SD, range 39-85 yrs) comprised 19 males
and 5 females. Patients had been on dialysis for periods ranging from 4 days to 12 years
and received three four-hourly sessions (typically) per week using Polyﬂux dialysis mem-
branes. The distribution in this period was highly positively skewed (median 10months,
range 0.1 - 141months).
Patients receiving dialysis treatment had a wide variety of underlying conditions including
renovascular disease, polycystic kidney disease, glomerulonephritis, obstructive uropathy,
IgA nephropathy, membranous nephropathy and diabetic nephropathy. Five of the twenty
four patients were diabetic.
Informed consent was obtained from all participants and the study was approved by the
Ethics committee of Universities West of Scotland NHS Trust.
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7.2.2 Breath ethane analysis
Ethane concentrations were analysed using the newly developed spectroscopy system. Due
to practical constraints, this pilot study involved breath collection using sample bags which
were subsequently measured in the Optics lab at the University of Glasgow, only a short
distance from the dialysis clinics used in the study. While the real-time nature of the
portable technology was therefore not fully exploited in this study, it did facilitate the
rapid turnaround of a large number of samples.
Figure 7.1: Breath samples were collected during dialysis treatment into Tedlar sample
bags using a simple single breath ﬁlling technique.
A key advantage of the technology is that the direct analysis of gas samples requires no
cooling or pre-concentration. Therefore each breath sample was analysed in less than one
minute. For example, the 38 samples collected for each patient (as described below) re-
quired a total measurement time of less than 40 minutes. Typically, we collected and
analysed the breath ethane of four patients in a day. The total number of samples anal-
ysed in the study was > 1000. This technique represents a considerable improvement in
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measurement eﬃciency and sample turnaround compared to traditional methods of breath
ethane detection.
7.2.3 Study Design
As previously outlined, the aim of the study was to monitor the OS level of patients during
a single visit to the dialysis clinic by regular measurement of their breath ethane. Each
patient acted as their own control. Baseline breath ethane levels vary between individuals
and therefore, in order to validate the comparison of patient data, we measured the extent
of the change in a patients breath ethane level from their respective baseline level. In other
words, a common datum was deﬁned with respect to patient baseline breath ethane levels
by setting these to zero.
Healthy volunteers in close proximity to the patients also provided a concurrent series of
breath samples using the same exhalation technique. This secondary control set was in
order to verify that the observed eﬀect was solely attributable to patient response and
independent of environmental factors.
Frequent sampling throughout the whole of the treatment session was incompatible with
the overriding requirement for good patient care. Fortunately, our early work had indicated
raised exhaled ethane levels at the beginning of the treatment session and so the most rapid
sampling was conﬁned to this period. The collection protocol was set at one sample every
2 minutes during an 8 minute period prior to dialysis, then every 2 minutes for the ﬁrst 10
min of dialysis followed by every 5 minutes during the next 20 minutes. Three samples were
then collected at 10 min intervals and subsequent samples were collected at hourly intervals
with a ﬁnal sample being collected at the end of the dialysis session. The deﬁnition of the
start of dialysis here is the point at which the dialysis machine commenced the blood ﬂow
returning to the patient, typically a few minutes after the initial attachment and ﬂushing
of the lines with saline. Precise times of breath collection were subject to small variations
(typically ±10 s) to avoid interference with clinical procedures or interventions. Patient
care was considered paramount throughout.
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Samples were collected in 5 l ethane-impermeable bags (Tedlar, SKC Ltd). Patients exhaled
through a disposable cardboard mouthpiece (Bedfont Scientiﬁc Ltd), connected to the
sample bags by a Teﬂon mouthpiece adaptor. The setup is shown in ﬁgure 7.1.
Breath sampling
To standardise the protocol, a consistent breath sampling technique was adopted. Each
breath sample was a single expiration of vital capacity. Patients found this approach
easy to reproduce as is evident from the consistent longitudinal baseline measurements.
The initial deep inhalation ensured each exhalation was more than minimum volume (1 l)
required for accurate ethane analysis. For each breath sample collected, a corresponding
room air sample was obtained using an oil-free hand pump and corrected breath ethane
measurements were obtained by subtraction of these ambient ethane levels (as described
in section 6.2.1.
Contamination issues
As described in section 4.1.3 the presence of contaminants is easily established using our
detection technique. Any contamination causes distortion of the continually monitored
ethane transition lineshape displayed in the software. All sampling equipment used was
checked for the production of ethane and/or contaminants and no source of either was
found. Commonly used hospital cleaning solutions were investigated as sources of con-
tamination. Chlorohexadine glucanoate solution is typically used for patients for whom
access is by way of a central line. In the case of ﬁstula access, chlorohexadine glucanoate
solution containing ethanol is used. The detection technique is insensitive to both of these
compounds. However, ethyl chloride, often used as a local anaesthetic, was found to be
a contaminant and was therefore avoided. In this study samples from four patients were
aﬀected by contamination due to ethyl chloride and were discarded.
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Data analysis
Data are presented as mean ± standard deviation or median and range. The data were
plotted to show the relationships between the magnitude of the ethane peak and other
clinical scores, including period on dialysis, age, gender and co-morbidity factors. The
Student t-test was used and where data were found not to conform to the parameters of
a normal distribution, signiﬁcance testing was performed using a Mann-Whitney test for
non-parametric data. Statistical signiﬁcance was accepted at P < 0.05.
7.3 Results
Patient breath ethane measurements were corrected for the ambient air ethane by sub-
tracting corresponding values (as described in section 6.2.1) and plotted against time.
Signiﬁcant short-lived increases in breath ethane were observed in 14 out of the 24 patients
within the ﬁrst few minutes of the dialysis session. For clarity, since these peaks are largely
coincident, a subset of 6 representative examples of the 24 are illustrated in ﬁgure 7.2. The
eﬀect was not observed in the healthy volunteers who acted as the secondary control group
(See ﬁgure 7.3) and no further signiﬁcant increases in breath ethane were observed after
the initial 30min of the treatment session.
Breath ethane levels prior to dialysis treatment (patient baseline levels) are seen to vary
between individuals (median 0.6 ppb, range 0 - 12 ppb). This is seen in the positioning of
the (background-corrected) traces along the y–axis in ﬁgure 7.2.
Ethane is a ubiquitous marker of OS and therefore a large number of factors will contribute
to baseline ethane levels. In order to assess the contribution from the dialysis treatment
per se the datasets were normalised by setting a common zero baseline ethane level. The
peak level of ethane (PE) was deﬁned as follows:
PE = Emax − E0 (7.1)
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Figure 7.2: Elevation of ethane in ﬁrst 30min of dialysis, plotted for six patients. These
values have been corrected for ambient ethane levels. The dotted lines have been added as
a guide for the eye to make it easier to distinguish between the six diﬀerent patient results.
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Figure 7.3: Comparison of room ethane, breath samples from a control subject and breath
samples from a dialysis patient. This demonstrates that the ethane elevation eﬀect is
conﬁned to the patient.
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where, Emax is the maximum background-corrected breath ethane concentration measured
within approximately 5 mins of start of dialysis and E0 is the mean background-corrected
breath ethane concentration measured prior to the start of dialysis. The peak ethane mea-
surements presented therefore correspond to the net change in breath ethane concentration.
Peak ethane values for each of the 24 patients along with corresponding patient clinical
data is shown in ﬁgure 7.4.
Diabetes 
present
Period on 
dialysis
Age
Type of 
access
Peak level 
of ethane
(1=yes) (months) (yrs) (1=fistula) (ppb)
1 1 4 43 0 4.77
2 1 4 74 1 7.45
3 1 15 48 0 3.02
4 1 1 82 1 4.66
5 Drug Induced-Lithium 0 11 80 1 0.85
6 0 60 57 1 0.34
7 0 141 39 1 0.15
8 0 4 39 1 0.31
9 0 20 72 1 0.28
10 0 120 72 1 0.47
11 0 0.1 47 0 6.28
12 0 6 85 0 7.28
13 Obstructive Uropathy 0 15 66 1 0.52
14 0 0.3 44 1 14.93
15 0 60 50 1 0.62
16 0 115 77 1 0.13
17 0 6 67 1 0.15
18 0 6 79 1 0.4
19 0 28 81 1 1.88
20 1 4.5 75 0 2.9
21 0 5 78 1 0.22
22 0 10 76 1 1.68
23 0 10 83 1 1.35
24 0 17 49 1 0.2
Patient
Polycyctic kidney disease
Unknown
Renovascular disease
Underlying condition
Diabetic Nephropathy
Glomerulonephritis
IgA nephropathy
Membranous Nephropathy
Figure 7.4: Clinical data and corresponding measured peak ethane values for the 24 re-
cruited patients in the study
The distribution in peak levels of ethane generated by equation (7.1) was also highly
positively skewed; median=0.7 ppb, and range 0.1 - 14.9 ppb. The distribution in the
Peak levels was not found to correlate with age. However, the distribution was found to be
signiﬁcantly diﬀerent in the two patient groups that used either a ﬁstula or a central line
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for access. (Mann-Whitney test signiﬁcant at 0.0069). For patients with a ﬁstula access
(n=19) the median Peak level of Ethane=0.5 ppb; range 0.1 - 14.9 ppb. For patients with a
central line (n=5) the median Peak level of Ethane=6.3 ppb; range 2.9 - 7.5 ppb. However,
this is likely to be misleading since patients new to dialysis treatment tend not to have had
a ﬁstula provided yet. Period on Dialysis and ﬁstula use are therefore not independent and
the ethane peak levels were found to be strongly dependent on the former.
A signiﬁcant correlation was found between Peak level of Ethane and Period on Dialysis
(PoD). See ﬁgure 7.5 a. Both variables demonstrated lognormal distributions and a natural
log-log plot (ﬁgure 7.5 b) yielded a linear relationship (R2 = 0.43). The ﬁtted trendline
follows
ln(PE)alldata = −0.5(lnPoD) + 1.2 (7.2)
Modiﬁed Charleson co-morbidity scores (CCS) were calculated for all patients (median 5,
range 2-11). No signiﬁcant correlation was found between Peak level of ethane and age,
gender or co-morbidity. Although peak ethane appeared to be higher in diabetic patients
(median 4.7 ppb, range 2.9 - 7.5 ppb) than non-diabetic patients (median 0.5 ppb, range
0.1 - 14.9 ppb), it was shown that diabetic status was not independent of ﬁstula use and
period on dialysis. This is discussed further in [139].
7.4 Discussion
Changes in oxidative stress (OS) have been monitored during dialysis treatment using
exhaled ethane as a biomarker. As shown in ﬁgures 7.2 and 7.3 we observed a single,
short-lived ethane peak on commencement of dialysis, suggesting that there is a signiﬁcant
increase in OS at this time. The absence of this eﬀect in both of the concurrent sample
sets of ambient air and exhaled breath from the healthy volunteers (see ﬁgure 7.3) suggests
that the eﬀect is solely attributable to patient response. The control trace essentially
mirrors the relatively ﬂat background air trace. It should be pointed out of course that
the healthy volunteers did not receive dialysis treatment. This set of controls should not
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Figure 7.5: (a) Peak ethane dependence on Period on Dialysis. (b) The same data trans-
formed to a natural log-log scatterplot.
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be confused with the primary control group. In this study the patients eﬀectively acted as
their own control. Each patient provided a series of samples that were referenced to their
own baseline breath ethane level, that is, the level measured immediately before the start
of their treatment session.
Possible errors due to inconsistent breath sampling were reduced using the breath sampling
protocol described in section 7.2.3. The consistency of the observed ethane elevation eﬀect
(observed in 14 out of the 24 patients) with ethane concentrations signiﬁcantly higher than
the breath to breath ﬂuctuations found even in healthy controls suggests that the eﬀect
could not be solely attributable to patient breathing dynamics. The peaks in breath ethane
are unlikely to be due to a reservoir of ethane stored in tissue since ethane is highly volatile
and poorly metabolised, rapidly diﬀusing into the blood stream upon production [72].
It is recognised that a large number of factors aﬀect the overall OS status of dialysis pa-
tients, such as age, lifestyle and underlying condition. For example, a higher level of OS has
been reported in diabetic haemodialysis patients [128]. While we recognise these factors,
this pilot study focused speciﬁcally on the detection of rapid changes in OS associated
with the dialysis treatment per se. Normalising peak ethane levels to the patients’ baseline
ethane levels enabled us to look at this short-term eﬀect across a limited number of patients
with a broad range of underlying conditions. Ethane is a ubiquitous marker of OS and
baseline ethane levels are known to vary considerably even between healthy control patients
[46] and can even vary signiﬁcantly in a healthy individual from day to day. For this reason
it is diﬃcult to extract relevant information from a single measurement of baseline ethane
from individual patients in a study with small patient numbers. No signiﬁcant relationship
was found between baseline ethane level and pathology in this pilot study. However, trends
may become apparent in a larger scale study. A paper has been published by our clinical
collaborators in which the potential biological and clinical relevant factors aﬀecting the
breath ethane production during dialysis are further explored [139].
The relatively low level of noise in the expired ethane traces indicate that the consistent
breath sampling protocol worked well and that possible variation in patient respiratory rate,
expired volume and background ethane had a minimal eﬀect. However, it is important to
note that the peak ethane measured for each patient is a conservative estimate of the
true maximum. This is due to the ﬁnite sampling intervals and the consequential limited
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resolution with respect to the changing breath ethane concentration. This may explain the
spread in the data shown in ﬁgure 7.5 and the relatively low value of R2 in ﬁgure 7.5 b.
More frequent sampling could help reduce this spread. However, in practice, acquiring
breath samples from a patient more regularly than at 2min intervals is diﬃcult without
disrupting clinical care.
Clearly the speed of the ethane response highlights the need for regular, continual sampling
for the detection of such transient events. For example, had patient breath sampling
been limited to pre- and post- dialysis, the eﬀect would have been missed completely
and the false conclusion drawn that ethane levels (and OS) are unchanged during dialysis
treatment. This could explain the conﬂicting results from a number of previous studies
of lipid peroxidation in dialysis patients [129, 137]. Our results are consistent with the
ﬁndings of Ward et al [133, 140] that neutrophil priming, as a consequence of interaction
with dialysis membranes, results in a respiratory burst that can lead to lipid peroxidation.
Kuwahara et al also noted this neutrophil activation [141]. This requirement for frequent
breath sampling has also been observed by Stenseth et al, who monitored exhaled breath
ethane during cardiac surgery. They found that rapid surges of exhaled ethane had a very
early onset, starting immediately during the surgical procedures [122]. A future possibility
would be to employ the portable instrument directly into the ward with single expirations
into the intsrument, enabling the breath sampling frequency to be increased.
Figure 7.5 a suggests that haemodialysis patients do become conditioned to their treatment
regime relatively quickly, since Peak Ethane levels decrease exponentially with Period on
dialysis. This is in keeping with ﬁndings of Sezer et al that OS was negatively correlated
with dialysis duration [142].
Since the observed ethane ﬂuctuations are transient, suggesting only short-term periods
of OS, it is unknown if there are any signiﬁcant long-term consequences of this oxidative
damage. It will be important to establish if the repetition of such events have an eﬀect on
morbidity or mortality outcomes. If so, it may be that the use of an appropriate intervention
could reduce the OS response in patients new to dialysis treatment. Recent approaches
include hemolipodialysis, infusion of antioxidants by dialysate and the use of vitamin E
bonded membranes [131, 136, 143]. Breath ethane is a speciﬁc marker of lipid peroxidation,
which antioxidants such as vitamin E can reduce. Therefore, breath ethane monitoring
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could oﬀer useful assessment of OS during hemodialysis and the eﬀect of vitamin E-bonded
membranes. For example, previous studies in other areas have shown that the production
of breath ethane arising from reperfusion injury during organ transplantation [90] or during
cardio pulmonary bypass [121] could be reduced using radical scavenging species. A review
by Abuja & Albertini [103] suggests that the increasing use of antioxidants in medicine will
lead to the requirement for monitoring of OS in a laboratory or hospital in the future.
Future studies with a much greater patient number and a more uniform sample will be
necessary in order to determine the potential clinical beneﬁt of such monitoring during
dialysis. In this pilot study, practical constraints prevented the recruitment of the ideal
patient group, resulting in highly skewed patient statistics (See section 7.2.1), which may
have contributed to the R2 value in ﬁgure 7.5 b. Increased patient numbers will also enable
better understanding of the variability in baseline levels of ethane among the patients and
the possible relationship with pathology and other factors.
A paper reporting on this study has been published in the Journal of Breath Research [144].
This was followed by the publication of a companion paper by our clinical collaborators
[139].
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Radiotherapy study
This chapter describes the collection and analysis of breath ethane in radiotherapy patients
with the motivation that such analysis may oﬀer potential as a clinical dose mediator. For
the ﬁrst time breath ethane was monitored in patients during the radiotherapy treatment
process.
8.1 Background
Cancer aﬀects one in three of the population [145]. In the UK, radiotherapy is a key
component of both radical and palliative treatment for cancer. Of those cured of their
cancer (ie. go on to survive at least 5 years), the use of radiotherapy either alone or in
combination with other treatments such as surgery contributes to that cure in ∼ 40% of
cases [145].
The main type of radiotherapy treatment is external beam radiotherapy in which high
energy X-rays are produced using a linear accelerator and directed in a focused beam,
from varying angles, onto the target area of the body. The X-rays used for treatment are
at energies typically between 4 and 20MeV, in contrast to the X-rays used for diagnosis,
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typically at keV energies [146]. Radiotherapy is delivered in ‘fractions’ (treatment sessions
over a number of days) to reduce the unwanted eﬀects of large doses of radiation on normal
tissue. Within our patient group, a typical treatment dose was 2 gray/fraction.
Radiotherapy doses are calculated to minimise the incidence of severe reactions in normal
tissue. Due to the signiﬁcant inter-patient variability of sensitivity to radiation, doses are
limited by the minority of patients whose normal tissues are particularly sensitive [147].
Therefore patients given a standard treatment are typically consistently ‘under-dosed’. If
the most sensitive patients could be identiﬁed prior to treatment then their doses could be
lowered to reduce their risk of severe complications [148]. Similarly, therapeutic outcomes
may be improved by increasing the dose in more resistant patients. One potential method
to identify sensitive patients is the use of predictive assays to determine the radiosensitivity
of ﬁbroblasts [148]. However data in this research area is not consistent and predictive tests
of cellular radiosensitivity do not allow clinical treatment decisions to be based upon them
[149]. Another disadvantage is the lengthy analysis time [150].
8.1.1 Ethane as a dose mediator
The main mechanism behind radiotherapy is believed to be radiation-induced damage to
the DNA of tumour cells, with subsequent cell death occurring after a number of cell
cycles. The DNA damage occurs directly by ionisation or indirectly via the generation of
free radicals [151]. The most reactive, and therefore potentially hazardous, oxygen-derived
radical is the hydroxyl radical (HO·). Ionizing radiation generates hydroxyl radicals either
directly by oxidation of water, or indirectly by the formation of secondary partially reactive
oxygen species (ROS), which may be subsequently converted to hydroxyl radicals in the
cell [102].
Lipid peroxidation may be initiated by free radicals produced during radiotherapy treat-
ment [102]. As described in section 6.3.4, ethane is a marker of free-radical induced break-
down of cellular lipids. Therefore we would expect an increase in breath ethane in response
to radiotherapy treatment. Further, the amount of ethane produced would be expected
to depend on the administered dose of radiation. Since each patient responds diﬀerently
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to radiation, there may be a relationship between the amount of ethane produced and
the patients’ individual response to radiation. Therefore, there is a possibility that breath
ethane may be useful in the determination of the optimum patient dose.
To determine if this is true it is necessary to ﬁrst show that increases in breath ethane
resulting from the radiotherapy treatment can be detected. This was the aim of our study.
If the resultant breath ethane changes are large enough to be detectible above normal
breath to breath ﬂuctuations then future steps would involve establishing a link between
the increase in breath ethane and the administered dose and investigating patient inter
and intra-variability.
8.2 Study Design
8.2.1 Previous study
An earlier trial conducted by our group had attempted to detect increases in ethane re-
sulting from the radiotherapy treatment via manual collection of pre-treatment and post-
treatment patient breath samples. Breath ethane was observed to be marginally higher
post-treatment [45]. However the results were not signiﬁcant. Having seen short-lived
ethane concentration spikes (over only around 5 - 15 minutes) in our dialysis study (chap-
ter 7), it was thought that the ethane elevation eﬀect was may have been too rapid and
short-lived, i.e. that by the time the radiotherapy treatment had ﬁnished and patients
were able to provide the ﬁrst of the post-treatment samples, the eﬀect had been missed.
The previous approach involved the collection of single exhalations of vital capacity in a
Tedlar gas sample bag along with a corresponding room air sample. However, samples could
not be obtained during treatment this way as the patients are required to remain in a ﬁxed
position on the treatment bed, to within a tolerance of 2mm [150]. At Ninewells hospital,
Dundee, where the trial took place, treatment sessions are typically scheduled every 15min.
The previous trial had required a double treatment session for each participating patient
in order that breath samples could be collected pre and post-treatment. This limited the
115
CHAPTER 8. RADIOTHERAPY STUDY
number of patients who could participate in the study each day and, more importantly,
restricted the number of patients that could receive treatment in one day. Since patient
care is the overriding priority a new system had to be developed to enable the collection of
the breath samples during treatment with the minimum disruption to the normal routine
in the clinic.
Design speciﬁcation for new system
1. Breath and room air samples to be collected during a single treatment session
2. Automated system required as personnel not able to access treatment room during
treatment
3. Patient must be able to remain in completely ﬁxed position on treatment bed
4. Total treatment session time of 15 min not to be compromised
5. Ability required to easily stop collection if necessary
6. Simple operation by non-specialists
7. Equipment must meet infection control standards
8.2.2 Automated collection system
According to the above speciﬁcation the following system was developed:
Mask assembly
The set-up is illustrated and photographed in ﬁgure 8.1. Patients were ﬁtted with a mask
which was connected to a pair of non-returnable valves. This allowed room air to be inhaled
by the patient, while the exhaled breath was directed into a 1.2 m length of open-ended
tubing of diameter 22mm (Flextube 1574, Intersurgical). This tubing acted as a reservoir
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for the exhaled breath. Breath was continually sampled from the top of this open tubing
(ﬁgure 8.1 b) using a peristaltic pump (313, Watson-Marlow). The breath was drawn
at ∼ 600mlmin−1 through a bioﬁlter and pumped through a length of neoprene 4.8mm-
diameter tubing into Tedlar sample bags using an automated sampling rig, as described
below. In addition, room air was also drawn through an identical length of the same
neoprene tubing for corresponding background sample collection. The mask assembly was
tested in the radiotherapy simulation room prior to patient use (ﬁgure 8.1 c).
Sampling rig
The peristaltic pump was ﬁtted with two pump heads, enabling simultaneous collection
of breath and room air. The gas samples were collected in 12 Tedlar bags: 6 for breath
samples and 6 for the corresponding room air samples. The automated system was designed
to direct the air drawn through the pump into the sample bags, ﬁlling them sequentially.
The sampling rig, shown in ﬁgure 8.2, contains the electronics to control the automated
collection. Circuit diagrams are shown in ﬁgure 8.3. A timer (LM555, National Semicon-
ductor) was used to produce a clock pulse and a counter (C4017, National Semiconductor)
was used to sequentially count through 8 outputs each triggered by the next clock pulse.
The ﬁrst output from the counter corresponded to a delay before sample ﬁlling commenced,
while the ﬁnal output terminated the sequencing. The other outputs sequentially switched
a pair of solid state relays, which in turn switched oﬀ a pair of 3-way valves (3/2 NC,
Microsol). This sequentially directed the air ﬂow through a series of manifolds into each
pair of breath and room air sample bags. Immediately prior to the sample bag ﬁlling,
and also when the sampling was complete, the air ﬂow was automatically directed into the
room. A switch on the outside of the sampling rig was used to reset the timer and counter,
initiating a new collection sequence cycle.
The system was user friendly, housed within a black box with an attached 24V power
supply. The clearly labeled switch could be set to START to initiate sample ﬁlling and
to STOP to terminate the sample collection at any point. The time to ﬁll each pair of
sample bags was adjusted using a variable resistor via a calibration dial on the outside of
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Exhaled air
Room
air
Open-ended tubing
Collected 
breath
Patient
mask
C	
Figure 8.1: (a) Schematic of the breath collection assembly. The non-returnable valves
allow only room air to be inhaled while exhaled breath is directed into a length of open-
ended tubing from which gas is drawn through a ﬁlter for sample collection. (b) and (c)
The mask assembly undergoing initial tests in the radiotherapy treatment simulation room.
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A	 B	
Figure 8.2: (a) The custom-designed sampling rig contains the electronics used to control
the automated collection. (b) The sampling rig is used in conjunction with a peristaltic
pump to sequentially ﬁll the pairs of gas sample bags (only 1 bag is shown).
the box. Since a minimum volume of 1 l of gas is required for ethane analysis using our
detection technique the ﬁlling time interval was made adjustable between 2 min and 3 min.
During the trial, it was realised that these time intervals were required to be reduced if
all sample bags were to be used during a single treatment session. The sampling tubing
was then replaced with one of a wider diameter (6.4mm) to increase the sample ﬂow rate
from ∼ 600mlmin−1 to ∼ 1100mlmin−1 and enable the collection of the minimum sample
volume of 1 l in each bag. If the patient set-up in the treatment room was rapid, it would
be possible to collect all 6 samples. The system was designed so that sample collection
could easily be stopped early, as was often required. This ensured that we did not overrun
the 15min allocated to standard radiotherapy treatment sessions. Pre and post-treatment
breath sampling was therefore not possible as the treatment session time was not to be
compromised in any way for the reasons described above. The equipment was tested for
electrical safety by the medical physics department at Ninewells hospital.
The sampling equipment was appropriately labeled and step-by-step instructions were pro-
vided for all staﬀ (See appendix C). In addition, two lunch-time presentations were deliv-
ered to the radiographers and medical physicists in Ninewells hospital. This was in order
to introduce ourselves and the project and to demonstrate the new equipment. The equip-
ment was tested prior to use in the radiotherapy simulation room. This enabled Professor
Alistair Munro (Surgery and Molecular Oncology, Ninewells) to experience using the mask
assembly and identify potential problems before requesting patient participation. In addi-
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Figure 8.3: Circuit diagrams of the electronics that control the automated sample collec-
tion. A C4017 counter sequentially counts through 8 outputs, at a time interval determined
by the clock pulse produced with a LM555 timer. The outputs sequentially switch a set of
3-way valves, each via a solid state relay (SSR) and direct the gas ﬂow into the appropriate
sample collection bags.
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tion, the equipment demonstration was used to emphasise to the clinical staﬀ that patient
treatment session times would not be compromised.
Ethane analysis
Collected breath and rooms samples were transported to the Optics lab at the University
of Glasgow and the ethane concentrations were measured using the newly-developed spec-
troscopy system. The samples volumes of ∼ 1 l corresponded to a measurement averaging
time of ∼ 20 s for each sample.
8.2.3 Patients
16 patients were approached to consider participation in the study. Informed consent was
obtained at least 24 hrs before participation and breath samples were obtained on the
3rd day of each patient’s treatment. Of the 6 patients who participated in the trial with
successful sample collection, 4 were male and 2 female, aged between 54 and 71.
8.3 Results
Of those 16 patients approached
  7: Successfully recruited
  2: Glasgow researchers unavailable to collect samples (same day)
  1: Patient unavailable
  2: Patient had dementia/psychologically unsuitable
  4: Patient anxious/unable to tolerate mask
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Figure 8.4: Exhaled breath, room air and background-corrected ethane for 6 patients,
each during a single radiotherapy treatment session. An asterix denotes a time when
radiotherapy was administered
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Patient No. of breath samples Mean ethane (ppb) Std dev (ppb)
a 4 0.24 0.08
b 5 11.54 0.58
c 2 0.39 0.09
d 4 1.13 0.22
e 5 0.45 0.22
f 5 0.27 0.12
Table 8.1: Mean ethane concentration of each set of breath samples collected and analysed
for six patients over the course of a single radiotherapy treatment. session.
The samples collected from the ﬁrst successfully recruited patient were too small to analyse
as the sampling rig calibration dial had been accidentally adjusted immediately before
sample collection.
For the other 6 successfully recruited patients, the exhaled ethane concentrations were
corrected for ambient air ethane by background subtraction, as described in section 6.2.1.
The corrected ethane concentrations for all 6 patients were plotted against time for the
duration of sample collection and are shown in ﬁgure 8.4. An asterix denotes a time when
radiotherapy was being administered. The error bars show the standard deviation of the
measurement over the sample measurement time (∼ 20 s).
The mean ethane concentration and standard deviation of the background-corrected breath
ethane samples, along with the number of samples obtained for each patient is shown in
table 8.1. For 5 out of the 6 patients, the mean breath ethane concentration was <2 ppb,
which is consistent with the typical ethane levels found in healthy controls (See section
6.4). Patient b, with an average breath ethane level of 11.54 ppb, was the only smoker,
whose last cigarette had been only 30min before the beginning of treatment. This explains
the higher observed concentration. In addition to the low average breath ethane levels,
the standard deviation across each patient’s breath measurements was also low, and was
typical of breath to breath ﬂuctuations observed even in a healthy control (See ﬁgure 6.2,
section 6.4). Breath ethane was therefore not seen to ﬂuctuate signiﬁcantly throughout
the treatment.
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8.4 Discussion
Although breath ethane has been previously analysed in patients who received ionising
radiation [152], this was the ﬁrst study in which breath ethane was monitored during the
adminstration of radiation. Signiﬁcant breath ethane elevation was not detected in any of
the patients who participated in the trial. It is possible that breath ethane ﬂuctuations
may have been detected in a larger scale study, particulary if extremely sensitive patients
had participated.
A number of diﬃculties were encountered in this trial. Firstly, the sampling equipment was
designed on the basis of a treatment time of approximately 12min, following discussions
with clinical staﬀ. Typically, the treatment involves the administration of radiation from
4 directions, separated by approximately 3min. However, in practice the timing of the
administration of the radiation varied signiﬁcantly between patients. Patients were only
situated on the treatment bed and wearing the mask for the required treatment time,
which varied from 3min (for patient 3 receiving 2-directional treatment) to between 5min
and 10min 30 s for all other patients who received 4 directional treatment. The scale
of this variation had not been anticipated when the system was designed. Although the
calibration dial could be adjusted on the sampling rig to vary the time interval between
collection and the ﬂowrate of the pump was increased, the approximate treatment timing
had to be ﬁrst estimated for each patient. The clinical staﬀ helped to anticipate treatment
timings for each patient. However, in practice this was entirely dependent on the speed and
ease with which the staﬀ accurately repositioned each individual patient between changes
in treatment direction. Therefore the timing of the collection of breath samples for each
patient was not optimised.
Secondly, the use of a mask assembly was necessary to enable collection of breath samples
without any additional movement from the patient. It was thought that potential breath
ethane eﬀects were likely to be more prominent in the ﬁrst patient treatment fraction.
However, asking patients to participate in the study on the ﬁrst day of their treatment
would be unfair given the apprehension they would already be experiencing. A compromise
was reached by asking patients to participate on the day of their 3rd treatment fraction.
However, many patients were still extremely anxious and uncomfortable with the idea of
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wearing a mask. In addition, of those patients who did view the mask and decide to
participate, a few patients did not comfortably tolerate the slight increase in breathing
resistance. Therefore, while the sampling equipment was demonstrated to be successful
in the ﬁrst automated collection of breath ethane during radiotherapy treatment, it is
clear that the technique is not feasible for use with all patients. Patients appear far more
comfortable with single breath exhalations into a collection bag, the technique used in
the dialysis study (see section 7.2.3), which was not possible for this study. This study
has emphasised that issues encountered in breath analysis lie not only in the technical
challenges in the ultra-sensitive gas detection and the interpretation of the results, but also
in the practicality and feasibility of introducing breath monitoring in a variety of clinical
areas.
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Intensive care study
This study provided pilot breath ethane data from ventilated patients to investigate the
possible clinical potential and feasibility of breath ethane monitoring in intensive care. For
the ﬁrst time measurements were made on-site using the portable instrument.
9.1 Background
There are several populations of intensive care patients whose clinical management may
beneﬁt from early indicators of oxidative stress (OS). Sepsis, for example, is a major cause
of mortality in intensive care units and is associated with increased OS [108, 153]. There-
fore the detection of changes in OS may be useful in clinical detection and/or subsequent
treatment of sepsis. Another potential group is patients who have suﬀered an acute central
nervous system injury: After brain injury by ischemic or hemorrhagic stroke or trauma,
the production of reactive oxygen species (ROS) may increase and could lead to tissue
damage [154]. It is also possible that measures of OS may be useful for the clinical pro-
cess of weaning patients oﬀ mechanical ventilation, as increased oxidative stress has been
associated with diaphragm fatigue [155].
126
CHAPTER 9. INTENSIVE CARE STUDY
The overall usefulness of breath ethane monitoring, for the assessment of OS, in intensive
care patients is unclear. Although breath ethane has been investigated in a range of clinical
conditions and procedures it has not been studied extensively in intensive care patients.
The aim of our study was to use the portable instrument on-site in a hospital to collect
pilot data from ventilated patients receiving intensive care. This was to broadly investigate
the possible clinical potential and feasibility of breath ethane monitoring in an intensive
care unit (ICU).
9.2 Study design
The study took place in the neurosurgical Intensive Therapy Unit (ITU) at the Southern
General hospital, Glasgow. The study was approved by the Multi Centre Research Ethics
Committee for Scotland. Patients were selected for participation in the trial if they fell into
one of the following four categories: Patients with possible/potential sepsis, patients with
sub-arachnoid haemorrhage, patients who had suﬀered a traumatic brain injury (TBI) or
patients who were being weaned oﬀ ventilation. Patients meeting this selection criteria
had written consent obtained from a relative. The patients had their inspired and expired
ventilatory gases sampled non-invasively and the ethane concentrations were immediately
determined on-site using the portable ethane spectroscopy system. Initially the instru-
ment was conveniently located in a room beside the ITU ward and the gas samples were
measured manually. Later in the trial the instrument was located in the ITU ward and
samples were measured using an automated system. The study was observational and non-
invasive, involving no additional intervention beyond the routine procedures and therapies
conventionally used in the ITU as part of their standard intensive care management. For
each patient, the measured breath ethane levels were compared with the corresponding
physiological data in order to investigate possible correlation.
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9.2.1 Physiological data collection
Patients admitted to the ITU have clinical parameters such as heart rate, respiratory
rate and arterial blood pressure (ABP) monitored and displayed on a screen above their
bed. In addition, the DocVu system, currently being piloted in the ITU by the Brain-IT
group [156], was used to record a range of other physiological data and it allows clinical
staﬀ to indicate the occurrence and time-stamp of speciﬁc medical procedures or clinical
events. This system collects minute-by-minute data from the bedside monitor, along with
additional comments entered into the system by clinical staﬀ, and archives it automatically
to an in-house server. Patient information such as name, date of birth and unit ID number,
are also stored. However, for the purposes of this study, each patient was also allocated
an anonymous Patient ID number, which was used for all further referrals to their clinical
and breath ethane data.
9.2.2 Breath sample collection
The patient breath samples were obtained using a peristaltic pump (WM313, Watson-
Marlow) which was connected to the ventilator using narrow bore (1.2mm) side-stream
sampling tubing (2734, Intersurgical). The pump, shown in ﬁgure 9.1, was used to contin-
ually draw gas from both the inspiratory and expiratory lines of the ventilator at a rate
of 300ml per minute (per line) and slowly ﬁll two 5 l gas sample collection bags (Tedlar
SKC). One sample bag was used for inspired gas and the other for expired gas. For safety,
the pumping mechanism was disabled in the reverse ﬂow direction ensuring that the ﬂow
of gases was solely from the ventilator and that no gas could accidentally be forced back
into the ventilator lines.
A ﬁlter (Clear-Guard Bacterial & Viral 1644, Intersurgical) on each line of the ventilator
tubing was used to protect the collection apparatus from contamination. The pump and
sample bags were situated on top of the ventilator, as shown in ﬁgure 9.1 b. The gas
samples were immediately measured using the portable instrument, either manually or
using the automated system. For each pair of gas sample bags, the measured inspired
ethane concentration was subtracted from the measured expired ethane concentration.
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The resulting subtracted ethane values were used to indicate the ethane contribution from
the patient.
Manual ethane measurement
Initially the gas sample collection bags were manually replaced at intervals of approximately
10min. All bags were labelled with the anonymous patient ID code and a bag sample code.
Upon removal the samples were immediately measured using the portable instrument,
conveniently located on-site in a medical physics room nearby the ITU ward. On-site
measurement was extremely eﬃcient and results were therefore made available immediately.
On occasion, on-site measurement was not possible due to practical diﬃculties and in such
cases the samples were stored and later measured in the lab.
A control experiment was run to check that no ethane was produced by the ventilator,
pump or tubing. This experiment involved an identical set-up and analysis to that used
with a patient, except an artiﬁcial lung was used in place of the patient.
Automated ethane measurement
After three patient datasets and a control dataset were obtained it was demonstrated that
the gas collection process was running smoothly, although the manual sample measurement
system was labour intensive. This manual system was then replaced by an automatic
measurement system. This was made possible by bringing the portable ethane spectroscopy
system into the ITU ward directly to the patient bedside. The instrument was placed out
of the way of clinical staﬀ, behind the patient’s bed, ventilator and other clinical equipment
as shown in ﬁgure 9.1 c.
After discussions with the medical physics team at the Southern General hospital it was
decided that the portable instrument should not be used to draw gas samples directly from
the ventilator. There are a number of reasons for this: Firstly, the portable instrument gas
sampling rate is not easily reduced to the maximum gas removal rate from the ventilator
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Figure 9.1: (a) The pump and sample bags used for breath gas collection. (b) The pump
was situated on top of the ventilator. Inspired and expired breath gases were drawn from
the ventilator and pumped into the sample bags. (c) The ITU ward in the Southern General
Hospital. The portable instrument was conveniently situated behind the vacant bed, where
disruption to clinical staﬀ was minimal.
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lines. Secondly, with the gas removal alternating between inspired and expired lines, the gas
removal is much harder to compensate for via adjustment of the ventilator settings. Thirdly,
it was desirable to automate the system quickly as the pilot study was well underway. The
main priority of course was patient safety.
With the above points in mind it was decided the easiest approach would be to make use
of the existing collection apparatus. The pump was connected as before to the ventilatory
tubing and used to continually draw gas from both the inspiratory and expiratory lines of
the ventilator. The gas was directed as previously, into two 5 l gas sample collection bags,
one for inspired and the other for expired gas. At intervals of approximately 4min, 1 l of gas
was sequentially removed from the two sample bags and automatically analysed using the
portable instrument. The sample bags essentially acted as buﬀer bags to enable a constant
removal of gas from each line of the ventilator (300mlmin−1) and allow subsequent removal
by the instrument at regular intervals with a much higher ﬂow rate (∼ 2 lmin−1).
The average measured inspired and expired ethane concentrations were automatically cal-
culated using the LabVIEW software. For each pair of sample bag measurements, the
inspired levels were subtracted from the expired levels. These indicate the ethane contri-
bution from the patient and results were updated immediately after measurement of each
sample pair. The second-by-second ethane data was also recorded for each patient. Figure
9.1 shows the use of the portable instrument, ventilator and sample collection device with
buﬀer bags (on top of the ventilator) during a trial run in the ward. This set-up was then
used for the collection of patient data.
9.2.3 System modiﬁcations
In order to enable automatic collection, the portable instrument required a number of
modiﬁcations: Firstly, normal operation of the instrument uses a 3-way valve to select
between the sample measurement line and the zero-referencing (nitrogen) line and draw
the selected gas into the Herriott cell. Following discussions with medical physics, it was
decided it would not be practical to use a cylinder of nitrogen gas in the ITU for the instru-
ment zero-referencing. The use of a large sample bag as a supply of nitrogen would prevent
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longer-term automatic use. Instead, measurements of ethane in the inspired and expired
gases were measured relative to the ambient ethane. While measured values of inspired and
expired would no longer be absolute, the relative diﬀerence between them would remain
mainly unaﬀected. This process required an additional 3-way valve for the selection of
either inspired, expired or room air. The additional valve was added and the instrument
LabVIEW software was modiﬁed to enable automatic selection between inspired, expired
and ambient air. The software was also modiﬁed to automatically average the ethane
concentration over the measurement intervals, subtract the inspired concentration from
the expired concentration and plot the resultant subtracted ethane concentration against
time. The ﬁlling and removal interval times, averaging times and response times could be
adjusted via user controls on the front panel of the software.
Secondly, even with the reduced gas ﬂow rate of 1.5 lmin−1 into the instrument, this gas
removal rate from the ventilator was thought to be possibly greater than the safe maximum.
Therefore, after a period of gas removal from the sample bags the newly-added valve on the
instrument was switched to draw room air into the instrument. This was for a suﬃcient
time to allow the peristaltic pump to completely replenish the sample bags. The total time
period used for measurement and replenishing of each pair of sample bags was 3min 20 s.
Continual ﬁlling of each bags at a rate of 300ml per min resulted in a total ﬁll volume of 1 l
for each bag in each time interval. For measurement, gas was removed by the instrument
for 25 s from each sample bag. This occurred at a ﬂow rate of 1.5 l per min, corresponding
to a removed volume from each bag of 625ml. Therefore, the overall ‘ﬁlling rate’ was set
to be higher than the overall ‘removal rate’ (averaged over the entire interval time) so that
there was no risk of the gas volume in the bags being signiﬁcantly reduced over time. In
order to prevent the bags from bursting due to the excess gas, a small piercing was made
on the inlet of each bag.
Thirdly, the gases were drawn into the instrument from the sample bags through narrow
bore tubing lines. This tubing was used as the connectors were compatible with the ven-
tilator connections and it could be easily obtained from the ITU for single use with each
patient. The usual instrument ﬂow rate of ∼ 3 lmin−1 is set by an air ﬁlter and regulator
valve on the inlet to the Herriott cell, with which a pressure of 40mB is maintained and
using wider bore tubing. However, the narrow tubing diameter of 1.2mm reduced the gas
ﬂow rate to 1.5 lmin−1 and reduced the pressure in the Herriott cell to 12mbar. Figure 9.2
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Figure 9.2: The gas ﬂow rate of the instrument depends linearly on the Herriott cell
pressure, which is adjusted using the regulator valve on the inlet to the cell.
shows that the ﬂow rate depends linearly on the Herriott cell pressure. However a ﬂow rate
sensor was used for these measurements, instead of the usual bag ﬁlling technique, along
with a change of tubing which altered the impedance of the system. This may account
for the observed diﬀerences in the ﬂowrate/pressure dependence compared with previously.
During automated measurement the instrument was therefore operated at a lower pressure
than normal. This, combined with other factors, resulted in the reduced instrument sensi-
tivity of ∼ 0.5 ppb. As mentioned in section 4.5.3, diﬀerences in ethane transition pressure
broadening between the reference and sample cell (due to diﬀerent background gases) may
also be a source of error.
9.2.4 Ventilator modes
Initial tests were performed at the Southern General hospital with the medical physics
department to ensure that the gas removal from the ventilators was completely safe for the
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patient. The ventilators are operated in a number of diﬀerent modes, depending on each
patient’s condition and their stage in the weaning process. A ‘leak compensation’ setting on
the ventilators automatically increases the delivered volume of gas to compensate for any
detected gas loss. It was necessary to determine the eﬀect of gas removal during operation
of a number of these diﬀerent ventilator modes with the leak compensation setting switched
on. The ﬂow rate of the peristaltic pump used for sample collection was determined to
be 300mlmin−1 from each line (inspiratory and expiratory). A experiment was performed
using an artiﬁcial lung to determine the eﬀect of gas removal at this rate on the ventilator
readings in the following ventilator modes:
IPPV
Typically, patients entering the ITU are immediately put on an Intermittent Positive Pres-
sure Ventilation (IPPV) mode. In this type of mode the ventilator delivers a preset number
of breaths and tidal volume, but no allowance is made for any eﬀort by the patient.
SIMV
In the Synchronized Intermittent Mandatory Ventilation (SIMV) mode the ventilator de-
livers preset breaths of a certain tidal volume. However, within the breath cycle time the
ventilator also allows the patient to trigger a preset breath. If the patient does not trigger
a breath in the cycle time, the ventilator again delivers a breath.
ASB
Assisted Spontaneous Breathing (ASB) modes are used to wean patients oﬀ the ventilator.
Here the ventilator is triggered to deliver a preset breath only when the patient initiates
a breath. However, auto-cycling is a problem that can occur if the ventilator interprets
ﬂuctuations in the circuit as a patient’s attempt to initiate a breath.
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9.2.5 Medical gases
The oxygen concentration in the inspired gas is set, monitored and adjusted via the ven-
tilator settings. Ventilated patients are normally receiving inspired gas with oxygen levels
between 30% and 100%. The required concentration is achieved using a mixture of med-
ical air (containing 20% oxygen) and medical oxygen (at 100%). By varying the oxygen
level in the inspired gas and measuring the resulting ethane concentration the approximate
ethane concentrations in medical air and medical oxygen were determined.
9.3 Results
9.3.1 Ethane in medical gases
Figure 9.3 shows the measured ethane concentrations in inspiratory gas for a number of
diﬀerent oxygen concentration settings. Measurements of the inspired gas show signiﬁcantly
higher levels of ethane (10’s of ppb) than typical room ethane levels (ppb).
Since the minimum inspired oxygen level of 20% is achieved using 100% medical air, the
concentration of ethane in medical air was found to be 2.7 ppb (from extrapolation to the y-
axis in ﬁgure 9.3. Similarly, 100% inspired oxygen levels are achieved using 100% medical
oxygen, determined to be 40.82 ppb. Ideally, the inspired ethane concentration would be
lower to make small ﬂuctuations in the expired ethane concentration more distinguishable.
However, this situation was unavoidable and therefore the inspired was carefully monitored
and the measured levels were subtracted from the expired as described above.
Unfortunately the oxygen concentration could not be automatically recorded during this
trial for potential correlation with measured changes in inspired ethane.
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Figure 9.3: Measured ethane concentrations in inspiratory gas for a number of diﬀerent
oxygen concentration settings. The inspiratory gas is a mixture of medical air (20% oxygen)
and medical oxygen (at 100%), with ethane concentrations for these gases determined to
be 2.7 ppb and 39.3 ppb respectively.
9.3.2 Ventilator mode safety tests
The following safety test results for a number of ventilator modes were obtained for a gas
removal rate of 300mlmin−1 from each line:
When operating in both the IPPV mode and the SIMV mode no disruption was caused to
the simulated ventilator process. The delivered tidal volume was reduced by ∼ 100ml and
this was easily compensated for manually in the input ventilator settings.
For the ASB mode, when the trigger level was set to a level of 2 (arbitrary units on
ventilator display) the ventilator sometimes continually triggered the delivery of preset
breaths. The trigger level could be increased and this auto-cycling stopped, but this would
require greater patient eﬀort to initiate a breath and could make the weaning process
more diﬃcult. It was decided by the medical physics department that the trigger level
could be safely raised to a level of 5 on the ventilator to ensure no auto-cycling without
compromising patient care.
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Figure 9.4: Control data obtained using an identical set-up as with a patient, except an
artiﬁcial lung was used in place of a patient. Inspired, expired and subtracted ethane levels
are shown. The mean subtracted ethane concentration was -0.03 ppb with a standard
deviation of 0.08 ppb. These results conﬁrm that there is no net ethane concentration
diﬀerence between the inspired and expired air.
9.3.3 Control experiment
Gas samples were collected during a control experiment using an artiﬁcial lung for a total of
four hours, with each pair of sample bags immediately analysed manually using the portable
instrument. The plotted inspired, expired and subtracted ethane concentrations are shown
in ﬁgure 9.4. The average value of the subtracted ethane values was -0.03 ppb with a
standard deviation of 0.08 ppb. This suggests that no additional ethane is produced in the
expiratory line and the subtracted ethane values obtained with a patient are attributable
to the contribution from that patient’s breath.
It can be seen that even for a constant oxygen concentration of 30% (determined by ventila-
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tor settings) the inspired ethane levels were seen to ﬂuctuate, with an average concentration
of 6.66 ppb and standard deviation of 0.34 ppb. Instrument error in the measurement will
have contributed to these ﬂuctuations, and possibly also a changing ethane concentration
in the room air which was used as a zero-reference. However it is also possible that the
ﬂuctuations were due to genuine changes in ethane concentration. One explanation is that
the oxygen concentration was ﬂuctuating. However, a real change of 1 ppb in ethane, for
example from 7ppb to 6 ppb would correspond to a change in oxygen from 29% to 27%.
The ventilator is speciﬁed to monitor oxygen levels to an accuracy better than 1% so it
is unlikely that the oxygen concentration changed as much. A second explanation is that
the concentration of ethane in the medical gases varies with time. The medical gases are
supplied centrally and the mixing ratio is determined by the ventilator settings. However,
we were assured by the medical physicists at the Southern General that the mixing process
is extremely accurate and therefore it is unlikely that this is the cause. A further test was
used to check that the instrument error does not fully account for these ﬂuctuations in
inspired ethane: The inspired and expired samples collected from one patient over several
hours were measured in a random order after all the samples had been collected. The
measured expired ethane concentrations still increased and decreased with the reported
inspired ethane levels, demonstrating that instrument error is not the only cause and that
the ﬂuctuations are real.
A second control experiment1 was performed to investigate the possible eﬀect of changes
in inspired oxygen (and therefore inspired ethane) and minute volume on the resultant net
ethane. As can be seen from ﬁgure 9.5, inspired and expired ethane concentration appear
to approximately follow the changes in oxygen concentration, which was varied between
50% and 100%. While the higher oxygen concentration led to an increase in the standard
deviation of these ethane measurements there did not seem to be a signiﬁcant eﬀect on
the net ethane concentration. As might be expected, a step increase in minute volume
(e.g. from 11.7 l to 18.2 l at 16.20) did not appear to signiﬁcantly aﬀect the net ethane
concentration.
1These results were recorded in April 2008 as part of the ongoing clinical study. The gas samples were
collected by a medical student at the Southern General hospital and were analysed by members of the
project team in the Glasgow Optics group.
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Figure 9.5: Second set of ITU control data obtained using an artiﬁcial lung in place of a
patient. Inspired oxygen levels (FiO2) and inspired volume per minute (min. volume) were
changed and the inspired, expired and subtracted ethane concentrations were measured
and recorded. Although increasing FiO2 leads to larger errors it does not appear to have
a signiﬁcant eﬀect on the net ethane concentration.
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9.3.4 Manual measurement of breath ethane
For each patient the measured inspired and expired ethane concentrations were plotted
against time. For each pair of sample bag measurements, the inspired levels were subtracted
from the expired levels and the resulting subtracted ethane values were also plotted. For
ease of presentation of the results each patient number simply refers to the order in which
the patients participated in the trial.
Patient 1
Patient 1 was admitted to the ITU with a traumatic brain injury. Breath ethane was
collected and measured manually as described above for seven hours. The inspired, expired
and subtracted breath ethane values are plotted in ﬁgure 9.6. Physiological data was
collected using the DocVu system as described above. A plot of several of these clinical
parameters is given in appendix D.2. Over the sampling period the patient was clinically
stable and the subtracted ethane levels were observed to be ﬂat, with a mean ethane
concentration of 0.26 ppb and standard deviation of 0.08 ppb. The reduction in inspired
ethane concentration towards the end of the sampling period was due to a reduction in the
patient’s oxygen concentration.
Patient 2
Patient 2 was admitted to the ITU with a traumatic brain injury. Breath ethane was
collected and measured manually for four and a half hours. Unfortunately the DocVu
physiological data could not be recovered after sampling due to a technical problem. How-
ever the patient had been clinically stable over the sampling period. Subtracted ethane
levels, shown in ﬁgure 9.7 were also relatively ﬂat, with a mean ethane concentration of
0.16 ppb and standard deviation of 0.12 ppb.
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Figure 9.6: Inspired, expired and subtracted breath ethane levels for ITU patient 1. The
subtracted ethane levels were observed to be ﬂat with a mean concentration of 0.26 ppb
and standard deviation of 0.08 ppb.
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Figure 9.7: Inspired, expired and subtracted breath ethane levels for ITU patient 2. The
subtracted breath ethane levels were observed to be fairly ﬂat, with a mean concentration
of 0.16 ppb and standard deviation of 0.12 ppb.
Patient 3
Patient 3 was also admitted to the ITU with a traumatic brain injury. Breath samples
were collected and measured manually over four consecutive days. The inspired, expired
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and subtracted breath ethane data collected over the four days is shown in ﬁgure 9.8. The
observed subtracted ethane levels for the ﬁrst three days were also relatively ﬂat, with
average baseline levels shown in table 9.1.
Day Mean ethane concentration (ppb) Standard deviation
1 0.80 0.29
2 1.57 0.47
3 0.31 0.26
4 (excl. peaks) 0.12 0.2
Table 9.1: Mean subtracted ethane concentration and standard deviation for each day of
breath gas collection for ITU patient 3.
On the fourth day two peaks in breath ethane were observed. The ﬁrst, observed at 11:46,
was an increase of 1.82 ppb above the inspired ethane concentration. The second, observed
at 15:12, was an increase of 5.23 ppb above the inspired concentration. Each peak was a
measurement of a single sample bag, with the subsequent sample (10min later) measuring
baseline level again, as shown in table 9.1. It is possible, although extremely unlikely that
the observed peaks could be caused by contamination of the sample bags used for the
breath gas collection.
The DocVu clinical data for the four days is shown in appendix D.3. Interestingly, the pa-
tient had been heavily sedated on the ﬁrst three days and on the fourth day, when ethane
peaks were observed, had shown variation in their level of consciousness and greater ﬂuc-
tuations in their monitored physiology. There also appeared to be some trend downwards
in blood pressure. No signiﬁcant clinical events were recorded over the four days for which
breath samples were collected. However on the fourth day at 15:10, just two minutes before
the second peak was observed, a physical examination of the patient had begun.
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9.3.5 Automated measurement of breath ethane
Patient 4
Patient 4 had suﬀered a subarachnoid haemorrhage (SAH). Breath samples were collected
and measured on three consecutive days using the automated sampling system. On the
second day, the instrument was thermally-cycled (as described in section 3.2) following
poor performance that morning. Therefore sampling was resumed in the evening. The
inspired, expired and subtracted breath ethane data collected over the three days is shown
in ﬁgure 9.9. It is likely that the increased variation in the measured values of inspired and
expired air reﬂect the fact that the instrument was zero-referencing using room air rather
than nitrogen gas. Larger deviations are also seen in these measurements, which were
obtained towards the end of the trial, due to a general slow deterioration of instrument
performance over several months.
No signiﬁcant peaks were observed in the subtracted breath ethane levels for the ﬁrst two
days. On the third day two peaks were observed. The ﬁrst increase in breath ethane
began at 13:10 and peaked at 13:42 with a value of 4.24 ppb with a standard deviation of
1.23 ppb. This coincided with the sedated patients family visiting. The second increase
began at 18:47 and peaked at 19:06 with a value of 5.51 ppb and a standard deviation of
1.52 ppb. This coincided with the patient becoming agitated and requiring further sedation.
The recorded physiological data is shown in appendix D.4. The ‘decay’ of the peaks in
breath ethane using the automated system will have been aﬀected by the ﬁltering eﬀect
of the buﬀer bags. However the slow increases in ethane, this time measured over several
sample bags, suggest that the increased rate of ethane production by the patient does
extend over a period of ∼ 30min.
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Figure 9.8: Inspired, expired and subtracted breath ethane levels for ITU patient 3 mea-
sured over four consecutive days.
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9.4 Discussion
Breath ethane was non-invasively monitored in a number of ventilated patients in the ITU.
Subtracted ethane concentrations were calculated from measurements of ethane of inspired
and expired air. The subtraction technique appeared to give a good indication of the
ethane contribution from the patient, even when the inspired ethane concentrations were
much higher than this contribution. It is also interesting to note that these subtracted
values also remained consistent when the inspired ethane concentration was adjusted, by
an increase or reduction in oxygen. This is in contrast to the ﬁndings by Schubert et al
that inspired substance concentrations can seriously aﬀect the accuracy and reliability of
breath analysis in mechanically ventilated patients and that a simple correction for inspired
substance concentrations is not possible [157].
Very recently (July 2008) a letter was published reporting that peaks of ethane of short
duration occur in breath of intensive care patients [158]. For the sample group of six pa-
tients, fewer breath ethane surges were observed for the three patients that had less serious
conditions than the others. Peaks were observed more frequently in the three patients, and
some were reported to occur along with recorded clinical events such as administration
of drugs, pulmonary toilette and arrhythmias. The high frequency of sampling enabled
short lived changes to be observed, although the sample measurement technique of gas
chromatography required laboratory analysis [93].
In our pilot study, breath ethane peaks in the subtracted values of >1.5 ppb were observed
in two out of the four patients for which breath gas was monitored before the end of
November 2007. Since then, the portable instrument remained on-site in the Southern
General (SG) hospital and the ITU trial was continued by other members of the team and
their clinical collaborators. Further breath ethane peaks have since been observed in a
patient with sepsis/spinal injury. In a study running in parallel with this one over the last
year, breath samples were collected from a number of sepsis patients in the Intensive Care
unit at Ninewells hospital, Dundee. These samples were also mainly measured using the
portable instrument and several breath ethane peaks were observed.
The underlying cause of the ethane peaks is unclear as there appeared to be no signiﬁcant
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correlations between breath ethane and other recorded clinical data. However, during the
ITU trial the breath ethane was seen to peak at times that correspond with an apparent
increased patient awareness. Similar increases were observed in the ICU Ninewells study
in a patient with spinal injury while being washed by the nursing staﬀ and also while a
patient was being prepared for a CT Scan. These observations suggest that anxiety or stress
induces metabolic changes that generate ethane. The origin of the ethane is uncertain but
it is possible that the central nervous system may be a major contributing tissue.
The limited number of patients currently monitored means it is diﬃcult to correlate the
measured ethane with physiological events. It may even be that the clinical markers cur-
rently monitored in the ITU are not appropriate for direct comparison with breath ethane,
or that the changes in such markers may be subject to a signiﬁcant delay. Future work
would require much larger scale studies, allowing in depth statistical analysis to be per-
formed. A larger scale follow-up study could be used to investigate if observed breath
ethane increases are linked at all to patient outcomes. A similar type of study is currently
being performed by the clinical physics department at the Southern General hospital where
the DocVu real-time physiological data recording system is being tested. The clinical data
that is currently recorded and displayed on the bedside monitor each second is being anal-
ysed and correlated with patient outcomes. The aim is for the potential optimisation of
patient care in the ITU.
147
Chapter 10
Summary and conclusions
10.1 Summary
In this thesis the development of a portable spectroscopy system for the real-time detec-
tion of breath ethane has been described. The instrument has dimensions 1m x 0.5m
x 1m and incorporates a closed-loop cooling system, enabling a factor of 3 volume re-
duction compared with the lab-based system. In addition to a signiﬁcant size reduction
the previously achieved high performance has been not only been sustained but improved
upon. A sensitivity of 70 ppt has been achieved based on a 1Hz sampling rate. This cor-
responds to the detection of a minimum absorbance of 11 cm−1. The performance of the
instrument has been characterized and the factors aﬀecting this performance have been
explored. An accuracy of > 78% has been demonstrated when measured ethane concen-
trations were compared with empirical concentration, shown to be reproducible provided
zero-referencing occurs at regular intervals. The instrument has been shown to have a
linear response and is relatively insensitive to common contaminating species. Pressure
and temperature ﬂuctuations have been shown to have little eﬀect, while shifting optical
fringes and changing modal properties of the laser do contribute signiﬁcantly to the working
sensitivity.
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An outdoor ﬁeld trial was conducted in which ethane concentration data was gathered
for the future development of gas dispersion and inverse models. Sub-ppb performance
of the instrument was observed even when driving over relatively rough terrain increasing
conﬁdence in the robustness of the system.
The instrument was used in a number of pilot clinical studies, both as an oﬀ-line and an
on-line analyser. In the dialysis study the real-time nature of the instrument was exploited
to enable the rapid turnaround of large numbers of discrete breath samples. Breath ethane
was monitored in patients as they received dialysis treatment and short term increases
in breath ethane were detected in 14 out of the 24 patients at the onset of the treatment
session. The observations are consistent with ﬁndings reported in the literature using other
OS markers. Breath ethane was collected for the ﬁrst time during radiotherapy treatment
using a custom-designed automated sampling rig although no signiﬁcant breath ethane
increases were observed in the 6 patients.
The instrument was then located on-site at the Southern General hospital, Glasgow where
inspired and expired breath samples were collected from ventilated patients in the Inten-
sive Therapy Unit. Initially, the breath samples were collected and measured manually,
with the convenient location of the instrument facilitating a rapid turnaround of sample
analysis. Later in the trial the instrument was modiﬁed to enable automated collection and
measurement of inspired and expired breath from ventilated patients. Signiﬁcant increases
in breath ethane were observed in two out of the four patients monitored in the ITU.
This trial continued and the portable instrument is still in regular use, having replaced the
previous lab-based system as the most sensitive, reliable breath ethane sensor.
10.2 Conclusions
On commencement of this project lead-salt lasers were the most practical choice of laser
source for the portable instrument: They were commercially available, essentially ’plug and
play’ in our systems, and they had previously been used to achieve high performance in the
lab-based systems. Therefore the portable instrument was based on these previous systems
and its development beneﬁted from the Glasgow Optics group’s previous experience. The
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key change in the way in which the laser is cooled has oﬀered several advantages: The
closed loop cooling cycle oﬀers higher temperature stability and enables longer-term on-
site use in a clinical setting. The induced vibrational noise from the cooling system does not
have a signiﬁcant eﬀect on the sensitivity, due to the nature of the wavelength modulation
technique. While the cooling system has enabled a reduction in size of the dewar and
dispensed with the need for a liquid nitrogen dewar, the instrument is still a signiﬁcant
size at 1m x 0.5m x 1m. The base, which encloses the compressor and scroll pump,
accounts for approximately half the height of the instrument. If the laser did not require
cryogenic cooling the base section would be unnecessary and the size would be reduced by
a factor of two.
Alternative mid-IR sources oﬀering room temperature operation could enable this. Ad-
ditionally, a higher power source could achieve a high signal to noise ratio over a shorter
pathlength. Despite a reduction in length as compared with lab-based systems, the multi-
pass Herriott cell in the portable instrument still contributes signiﬁcantly to the size of
the instrument. Reducing the length of the Herriott cell requires the number of passes
to be increased to sustain the pathlength, and therefore, sensitivity. As was shown, this
is oﬀset by mirror transmission losses and therefore there is a fundamental limit on the
length reduction for a given laser power. At high powers, a lower number of passes will
permit smaller cells to be used. The reduction in cell volume has the added advantage
of increasing the gas response time. The portable instrument response time of ∼ 2 s is
currently limited by the cell volume of 3.2 l. For future breath analysis studies, especially
by ‘side-stream’ sampling from a ventilator for example, a lower volume of gas required for
analysis should be required.
Breath monitoring
In our breath analysis studies the portable ethane spectroscopy system enabled a large
turnaround of breath samples at high sensitivity and selectivity. The dynamic breath
ethane patterns observed in patients during dialysis treatment indicated increased oxidative
stress at the onset of dialysis treatment. Further larger scale studies will be required to
oﬀer greater insight into the ethane elevation eﬀect and potential clinical beneﬁt of breath
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ethane monitoring and the possibility of intervention. The key observation is the speed
of the response, and following this trial our approach to breath sampling was modiﬁed to
take this into account.
The portable instrument and corresponding gas sampling system enabled the ﬁrst au-
tomated analysis of breath ethane in ventilated patients in an intensive therapy unit.
Although samples were ‘averaged’ over periods of minutes, the automated technique al-
lowed unsupervised use over periods of hours, and minimum disruption to clinical staﬀ
and visiting friends or family compared with the manual system. The control experiments
demonstrated that the measured net ethane concentration between expired and inspired
air was attributable to the patients.
These increases in the net exhaled ethane during visits by family and interventions by
nursing staﬀ suggest that stress or anxiety can trigger the production of ethane even in
situations where other clinical parameters are not signiﬁcantly altered. Results obtained
across various studies were discussed with the clinical biochemist collaborating with our
team. It was suggested the breath ethane data collected to date point to alterations in
cerebral activity as the causative factor in elevated ethane. This could have important
implications for further breath ethane studies, and applications of the technology.
10.3 Future work
Further advances in both laser technology and spectroscopic techniques will enable future
development of compact, robust gas sensors with high sensitivity and selectivity. There
have been a number of advances in compact laser technologies for the generation of widely
tunable mid-IR radiation around 3μm. Recently, a limited number of alternative sources
have become commercially available. For example, M Squared Lasers Ltd (Glasgow, UK)
produce a widely tunable, pulsed OPO (Fireﬂy-IR) with an ‘idler’ wavelength range of
∼ 2.4 to 4.7μm. Despite the high average power (> 100mW at 350 kHz) the linewidth of
several GHz is a limiting factor. Aculight (Bothell, WA, USA) also produce a tunable,
single frequency OPO (Argos Model 2400) with idler wavelength range of 3.2–3.9μm with
a linewidth < 1MHz and power > 1W. Multimode interband cascade lasers designed for
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operation between 3 and 4μm are available from Maxion technologies, Inc (College Park,
MD, USA) [159].
QC lasers are potential alternatives that may oﬀer room temperature and high power
around 3μm in the near future for spectroscopic gas sensing. Researchers and collabora-
tors at the Jet Propulsion Lab (JPL) are developing a new generation of miniature, room
-temperature mid-IR QCL spectrometers for measurement of atmospheric and planetary
gases, including ethane. Currently, the Glasgow Optics group are working on a UK collab-
orative interdisciplinary project to develop a trace gas sensor based on quantum cascade
lasers for oil and gas prospecting. The collaboration comprises the Compound Semiconduc-
tor Technologies (CST), the Universities of Sheﬃeld and Glasgow, Shell Global Solutions
and laser system specialist Cascade Technologies and is funded by the UK government’s
previous Department of Trade and Industry (DTI) [160]. The QCL structures are being
developed at the University of Sheﬃeld, using novel antimonide-based epitaxy, which will
be used to target the absorption band of ethane at 3.34μm. Working with the electronics
and electrical engineering department at Glasgow, CST will fabricate laser devices from the
material produced at Sheﬃeld. Cascade will provide module-level packaging and control
electronics. The Glasgow Optics group will then develop the photoacoustic instrument, in
conjunction with Shell, and it will be then be tested in a number of ﬁeld trials.
In healthcare, ethane is of considerable interest as a marker of OS. A number of researchers
and collaborators are keen to build on the previous work in ethane breath analysis using
new online analysers. Preliminary studies such as those described in this thesis, point to
the need for frequent sample collection to observe short-lived changes in breath ethane.
In contrast to studies which suggest that ethane may have diagnostic potential [75], our
results suggest ethane has more potential for clinical monitoring. More research is needed
to truly determine if breath monitoring of ethane will be feasible in the future, and more
importantly, if it will be clinically useful. It is only with more extensive research, and
larger scale studies that this will become clear. As has been shown with the case of NO,
the measurement of certain gases is actually being incorporated into clinical practice. This
has been made possible by the development of low cost, ‘turn-key’, portable breath gas
analysers. For other breath gases, such as ethane, the measurement technologies require
further development. Breath analysis is a growing ﬁeld with exciting prospects, despite a
number of challenges to be overcome. As the ﬁeld of breath analysis expands and breath
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gas detection methods improve there is a growing need for standardization of breath sam-
pling techniques [90, 161]. While technological development, particularly of laser-based gas
sensors, will overcome a number of obstacles, a great deal of progress has been, and will
continue to be made, through a collaborative and interdisciplinary approach.
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Circuit diagrams
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Figure A.1: A sinusoidal waveform used to modulate the laser wavelength modulation is
generated using a waveform generator (MAX038CPP, Maxim).
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Figure A.2: A bandpass ﬁlter (UAF42AP Burr-Brown series, Texas Instruments) is used
to ﬁlter the generated sinusoidal waveform and also the detected AC signals from the
photodetector modules.
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Figure A.3: A summing op-amp (TL071, Texas Instruments) was used to add the sinusoidal
waveform to the ramp signal.
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Figure A.4: Before being ﬁltered the detected AC signals at 16 kHz from the photodetector
modules were ampliﬁed using a low noise op-amp (LT1028) with an AC gain of ∼10.
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Rayleigh range approximation
Two key parameters of a Gaussian beam are beam size, ω, and wavefront curvature, RW ,
as a function of distance, z. The position z = 0, where ω = ωmin = ω0, is called the beam
waist. The wavefront curvature is a minimum at the Raleigh range zr.
We have1
ω(z) = ω0
√
1 + (
z
zr
)2 (B.1)
RW (z) =
1
z
(z2 + z2r) (B.2)
For a confocal cavity the two mirrors, each of radius of curvature, R, are placed at the
Raleigh range, zr, and we have
2zr = d = R = Rw(z = zr) (B.3)
Rewriting equation B.2 for z gives
z =
R
2
±
√
R2 − 4z2r
4
(B.4)
1The following working was modiﬁed from notes taken during the Modern and Nonlinear Optics under-
graduate lectures delivered by Prof Miles Padgett at the University of Glasgow
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Using d = 2z and B.4 we obtain the following expression for zr
zr 
√
d(2R− d)
4
(B.5)
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Radiotherapy sampling equipment
staﬀ instructions
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APPENDIX C. RADIOTHERAPY SAMPLING EQUIPMENT STAFF
INSTRUCTIONS
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Figure C.1: The instruction sheet for operation of the sampling equipment developed to
collect breath samples from patients receiving radiotherapy treatment. The sheet was
distributed to clinical staﬀ in the Radiotherapy unit, Ninewells hospital, Dundee.
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ITU patient physiological data
The DocVu system currently being piloted in the ITU by the Brain-IT group [156] was
used during the breath ethane study to record a range of physiological data.
The recorded patient physiological data corresponding to the dates and times of breath
ethane sampling are shown in ﬁgures D.2–D.4. For a key to the parameters shown in all
three ﬁgures, please refer to ﬁgure D.1. A point to note is that the unfeasible dramatic
increases in certain physiological parameters was often as a result of an interruption to
the sensor due to a clinical assessment or treatment procedure. For example, the apparent
increases in central venous pressure from ∼20 to ≥100 are artefacts.
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Arterial blood pressure (mean) 
Central venous pressure (mean)
Intracranial pressure (mean)
Temperature
Central perfusion pressure 
Heart rate
Respiratory rate
Saturation of peripheral oxygen
Figure D.1: Key to displayed physiological data collected from ventilated ITU patients
using the DocVu system.
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Figure D.2: DocVu data for patient 1 recorded on 4/06/07. Refer to ﬁgure D.1 for key.
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Figure D.3: DocVu data for patient 3 recorded on four consecutive days 14/08/07–
17/08/07. Refer to ﬁgure D.1 for key.
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Figure D.4: DocVu data for patient 4 recorded on three consecutive days 27/11/07–
29/11/07. Refer to ﬁgure D.1 for key.
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Abstract
We report on a maintenance-free, ward-portable, tunable diode laser
spectroscopy system for the ultra-sensitive detection of ethane gas. Ethane
is produced when cellular lipids are oxidized by free radicals. As a breath
biomarker, ethane offers a unique measure of such oxidative stress. The
ability to measure real-time breath ethane fluctuations will open up new
areas in non-invasive healthcare. Instrumentation for such a purpose must be
highly sensitive and specific to the target gas. Our technology has a
sensitivity of 70 parts per trillion and a 1 s sampling rate. Based on a
cryogenically cooled lead-salt laser, the instrument has a thermally managed
closed-loop refrigeration system, eliminating the need for liquid coolants.
Custom LabVIEW software allows automatic control by a laptop PC. We
have field tested the instrument to ensure that target performance is
sustained in a range of environments. We outline the novel applications
underway with the instrument based on an in vivo clinical assessment of
oxidative stress.
Keywords: ethane, breath, oxidative stress, infrared
(Some figures in this article are in colour only in the electronic version)
1. Introduction
There is increasing interest among clinicians in the field of
breath analysis. This is due in part to the relatively recent
advent of accurate real-time measurement technologies. While
the field of optical sensors in medicine has progressed in
areas such as imaging technology [1] and adoption of new
laser treatments [2], there is also a significantly important
movement towards breath measurement technologies. Of
interest to clinicians are techniques that target gases with
known biochemical pathways [3–5]. Due to its proven role
as a biomarker for free-radical-induced cell attack, ethane is
of particular interest [6]. Oxidative attack on cell membrane
lipids (lipid peroxidation) is regulated by the balance between
free-radical production and scavenging within the body [7].
The resulting equilibrium is referred to as the level of oxidative
stress (OS) [8]. Ethane is thus an excellent indicator of OS
and its presence in breath could offer non-invasive, dynamic
assessment of ongoing cell damage. Almost all clinical studies
involving ethane have been conducted using non-real-time
techniques such as gas chromatography (GC) coupled with
mass spectroscopy and other variants. Such work has been
pivotal in stimulating interest in ethane and while improved GC
improved methods have been developed [9], the real potential
of ethane as an adoptable measure of dynamic OS has been
hampered by the absence of real-time technology of sufficient
sensitivity. Here we describe a compact, sub-part-per-billion,
maintenance-free ethane spectroscopy system. This enables
continuous non-invasive in vivo assessment of oxidative stress
in a hospital setting.
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Figure 1. Schematic of the optical configuration. All optics are mounted on a 90 cm by 45 cm lightweight optical table.
Figure 2. 2f sample lineshape and fitted lineshape as the laser wavelength is scanned over the ethane transition. A LabVIEW least squares
fitting algorithm is used to calculate the ethane concentration.
2. Description of the spectroscopy system
Our instrument is based on highly resolved absorption
spectroscopy across a transition for ethane gas at
2990.09 cm−1. A schematic of the optical configuration is
shown in figure 1. A cryogenically cooled lead-salt laser diode
(IR-2990-GMP-WM, Laser Components) emits ∼0.2 mW of
light which passes through a Herriott optical sample cell,
0.55 m in length. The light undergoes 366 passes and
exits onto a low noise thermo-electrically cooled HgZnCdTe
photodetector PD1 (VIGO PVI-2TE). Sample gas is drawn
through a sample inlet pipe to the Herriott cell by a
240 l min−1 pump (Varian, Inc.). An air filter and regulator
valve on the inlet to the cell maintains a pressure of
40 mbar ±2% corresponding to a sample inlet flow rate
of 3 l min−1. Around 5% of the light is split off before
the Herriott cell and directed through a 10 cm reference
cell containing a known concentration of ethane also at
40 mbar and onto a second photodetector PD2. This allows
for continual calibration and wavelength stability checks. A
second harmonic wavelength modulation scheme is used,
whereby the laser light is sine-wave modulated at 8 kHz and
continually ramped through the ethane transition at 1 Hz. The
reported sample cell concentration is based on curve fitting
between the demodulated signals from PD1 and PD2. See
figure 2. This is achieved using a least squares fitting algorithm
in the LabVIEW software, which compares the 2f lineshape
from the sample channel to that of the reference channel and
reports coefficients for the scaling factor and offset. The
former of these coefficients is used to calculate the ethane
concentration.
As the height of the ethane transition in the sample and
reference channels is linearly proportional to the dc light levels
at PD1 and PD2 respectively, the calculated concentration
is also multiplied by the ratio of the light levels at PD1
and PD2. This normalizes for changes in the overall light
level and also for relative changes in the dc levels between
the photodetectors. The entire modulation scheme and data
analysis process is controlled by custom-written LabVIEW
software controlling a commercial laser controller (Profile
PRO8000).
All electronics for modulation and signal processing is
designed in house with the exception of two PSDs (Femto
LIA-MV-200-H). The laser cooling is achieved by a closed-
loop compressor and throttle. The instrument is thus
completely self-contained, and the only additional requirement
is hydrocarbon-free nitrogen gas for zero referencing. With the
above configuration, we have achieved a working sensitivity of
70 parts per trillion (ppt) with a 1 Hz sample rate. This equates
to a minimum detectable absorption coefficient for ethane of
1.05 × 10−9 cm−1 Hz− 12 . Further details about the second
derivative modulation spectroscopy technique can be found
in [10, 11].
3. Design aspects essential for clinical use
Our instrument offers essential enhancements over previous
technologies. Firstly, the physical dimensions of the system
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(a) (b)
Figure 3. (a) The optical table section has been rotated to show the compressor and vacuum pump positions in the base. Thermal
management is achieved via cooling fans with air flow controlled by foam partitioning. (b) The packaged instrument measures
1 m × 0.5 m × 1 m (L × W × H), allowing ease of transportation to the bedside.
are 1 m × 0.5 m × 1 m (length × width × height), occupying
three times less volume and footprint compared with our own
previously published best performance [10].
Furthermore, the self-contained cooling system dispenses
with the need for liquid nitrogen, enabling use in a clinical
environment. Issues such as intermittent filling with
liquid nitrogen, requiring temperature re-equilibration, have
been eliminated. We observe continuous operation over
several days with steady operating parameters and consistent
sensitivity. The closed-loop cooling system has enabled a
more compact laser cold finger to be incorporated, and thus
the entire laser dewar has been downsized by around a factor
of 2 in volume from our lab-based system. To accommodate
these design aspects, the instrument has been arranged in three
sections as shown in figure 3(a). The base houses two sections
containing compressor and vacuum pump, each with separate
thermal management. The third (upper) section consists of
the optical table on which the laser and optics are mounted.
The complete instrument, being used in a physiology study, is
shown in figure 3(b).
4. Performance of the spectroscopy system
The working sensitivity (70 ppt) is determined by the standard
deviation measured over 1 min as hydrocarbon-free nitrogen
gas is drawn through the sample cell. Example breath ethane
measurements for both online and offline samples are shown
in figures 4(a)–(d). In particular, online sampling allows the
increase in ethane associated with the gas exchange regions
within the lung to be observed over the course of a single
exhalation (the so-called alveolar gradient). This level of
resolution may provide additional clinical information over
and above time-averaged ethane elevations.
We consider the accuracy of our instrument in terms of
its absolute calibration and reproducibility. To address these
issues we have performed various measurements, examples
of which are shown in figure 5. In figure 5(a), a typical
graph of measured concentration versus empirically calculated
concentration is shown. Figure 5(b) shows the basic
concentration reproducibility associated with measuring a
constant ethane sample over a period of hours. Further details
of the accuracy associated with our spectroscopic approach
can be found in [10].
(a) (b)
(d)(c)
Figure 4. The performance of the ethane sensor. (a) Room air
measured over 10 min, with regular nitrogen zero referencing.
(b) Nitrogen gas measured over 60 s. (c) Room air followed by a
breath sample contained in a Tedlar sample bag. (d) Room air
followed by a breath sample exhaled directly into the instrument,
whereupon the rise in ethane can be detected over a single breath
4.1. Zero referencing and absolute calibration
To provide a zero reference for the ethane figure, hydrocarbon-
free nitrogen gas is measured for 12 s in every minute. This
technique primarily eliminates optical fringing in the Herriott
cell, which can affect the sample 2f lineshape. Optical fringing
does not significantly affect the reference 2f lineshape since
the reference cell contains a high concentration of ethane
(500 ppm), and therefore the transition height is considerably
larger than that of the fringes. As an additional measure to
suppress optical fringing, the reference cell is placed in the
beam path at an angle. In situations where the difference
in ethane between two sources is to be examined, the zero
reference can be taken as one of these sources, eliminating
the need for an external reference such as nitrogen. Thus,
in one of our most interesting clinical applications, namely
the monitoring of intubated patients in intensive care wards,
we can use the inspired and expired ports of the breathing
ventilator and measure only the excess ethane contributed by
the patient.
In addition, calibration is independently confirmed using
a hydrocarbon reference standard certified in accordance with
ISO9001 (National Physical Laboratory). This contains ethane
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(a) (b)
Figure 5. (a) A sequence of measured ethane concentrations showing the level of agreement with empirically calculated ethane
concentrations. (b) Reproducibility of measurements of a constant ethane sample over a period of hours. The readings agree to within 0.07
parts per billion.
(a) (b)
Figure 6. (a) Noise spectra measured post-photodetector electronics but pre-PSDs. The contributions due to shot noise, photodetector dark
noise and electronic circuit noise (circuit grounded at photodetector input with a 50  terminator) are shown. (b) Comparison of dc-coupled
intensity noise measured at the sample cell photodetectors in our new instrument and existing lab-based system. Despite clear coupling of
vibration from the compressor and pump housed within the new unit, potential up-conversion of this noise has no noticeable effect on
measured sensitivity.
at 4.01 parts per billion (ppb) with a certification accuracy
of 2%.
4.2. Factors affecting performance
Noise contributions from the detectors and electronics were
measured using a Stanford Research Systems SR780 analyser.
The sensitivity of the instrument is limited by a combination
of photon shot noise, electronic noise and optical fringing.
The basic electronic and photon shot noise is shown in
figure 6(a). The photon shot noise at the sample detector
equates to a fundamental sensitivity of around 20 ppt. As can
be seen from figure 6(a), the carefully designed electronics do
not compromise the shot noise figure. However, in practice,
the sensitivity is limited by more subtle effects that are difficult
to quantify, such as shifting interference patterns due to optical
fringing and variation in mode purity. We have considerable
experience with lead-salt laser spectroscopy systems and have
noted that over a number of years the modal properties can
decline.
Vibrational noise is introduced from the compressor and
vacuum pump within the base compartment of the instrument.
However, the overall sensitivity is not compromised as
compared to our lab-based system in which the pump is
isolated and liquid nitrogen is used. A comparison of the
dc-coupled light level from the sample cell photodetector in
our lab-based system and the portable instrument is shown in
figure 6(b). Despite the considerable increase in vibration-
induced light noise at the photodetectors, there is no up-
conversion of this noise compromising the signal at the
detected frequency. It is reassuring that the coupling of
such noise is so small since it would otherwise be difficult
to suppress given the need for a compact design.
We should point out that we do not actively control the
pressure or temperature of either the reference or sample
cells in our configuration. While fluctuations here will have
a small impact on accuracy via relative variations in the 2f
lineshape, we find that optical issues mentioned above impact
on sensitivity and accuracy to a much greater extent. Having
said this, we do monitor sample cell pressure carefully and
strive to keep the operating pressure to within 2% of 40 mbar.
The reference cell pressure can be monitored via the width
of the 2f lineshape displayed in the reference channel of
the instrument. Additionally, the reference cell pressure is
manually checked every few months and refilled if necessary.
Finally, although the temperatures of the cells are not actively
controlled, we find that the operating performance of the
enclosed system does not depend on ambient temperature and
we have seen good performance across a range of temperatures
both indoor and outdoor.
4.3. The choice of laser
The modal properties of the laser are crucial in occupying a
contaminant-free part of the infrared (IR) spectrum. We have
found that a single mode operation at one of two transitions,
2986.73 cm−1 and 2990.09 cm−1, is essential for our reported
ethane sensitivity. While not an easily quantifiable source
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of noise in terms of sensitivity reporting, we consider it
a significant contributor to practical sensitivity. However,
despite the perceived disadvantages of lead-salt lasers relating
to reliability and longevity, we find that their use in our
application offers many advantages. As indicated above,
despite long-term modal changes in their output, we have
shown them to be compatible with the requirements of a
maintenance-free instrument. Given the need for cryogenic
cooling, they are nevertheless compact and offer the necessary
tuning for spectroscopic applications.
Until the commercial availability of mid-IR laser sources
improves, probably by the development of mid-IR quantum
cascade lasers (QCLs), lead-salt systems are likely to provide
the most robust use in a compact design. Of course, we look
to the future potential offered by higher power QCLs. If
the need for cryogenic cooling can be relaxed, then a further
generation of our technology would be made possible in terms
of size, weight and perhaps, above all, cost. Alternative
mid-IR laser sources include optic parametric oscillators
[12] and difference frequency generators [13]. Several
groups have reported sensitive ethane detection combining
such sources with photoacoustic [14] or cavity leak-out
[15, 16] spectroscopy. However as far as we are aware, no
competing technique offers our combination of field-tested
ultra-sensitivity (70 ppt), automatic operation, portability and
real-time analysis.
Finally, we should point out that in addition to running
the instrument indoors we have tested its robustness in a more
hostile outdoor environment. By using a 4 kW portable
generator, we have measured ambient ethane levels from
within a moving vehicle. We achieved sub-ppb sensitivity
while moving at speeds of up to 3 m s−1 over relatively
rough terrain, as the system is highly robust to vibration and
is liquid nitrogen free. This demonstrates its suitability to
environmental or industrial monitoring, an area on which much
of our earlier work was focused [17, 18].
5. Conclusion
We have demonstrated a novel, maintenance-free, lead-salt
optical spectroscopy system for trace ethane detection. The
ruggedized, portable design offers ease of use in a hospital
environment. A closed-loop cooling system within a custom-
built casing with careful thermal management has removed
the need for liquid nitrogen cooling of the laser diode. All
aspects of the wavelength modulation scheme, signal analysis
and data processing are controlled by custom-written software
requiring little or no operator intervention.
An analysis of the noise sources that limit our performance
suggests that we are operating within 10 dB of the photon shot
noise limit. Vibration induced by the compressor and vacuum
pump introduces considerable intensity noise in the detected
light signals at the photodetectors, but does not couple into the
demodulated signals. Our achieved sensitivity of 70 ppt for a
1 s sampling rate offers an unparalleled performance for breath
ethane measurement where typical concentrations are of order
1 ppb. The fast sampling allows analysis of the varying ethane
concentration over the course of one breath, paving the way
for on-site measurement of alveolar gradients.
We believe our work is particularly timely, given the
current clinical interest in oxidative stress and the need for non-
invasive assessment techniques. Many clinicians are familiar
only with non-real-time processes for breath gas measurement,
highlighting the need to raise awareness and discussion within
the medical community of the opportunities created by optical
spectroscopy. Currently, we are collaborating with various
medical consultants and have in place a selection of ethics
applications, some of which are now granted, for forthcoming
trials. For example, we have approval for a study investigating
oxidative stress in sepsis patients within intensive care wards.
We are also exploring the potential of an ethane breath test as
a dose mediator in radiotherapy treatment.
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Abstract
The application of optical spectroscopy for rapid accurate measurement of breath biomarkers
has opened up new possibilities for monitoring and diagnostics in recent years. Here, we
report on how our recent advances in optical detection of ethane have enabled us to record
dynamic breath ethane patterns for patients undergoing kidney dialysis. Ethane is well
established as a breath biomarker for free radical induced cell degradation. Moreover, renal
dialysis is known to induce such oxidative attack, and our measurements may offer insight into
the nature of this assault. Specifically, we have discovered that patients undergo significant
breath ethane elevation at the beginning of each dialysis session. We have found an inverse
relationship between the magnitude of this effect and number of months patients have been
receiving treatment. We comment on how further refinements of our technology will allow a
more detailed evaluation of the ethane elevation effect and ultimately lead to the assessment of
potential interventions.
(Some figures in this article are in colour only in the electronic version)
1. Introduction
Over the last two decades, evidence linking oxidative stress
and dialysis has grown. A number of groups have reported
elevation in markers of oxidative stress in haemodialysis
patients compared with healthy control groups [1–4]. While
increased oxidative stress is considered to be a major factor
in morbidity and mortality in dialysis patients [5], the factors
contributing to this increase are not clear [6, 7]. Suggested
causes include the uremic state [6], vitamin C deficiency
[8], inflammatory status and duration of treatment [1]. In
particular, it has been reported that the dialysis treatment per
se may cause oxidative damage due to dialysate quality or
dialyzing membranes, possibly by the stimulation of primed
neutrophils [6, 9]. Techniques directed towards preventing
the damage from oxidative stress are under investigation, such
as the effect of antioxidants [10, 11] and bio-compatible or
vitamin E-coated membranes [12].
A number of biomarkers can be used for the measurement
of oxidative stress. Blood markers include malondialdehyde
(MDA), thiobarbituric acid reactive substances (TBARS), F2-
isoprostanes, glutathione (GSH) and oxidized low density
lipoproteins (LDL) [5, 13–15]. Breath markers of oxidative
stress such as exhaled hydrocarbons offer the advantage of
non-invasive monitoring [16]. Here, we have focused on
ethane as a well-established marker of oxidative stress [17–19].
Ethane is a product of free-radical-induced lipid peroxidation
of omega-3 fatty acids in the cell membrane [20]. It is
a particularly good marker of oxidative stress for several
reasons. Its means of generation is well understood [16] and
1752-7155/07/026005+08$30.00 1 © 2007 IOP Publishing Ltd Printed in the UK
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other potential sources (for example, from the metabolism
of bacteria in the colon) are not considered to contribute
significantly [21]. Most importantly, however, ethane appears
in the breath within seconds of the release of free radicals in
the tissue [22]. Being both poorly metabolized and poorly
soluble in the body, volatile ethane diffuses rapidly into
the bloodstream and is transported to the lungs where it
is exhaled [21]. This speed facilitates non-invasive patient
monitoring applications when an appropriately periodic and
rigorous sampling regime is used. Such monitoring has been
recognized as important for gaining insight into oxidative
damage in various clinical conditions [16, 23].
Past studies of oxidative stress using breath ethane have
often involved only a small number of ‘one-off’ measurements,
for example, before and after a treatment session. However,
this approach lacks the resolution to track rapid or short-lived
effects and this may have contributed to inconsistent results
seen in the literature [4, 24].
Methods based on gas chromatography are generally time
consuming for large numbers of samples, although improved
methods have been developed for sequential breath sampling
[25]. Optical techniques are inherently better suited to breath
monitoring applications due to the combination of sensitivity
and speed. For example, Narasimhan et al used photo-
acoustic spectroscopy to measure breath ammonia in patients
undergoing haemodialysis treatment [26]. Cavity-ring down
spectroscopy also enables rapid breath ammonia detection
[27]. Such techniques are of interest for possible monitoring
of kidney function and efficacy of dialysis.
Similarly, real-time techniques for the measurement of
ethane could open up a new window on the monitoring of
oxidative stress. Real-time ethane detection is currently only
possible using optical techniques, such as cavity leak-out
spectroscopy [28, 29] and our adopted technique of wavelength
modulation absorption spectroscopy. Another sensitive
technique is photoacoustic spectroscopy [30], although
measurement integration times are typically longer than 1s.
The aim of this study was to monitor dialysis patients’
changing ethane levels at regular intervals during single
dialysis sessions. We achieved this using an ultra-sensitive
laser absorption spectroscopy system developed within our
team [31, 32] and located a short distance from the dialysis
clinics used in the study. The system offers real-time
measurement of ethane at the trace levels present in exhaled
breath. Due to practical constraints, this pilot study involved
breath collection using sample bags which were subsequently
measured in the laboratory. While the real-time nature of our
technique was therefore not fully exploited, it did facilitate
the rapid turnaround of a large number of samples. We
plan to employ our technology directly in the ward in future
studies.
2. Materials and methods
2.1. Participants
Thirty subjects were recruited from patients presenting at
the renal dialysis clinics at Glasgow Western Infirmary and
Glasgow Gartnavel General Hospital. Patients were recruited
subject to the requirement that they were non-smokers and had
not consumed alcohol for at least 12 h prior to their arrival at the
clinic. This was to minimize the risk of known contamination
issues. Six sets of patient samples were later excluded: four
due to anaesthetic contamination, one due to unexplained
excessive background fluctuation that swamped the breath
samples and the other due to an inconsistent patient breathing
technique.
The remaining 24 patients (age 65 ± 16 yr, mean ± SD,
range 39–85 yr) comprised 19 males and 5 females. Patients
had been on dialysis for periods ranging from 4 days to 12 years
and received three four-hourly sessions (typically) per week
using Polyflux R© dialysis membranes. The distribution in this
period was highly positively skewed (median 10 months, range
0.1–141 months).
Patients receiving dialysis treatment had a wide variety
of underlying conditions including renovascular disease,
polycystic kidney disease, glomerulonephritis, obstructive
uropathy, IgA nephropathy, membranous nephropathy and
diabetic nephropathy. Five out of the twenty four patients
were diabetic.
Informed consent was obtained from all participants and
the study was approved by the Ethics committee of Universities
West of Scotland NHS Trust.
2.2. Measurement of breath ethane using laser spectroscopy
Ethane concentrations were analysed using a laser
spectroscopy system developed at Glasgow University. This
technology is recognized as state-of-the-art in the field of trace
gas detection.
The technology, photographed in figure 1 and
schematically illustrated in figure 2, is summarized below.
We perform high resolution absorption spectroscopy targeted
at ∼3.4 µm (2990.09 cm−1) using a cryogenically-cooled,
tunable, lead-salt diode laser (IR-2990-GMP-WM, Laser
Components). This absorption line is well separated from
common contaminating species in the mid-IR window such as
water and methane. The laser light is directed along two main
optical paths: the principal path contains a Herriott optical
delay line (AMAC-100, Aerodyne) with an optical path of
>150 m, through which the target gas sample is drawn by a
240 litre min−1 rotary pump (Varian, Inc.). The other path
contains a short reference cell filled with a known ethane
concentration. The laser light from each path is detected using
two thermo-electrically cooled HgZnCdTe photodetectors,
PD1 and PD2 (PVI-2TE Vigo). A helium–neon laser is used
for alignment. A second derivative modulation scheme is
used where the laser wavelength is modulated at 8 kHz and
ramped through the ethane transition at 1 Hz. The signals
are demodulated using two phase sensitive detectors, PSD1
and PSD2 (LIA-MV-200-H, Femto). The reported sample
cell concentration is based on least-squares fitting between the
demodulated signals, DEM1 and DEM2, from photodetectors
PD1 and PD2 (see figure 2). A thermally-managed closed-
loop cooling system (CryoTiger) eliminates the need for liquid
coolants, enabling long term, uninterrupted use. The system
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Figure 1. The ultra-sensitive, real-time ethane spectroscopy system
developed at the University of Glasgow. The instrument with
dimensions 1 m × 0.5 m × 1 m (L × W × H) is completely
self-contained.
Figure 2. A schematic of the optical configuration. Patterson et al [31] provides the necessary information to reproduce the technology
described in this report.
has a sensitivity of 70 parts per trillion, and data are returned at
the rate of one value every second: essentially real-time data.
All aspects of instrument control are automated by custom-
written LabVIEW software, which controls a commercial laser
controller (Profile PRO8000).
The instrument is arranged in three sections: the base
houses the compressor, used to cool the laser, and vacuum
pump, used to draw the gas into the sample cell, each with
separate thermal management. The upper section, which can
be completely separated from the base, supports the optical
table on which the laser and optics are mounted, the laser
controller and the detection electronics. Finally, there is a lid,
which can also be removed. The instrument, with dimensions
1 m × 0.5 m × 1 m (L × W × H) is thus completely self-
contained as shown in figure 1.
Our confidence in our reported data stems from a reliable
and reproducible instrument performance as previously
reported in [31]. The instrument self-calibrates every
second using the in-built ethane reference cell. In addition,
hydrocarbon-free nitrogen gas (BOC Ltd) is measured for
12 s in every minute as a zero reference. The absolute accuracy
is also regularly checked using a hydrocarbon reference
standard supplied by the National Physical Laboratory. This
standard contains ethane at 4 ppb with a tolerance of
2% certified in accordance with a ISO9001 specification
technique, and allows independent confirmation of the ethane
measurement at the typical levels measured in the study.
A key advantage of this technology is that the direct
analysis of gas samples requires no cooling or pre-
concentration. Therefore each breath sample was analysed
3
J. Breath Res. 1 (2007) 026005 C S Patterson et al
in less than 1 min. For example, the 38 samples collected for
each patient (as described below) required a total measurement
time of less than 40 min. Typically, we collected and
analysed the breath ethane of four patients in a day. The
total number of samples analysed in the study was >1000.
This technique represents a considerable improvement in
measurement efficiency and sample turnaround compared to
other methods of sub-ambient ethane detection.
Further details of the system and its performance have
been reported previously [31, 32] and further details can be
obtained from the authors. The current system incorporates a
laser with a tuning range that has enabled methane detection
and could enable ethylene detection. The technology could be
easily adapted to monitor other hydrocarbons such as propane,
butane or pentane by use of a laser with the appropriate
wavelength tuning range. Given the crucial role the laser
plays in our system, the future progress and general cost-
effectiveness of such instrumentation is strongly coupled
to new developments in quantum cascade laser and optical
parametric oscillator technology in the mid-IR range [33].
2.3. Study design
As previously outlined, the aim of the study was to monitor
the oxidative stress level of patients during a single visit to
the dialysis clinic by way of regular measurement of breath
ethane. Each patient acted as their own control. Baseline
breath ethane levels vary between individuals and therefore, in
order to validate the comparison of patient data, we measured
the extent of the change in each patient’s breath ethane level
from their respective baseline level. In other words, a common
datum was defined with respect to patient baseline breath
ethane levels by setting these to zero.
Healthy volunteers in close proximity to the patients also
provided a concurrent series of breath samples using the same
exhalation technique. This secondary control set was in order
to verify that the observed effect was solely attributable to
patient response and independent of environmental factors.
Frequent sampling throughout the whole of the treatment
session was incompatible with the overriding requirement for
good patient care. Fortunately, our early work had indicated
raised exhaled ethane levels at the beginning of the treatment
session and so the most rapid sampling was confined to this
period.
The collection protocol was set at one sample every 2 min
during an 8 min period prior to dialysis, then every 2 min for the
first 10 min of dialysis followed by every 5 min during the next
20 min. Three samples were then collected at 10 min intervals
and subsequent samples were collected at hourly intervals with
a final sample being collected at the end of the dialysis session.
The definition of the start of dialysis here is the point at which
the dialysis machine commenced the blood flow returning to
the patient, typically a few minutes after the initial attachment
and flushing of the lines with saline. Precise times of breath
collection were subject to small variations (typically ±10 s)
to avoid interference with clinical procedures or interventions.
Patient care was considered paramount throughout.
Samples were collected in 5 litre ethane-impermeable
bags (Tedlar, SKC Ltd). Patients exhaled through a disposable
Figure 3. Breath samples were collected using a simple single
breath filling technique into SKC Tedlar sample bags.
cardboard mouthpiece (Bedfont Scientific Ltd), connected to
the sample bags by a Teflon mouthpiece adaptor. The setup is
shown in figure 3.
2.3.1. Breath sampling. To standardize the protocol, a
consistent breath sampling technique was adopted. Each
breath sample was a single expiration of vital capacity.
Patients found this approach easy to reproduce as is evident
from the consistent longitudinal baseline measurements. The
initial deep inhalation ensured each exhalation was more
than minimum volume (1 litre) required for ultra-precise
ethane measurement. For each breath sample collected, a
corresponding room air sample was obtained using an oil-free
hand pump and corrected breath ethane measurements were
obtained by subtraction of these ambient ethane levels.
2.3.2. Contamination issues. Our spectroscopic window
is extremely small, covering the width of our target ethane
transition and no more. Consequently, we find contamination
issues from other commonly present gases to be effectively
eliminated. These include other VOCs and other compounds.
The use of a second derivative detection scheme reduces the
effects of a broadband absorption (e.g. water or isoprene) in the
vicinity of the ethane transition. Methane and ethylene do have
sharp absorption features neighbouring the ethane transition;
however, contamination only occurs at concentrations of these
gases much higher than levels found in ambient air and breath.
Importantly, the presence of contaminants is easily
established using our detection technique. Any contamination
causes distortion of the displayed ethane transition shape
and constant monitoring of this via a curve-fitting algorithm
provides a continuous check against such contamination.
All sampling equipment used was checked for the
production of ethane and/or contaminants and no source
of either was found. Commonly used hospital cleaning
solutions were investigated as sources of contamination.
Chlorohexadine glucanoate solution is typically used for
patients for whom access is by way of a central line. In
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Figure 4. Elevation of ethane in first 30 min of dialysis, plotted for
six patients. These values have been corrected for ambient ethane
levels.
the case of fistula access, chlorohexadine glucanoate solution
containing ethanol is used. The detection technique is
insensitive to both of these compounds. However, ethyl
chloride, often used as a local anaesthetic, was found to be
a contaminant and was therefore avoided.
In this study, samples from four patients were affected by
contamination due to ethyl chloride and were discarded. We
can verify that the observed increases in breath ethane reported
here were not due to contamination.
2.4. Data analysis
Data are presented as mean ± standard deviation or median
and range. The data were plotted to show the relationships
between the magnitude of the ethane peak and other clinical
scores, including period on dialysis, age, gender and co-
morbidity factors. The Student t-test was used and where
data were found not to conform to the parameters of a normal
distribution, significance testing was performed using a Mann–
Whitney test for non-parametric data. Statistical significance
was accepted at P < 0.05.
3. Results
Patient breath ethane measurements were corrected for the
ambient air ethane by subtracting corresponding values and
plotted against time. This standard technique [16, 34] takes
account of modest variations in ambient ethane levels. A key
advantage of our technology is that it enables the resolution
of even relatively small changes in breath ethane above higher
ambient levels. Other techniques include the breathing of
purified air [18], a technique we considered unsuitable for
this trial due to practical constraints. Significant short-
lived increases in breath ethane were observed in 14 out of
24 patients within the first few minutes of the dialysis session.
For clarity, since these peaks are largely coincident, a subset
of six representative examples of the 24 are illustrated in
figure 4. The effect was not observed in the healthy volunteers
who acted as the secondary control group (see figure 5) and
no further elevated breath ethane levels were observed at any
time after the initial 30 min of the treatment session.
Figure 5. Comparison of room ethane, breath samples taken from a
control subject and breath samples taken from a dialysis patient.
This robustly demonstrates that the ethane elevation effect is
confined to the patient.
Breath ethane levels prior to dialysis treatment (patient
baseline levels) are seen to vary between individuals (median
0.6 ppb, range 0–12 ppb). This is seen in the positioning
of the (background-corrected) traces along the y-axis in
figure 4.
Ethane is a ubiquitous marker of oxidative stress and
therefore a large number of factors will contribute to baseline
ethane levels. In order to assess the contribution from the
dialysis treatment per se the datasets were normalized by
setting a common zero baseline ethane level. The peak level
of ethane (PE) was defined as follows:
PE = Emax − E0, (1)
where Emax is the maximum background-corrected breath
ethane concentration measured within approximately 5 min
of start of dialysis and E0 is the mean background-corrected
breath ethane concentration measured prior to the start of
dialysis.
The peak ethane measurements presented therefore
correspond to the net change in breath ethane concentration.
Peak ethane values for each of the 24 patients along with
corresponding patient clinical data is shown in figure 6.
The distribution in peak levels of ethane generated by
equation (1) was also highly positively skewed; median =
0.7 ppb, and range 0.1–14.9 ppb. The distribution in the
Peak levels was not found to correlate with age. However,
the distribution was found to be significantly different in the
two patient groups that used either a fistula or a central line
for access. (Mann–Whitney test significant at 0.0069). For
patients with a fistula access (n = 19) the median Peak level
of ethane = 0.5 ppb, range 0.1–14.9 ppb. For patients with a
central line (n = 5) the median peak level of ethane = 6.3 ppb;
range 2.9–7.5 ppb. However, this is likely to be misleading
since patients new to dialysis treatment tend not to have had
a fistula provided yet. Period on dialysis and fistula use are
therefore not independent and the ethane peak levels were
found to be strongly dependent on the former.
A significant correlation was found between peak level
of ethane and period on dialysis (PoD) (see figure 7(a)).
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Figure 6. Clinical data and corresponding measured peak ethane
values for the 24 recruited patients in the study.
(a)
(b)
Figure 7. (a) Peak ethane dependence on period on dialysis.
(b) The same data transformed to a natural log–log scatterplot.
Both variables demonstrated lognormal distributions and a
natural log–log plot (figure 7(b)) yielded a linear relationship
(R2 = 0.43). The equation of the fitted line is
ln(PE)alldata = −0.5(lnPoD) + 1.2. (2)
Modified Charleson co-morbidity scores (CCS) were
calculated for all patients (median 5, range 2–11). No
significant correlation was found between peak level of ethane
and age, gender or co-morbidity. Although peak ethane
appeared to be higher in diabetic patients (median 4.7 ppb,
range 2.9–7.5 ppb) than non-diabetic patients (median 0.5 ppb,
range 0.1–14.9 ppb), it was shown that diabetic status was not
independent of fistula use and period on dialysis. This is
discussed further in [36].
4. Discussion
We have monitored changes in oxidative stress during dialysis
treatment using exhaled ethane as a biomarker. As shown
in figures 4 and 5 we observed a single, short-lived ethane
peak on commencement of dialysis, suggesting that there is a
significant increase in oxidative stress at this time.
The absence of this effect in both of the concurrent
sample sets of ambient air and exhaled breath from the healthy
volunteers (see figure 5) confirms that the effect is solely
attributable to patient response. The control trace essentially
mirrors the relatively flat background air trace. It should
be pointed out of course that the healthy volunteers did not
receive dialysis treatment. This set of controls should not be
confused with the primary control group. In this longitudinal
study, the patients acted as their own control in the strictest
sense. Each patient provided a series of samples that were
referenced to the their own baseline breath ethane level, that
is, the level measured immediately before the start of their
treatment session.
The peaks in breath ethane are unlikely to be due to a
reservoir of ethane stored in tissue since ethane is highly
volatile and poorly metabolized, rapidly diffusing into the
blood stream upon production [22]. Possible errors due to
inconsistent breath sampling were reduced using the breath
sampling protocol described in section 2.3.1. The consistency
of the observed ethane elevation effect (observed in 14 out
of the 24 patients) with ethane concentrations significantly
higher than the breath to breath fluctuations found even in
healthy controls suggests that the effect could not be solely
attributable to patient breathing dynamics.
It is recognized that a large number of factors affect the
overall oxidative stress status of dialysis patients, such as age,
lifestyle and underlying condition. For example, a higher level
of oxidative stress has been reported in diabetic haemodialysis
patients [3]. While we recognize these factors, this pilot
study focused specifically on the detection of rapid changes
in oxidative stress associated with the dialysis treatment per
se. Normalizing peak ethane levels to the patients’ baseline
ethane levels enabled us to look at this short-term effect
across a limited number of patients with a broad range of
underlying conditions. Ethane is a ubiquitous marker of
oxidative stress and baseline ethane levels are known to vary
considerably even between healthy control patients [35] and
can even vary significantly in a healthy individual from day
to day. For this reason it is difficult to extract relevant
information from a single measurement of baseline ethane
from individual patients in a study with small patient numbers.
No significant relationship was found between baseline ethane
level and pathology in this pilot study. However, trends may
become apparent in a larger scale study (see below). A paper
is in preparation by our clinical collaborators in which the
potential biological and clinically relevant factors affecting
breath ethane production are further explored [36].
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The relatively low level of noise in the expired ethane
traces indicate that the consistent breath sampling protocol
worked well and that possible variation in patient respiratory
rate, expired volume and background ethane had a minimal
effect.
It is important to note that the peak ethane measured
for each patient is a conservative estimate of the true
maximum. This is due to the finite sampling intervals and the
consequential limited resolution with respect to the changing
breath ethane concentration. This may explain the spread in
the data shown in figure 7 and the relatively low value of R2
in figure 7(b). More frequent sampling could help reduce this
spread. However, in practice, acquiring breath samples from
a patient more regularly than at 2 min intervals is difficult
without disrupting clinical care.
Clearly the speed of the ethane response highlights the
need for regular, continual sampling for the detection of such
transient events. For example, had patient breath sampling
been limited to pre- and post-dialysis, the effect would have
been missed completely and the false conclusion drawn that
ethane levels (and oxidative stress) are unchanged during
dialysis treatment. This could explain the conflicting results
from a number of previous studies of lipid peroxidation in
dialysis patients [4, 24]. Our results are consistent with the
findings of Ward et al [9, 37] that neutrophil priming, as a
consequence of interaction with dialysis membranes, results
in a respiratory burst that can lead to lipid peroxidation.
Kuwahara et al also noted this neutrophil activation [38].
Figure 7(a) suggests that haemodialysis patients do
become conditioned to their treatment regime relatively
quickly, since peak ethane levels decrease exponentially with
period on dialysis. This is in keeping with findings of Sezer
et al that oxidative stress was negatively correlated with
dialysis duration [39].
Since the observed ethane fluctuations are transient,
suggesting only short-term periods of oxidative stress, it is
unknown if there are any significant long-term consequences
of this oxidative damage. It will be important to establish
if the repetition of such events have an effect on morbidity
or mortality outcomes. If so, it may be that the use
of an appropriate intervention could reduce the oxidative
stress response in patients new to dialysis treatment.
Recent approaches include haemolipodialysis, infusion of
antioxidants by dialysate and the use of vitamin E bonded
membranes [7, 12, 40]. Breath ethane is a specific marker
of lipid peroxidation, which antioxidants such as vitamin E
can reduce. Therefore, breath ethane monitoring could offer
useful assessment of oxidative stress during haemodialysis
and the effect of vitamin E-bonded membranes. For example,
previous studies in other areas have shown that the production
of breath ethane arising from reperfusion injury during organ
transplantation [18] or during cardio pulmonary bypass [41]
could be reduced using radical scavenging species. A review
by Abuja and Albertini [23] suggests that the increasing use
of antioxidants in medicine will lead to the requirement for
monitoring of oxidative stress in a laboratory or hospital in the
future.
Future studies with a much greater patient number and a
more uniform sample will be necessary in order to determine
the potential clinical benefit of such monitoring during
dialysis. In this pilot study, practical constraints prevented
the recruitment of the ideal patient group, resulting in highly
skewed patient statistics (see section 2.1), which may have
contributed to the R2 value in figure 7. Increased patient
numbers will also enable better understanding of the variability
in baseline levels of ethane among the patients and the possible
relationship with pathology and other factors.
In this study, we have exploited the real-time nature of our
technology to enable the rapid turnaround of large numbers of
discrete breath samples. However, our real-time technology
has recently been developed into a ward-portable form for on-
site use [31]. This will allow us to further resolve changes in
breath ethane. We now have the ability to embark on future
studies where continuous ethane monitoring can be supported.
This is likely to offer greater insight into the ethane elevation
effect and the factors contributing to oxidative stress during
dialysis.
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